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CHAPTER I 
General Introduction 
General introduction 
The use of molecular markers in the study of biological processes, and in 
particular in the study of neoplasms, is increasing at a steady pace. This 
increase is stimulated by the insight that the results may be translated into 
clinical practice, including surgical pathology. 
The markers are detectable by antibodies and nucleotide probes. Antibodies 
recognizing differentiation related molecules are a group of particular interest. 
Amongst the differentiation markers, intermediate filament proteins (IFPs) hold 
an important position, based on the fact that they were claimed to exhibit a cell 
lineage-specific expression pattern 1 4 . Although many reports by now have 
shown that the expression of certain IFPs may be lost during malignant transfor­
mation, or that aberrant or ectopic expression can occur, the use of IFPs as 
differentiation markers still deserves much attention in tumor biology and 
diagnostic pathology (see reviews t 8 ) . 
IFPs are major components of the mammalian cytoskeleton. They have an 
average diameter of approximately 10 nm, a size between that of microfi­
laments (6 nm) and microtubules (25 nm). They have been tentatively assigned 
a specific role in the maintenance of cell shape, in intracellular trafficking of 
cytoplasmic organelles, and in the constitution of certain intercellular junctional 
complexes '" n. 
Six types of IFPs (types I to VI, see Table I) are now distinguished, based on 
amino acid sequence homology and patterns of tissue distribution e·12·13. The 
largest group of IFPs is formed by the cytokeratin (CK) family, which is mainly 
found in epithelia. CKs consist of type I (small, acidic; including CK9-CK20) and 
type II (large, neutral to basic; including CK1-CK8) subtypes 1 4 1 &. Type III IFPs 
comprise the mesenchymal protein vimentin, the protein desmin specific for 
muscle tissue, glial fibrillary acidic protein expressed in glial cells and astrocytes 
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 and peripherin, specific for neuronal cells 17. Type IV IFPs represent the 
neurofilament protein triplet expressed in nerve cells 18, type V the nuclear A 
and B-type lamin proteins which constitute the nuclear lamina 1β"2' and the type 
VIIFP compises nestin, associated with CNS stem cells " . 
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Table I. Types of intermediate filament proteins and their tissue type specificity 
TYPE of TYPES of 
INTERMEDIATE FILAMENT PROTEINS TISSUE or CELLS 
I CYTOKERATINS numbers 9-20 EPITHELIUM 
II CYTOKERATINS numbers 1-8 EPITHELIUM 
III VIMENTIN MESENCHYMAL TISSUE 
DESMIN MUSCLE TISSUE 
GLIAL FIBRILLARY ACIDIC PROTEIN ASTROCYTES 
PERIPHERIN NEURONAL CELLS 
IV NEUROFILAMENTS NERVE CELLS 
V LAMINS NUCLEAR LAMINA of 
ALL CELLS 
VI NESTIN CNS' STEM CELLS 
* central nervous system 
The initial studies in the IFP field were performed by biochemical analysis (i.e. 
gel electrophoresis) of cultured cells and tissues. However, this technique is 
quite laborous and does not allow direct morphological correlation to the object 
under study. Therefore, immunohistological procedures have been used increa­
singly after the development of monoclonal antibodies (mAbs), specifically reac­
ting with individual CKs 1Э. These techniques have improved the sensitivity of 
the studies, allowing more detailed information. At present, the applicability of 
most mAbs on frozen tissue sections only poses an important limitation for a 
wide use in surgical pathology. This is caused by the routine tissue processing 
techniques that change the antigenic sites of the proteins, resulting in loss of 
many antigenic epitopes 7 " . Recently, however, epitope retrieval techniques 
seem to be very promising in this respect. 
CKs form obligatory pairs, resulting in heteropolymers of type I and type II IFPs, 
and combinations of at least two CKs occur in a differentiation related pattern in 
the diverse epithelia according to certain rules 1 3 · 2 \ Initially these CK combinati­
ons appeared to be fully retained in the corresponding carcinomas as a sort of 
"fingerprint" 1 4 · 2 6 - 2 7 . These diverse CK combination were therefore thought to be 
useful in tracing the site of origin of a carcinoma, in determining the exact 
cellular origin of carcinoma types, or more generally in detecting the direction of 
differentiation. After more CK-subtype antibodies have become available, rather 
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complicated patterns and exceptions to the fingerprint concept emerge, such as 
loss of the originally CKs. Also, re-expression of CKs normally only present 
during embryogenesis have been observed 2 8 3 ° . Although these aberrant 
expression patterns may complicate the identification of the precise type of 
cellular differentiation, they may shed new light on the abnormal organization of 
the cytoskeleton in tumors. We therefore wondered if the process of tumor pro-
gression would be associated with particular changes in CK expression. 
The process of tumor progression in epithelial cancer can morphologically be 
followed by a spectrum of preneoplastic changes, ranging from hyperplasia, to 
dysplasia, and subsequently to invasive cancer with the potential for metastatic 
spread. Several cancers seem to follow this sequence of events, e.g. squamous 
cell carcinoma of the uterine cervix and colonic adenocarcinoma. Transitional 
cell carcinoma of the urinary tract is also representative in this respect. Transiti-
onal cell carcinoma forms a spectrum, from noninvasive tumors with low cellular 
anaplasia and favourable prognosis at one end, and highly anaplastic, deeply 
invasive carcinomas with a poor prognosis at the other end 313B. 
The underlying studies are an extension on the observation describing that the 
expression of CK18 increased during malignant progression of bladder carcino-
ma 39. The study was limited to CK 18, as it dealt with one of the first m Abs to 
recognize an individual CK. This observation was important because it might 
result in additional prognostic parameters applicable to patients with a transiti-
onal cell carcinoma of the urinary tract. 
Subsequently, the number of monospecific anti-CK mAbs has increased and 
allowed a more extensive study of a possible role of other CKs in the progressi-
on of transitional cell carcinoma. Based on our interest for urological pathology 
in particular and tumor progression in general, and the availability of the specific 
reagents, we decided to embark on a CK immunophenotyping study of the 
normal and neoplastic transitional epithelium of the urinary tract. 
In this thesis we have adressed the following specific questions: 
1. Does the CK expression pattern of normal urothelium differ from that in 
transitional cell carcinoma? 
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2. Can heterogeneity of the CK expression patterns in the various grades 
and stages of transitional cell carcinoma be found? If so, what are 
possible explanations? 
3. Can aberrant CK expression or loss of expression be detected during 
progression of transitional cell carcinoma. If so, are there any physiologi­
cal or clinical implications? 
4. Can the observations on CK expression in transitional cell carcinoma be 
adopted to other types of carcinoma? 
5. What is the clinical relevance of CK subtyping in tumor lesions? 
We approached these questions in a series of studies on human normal tissues 
and tumor lesions, mainly employing immunohistochemical techniques. Special 
attention was given to the correlation of the staining patterns with the patho-
morphological findings, such as grade of differentiation and level of invasion of 
the tumors. 
Normal urothelium was studied first (Chapter 2) to obtain a basis for the 
comparison with transitional cell carcinoma (Chapter 3). As it appeared that 
certain CKs were aberrantly expressed in the invasive component of these 
neoplasms, we extended the study to autologous metastases in Chapter 4. The 
extent of the aberrant expression was further explored in another type of 
carcinoma, i.e. squamous cell carcinoma (Chapter 5). Finally, we reviewed the 
literature on the clinical relevance of CK subtyping with emphasis on its use in 
surgical pathology (Chapter 6). 
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CHAPTER II 
Distribution of cytokeratin polypeptides in epithelia 
of the adult human urinary tract 
H.E.Schaafsma1, F.C.S.Ramaekers1, 
G.N.P. van Muijen1, E.C.M.Ooms2, D.J.Ruiter1 
1 ) Department of Pathology, University Hospital Nijmegen, The Netherlands 
2) Department of Pathology, Westeinde Hospital, The Hague, The Netherlands 
Published in: Histochemistry (1989) 91:151-159 
SUMMARY 
Cytokeratin expression was studied in the epithelia lining the normal human 
urine conduction system using immunohistochemistry on frozen sections 
employing a panel of 14 monoclonal antibodies. Eleven of these anti-cytokeratin 
antibodies reacted specifically with one of the 19 human cytokeratin polypepti-
des. Profound differences were found in the cytokeratin expression patterns 
between the different types of epithelium in the male and female urinary tract. 
In the areas showing morphological transitions of transitional epithelium to 
columnar epithelium and of nonkeratinizing squamous epithelium to keratinizing 
squamous epithelium gradual shifts of cytokeratin expression patterns were 
observed, often anticipating the morphological changes. However, also within 
one type of epithelium, i.e. the transitional epithelium, two different patterns of 
cytokeratin expression were found. Expression of cytokeratin 7 was homogene-
ous in the transitional epithelium of renal pelvis and ureter but heterogeneous in 
the transitional epithelium of the bladder. Furthermore, intraepithelial differences 
in cytokeratin expression could be shown to be differentiation related. Using a 
panel of chain-specific monoclonal antibodies to cytokeratins 8 and 18 confor-
mational and/or biochemical changes in the organization of these intermediate 
filaments were demonstrated upon differentiation in columnar and transitional 
epithelium. 
INTRODUCTION 
Normal human epithelial cells and their tumors contain cytokeratins (CKs) as 
their intermediate filament constituents. It has been shown that CKs consist of 
a family of 19 diferent polypeptides (Moll et al. 1982) while subsets of 2 to 10 
of these CK polypeptides are expressed in the different epithelia depending on 
their type of differentiation (Tseng et al. 1982; Quinlan et al. 1985). For many 
of these tissues data concerning CK distribution are available, as based on (two-
dimensional) gel electrophoretic analyses of total epithelium or of isolated areas, 
as well as cell cultures (Moll et al. 1982; Moll et al. 1983a; Moll et al. 1983b; 
20 
Achtstätter et al. 1985; Rheinwald et al. 1985). Monoclonal anti-CK antibodies, 
and especially chain-specific antibodies recognizing only one CK polypeptide, 
enable the study of expression of this type of intermediate filament proteins in 
more detail, even at the single cell level, using immunohistochemical methods 
(Ramaekers et al. 1987a; Cooper et al. 1985). 
Achtstätter et al. (1985) reported the presence of 11 different CK polypeptides 
in the different epithelia of the male urinary tract using two-dimensional gel 
electrophoresis. Differences in CK patterns were related to known morphological 
differences in the different areas studied. 
In the current study normal adult human male and female epithelia, lining the 
urine conducting system were examined immunohistochemically using a large 
panel of monoclonal anti-intermediate filament antibodies. As a result, we were 
able to identify and localize separately 7 of 11 CKs reported by Achtstätter et 
al. (1985) in these tissues. The advantages of this approach over gel electrop-
horetic analysis of tissues became clear by our observation that certain cytoke-
ratins may be distributed heterogeneously throughout morphologically homoge-
neous epithelial layers. 
MATERIALS AND METHODS 
Tissues. The tissue specimens used in this study were obtained from the human 
urinary tract at autopsy, which was performed within 5.5 h after death. Tissues 
from six males and three females were snapfrozen and stored in liquid nitrogen. 
The age of the patients ranged from 61 to 85 years with an average of 74 
years. In each case tissue samples were taken from at least 11 different sites, 
which included renal calyx, renal pelvis, ureteropelvic junction, ureter, bladder 
(dome, lateral wall, trigone), urethra (proximal, middle, distal) and external 
urethral orifice (see Fig. 1). Transitional epithelium of one male and urethral 
epithelium of two males appeared to be unsuitable for examination because of 
severe mechanical or autolytic damage. Of all nine cases at least six samples 
per site were examined. Examination of the tissues in H&E stained sections 
revealed no significant abnormalities. 
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Figure 1. Schematic representation of the urinary tract showing the sites from 
where the tissue samples were obtained. 1 renal calyx (in one sample also 
containing a renal papilla); 2 renal pelvis; 3 ureteropelvic junction; 4 ureter; 5 
near ureterovesical junction; 6 bladder dome; 7 lateral bladder wall; 8 trigone; 9 
proximal urethra; 10 mid urethra; 11 distal urethra and urethral orifice, in male 
containing distal urethra, fossa naviculars and glans penis. 
The main type of epithelium in 1-9 is transitional epithelium, while the main type 
of epithelium in 10-11 in female is nonkeratinizing squamous epithelium. In male 
these are (pseudo)stratified columnar epithelium in the urethra, nonkeratinizing 
squamous epithelium in the fossa navicularis and keratinizing squamous epitheli-
um in the glans penis 
Antibodies. Fourteen monoclonal anti-CK antibodies, two monoclonal anti-
vimentin antibodies and one anti-desmin antibody were used in this study. 
The specificity of these different antibodies has been summarized in Table 1, 
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and has been described previously (for references see Table 1). Recent investi-
gations have indicated that M20 antibody does not recognize CK18 but reacts 
exclusively with CK8, which may show breakdown products in the CK18 region 
(van Muijen et al. 1987a). Figure 2 shows the immunoblotting results of the 
M20 antibody on some carcinoma cell lines (T24, RT4 and A431), expressing 
amongst others CK8. The results in lanes 1, 3 and 5 demonstrate that this 
antibody reacts with a protein band at 52kDa, corresponding to CK8. However, 
in the RT4 cell line preparation also some faint protein bands, representing CK8 
breakdown products are seen (lane 3). The position of the 52kDa protein band 
is further confirmed by subsequent incubations with the other monoclonal CK 
antibodies recognizing CK7 and CK18 (lanes 2, 4 and 6). Immunoblotting was 
performed as described before (Broers et al. 1986). 
Table 1. Specificity of monoclonal intermediate antibodies used 
in this study 
Antibody 
clone 80 
RCK102 
RCK103 
6B10 
RCK105 
LE41 
M20 
RKSE60 
1C7 
RGE53 
2C8 
RCK106 
CK18-2 
LP2K 
V9 
RV202 
D33 
Protein(s) 
recognized 
most CKs 
CKs 5 + 8 
• 
CK 4 
CK 7 
CK 8 
CK 8 
CK 10 
CK 13 
CK 18 
CK 18 
CK 18 
CK 18 
CK 19 
vimentin 
vimentin 
desmin 
Reference 
van Muijen et al. 1984 
Broers et al. 1986 
Ramaekers et al. 1987a 
van Muijen et al. 1986 
Ramaekers et al. 1987a 
Lane, 1982 
van Muijen et al. 1987a 
Ramaekers et al. 1983; 1987b 
van Muijen et al. 1986 
Ramaekers et al. 1983 
unpublished 
Ramaekers et al. 1987a 
Broers et al. 1986 
Lane et al. 1985; 
Broers et al. 1986 
van Muijen et al. 1987a 
Ramaekers et al. 1987a 
van Muijen et al. 1987a 
* Not yet fully characterized 
Abbreviation: CK = cytokeratin 
Immunohistochemistry. The indirect immunoperoxidase staining procedure was 
performed on frozen sections as described previously (van Muijen et al. 1986). 
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Staining patterns were designated as homogeneously positive when all cells in a 
particular cell layer were positive, or heterogeneously positive when both 
negative and positive cells were observed in the same cell layer(s). 
I 
CK7 
>CK8 
-CK18 
Figure 2. Immunoblotting study on cytoskeletal preparations from the two 
bladder carcinoma cell lines T24 (lanes 1 and 2) and RT24 (lanes 3 and 4), and 
the cell line A431 , derived from an epidermoid carcinoma of the vulva (lanes 5 
and 6). The nitrocellulose strips were incubated with the antibody M20 (lanes 1, 
3 and 5) and subsequently with the antibodies RCK105, staining the CK7 
protein band, and RCK106, staining the CK18 band (lanes 2, 4 and 6) 
RESULTS 
In Fig. 3 the CK phenotype of the epithelial lining of the urinary tract at different 
sites, as recognized by the monoclonal anti-cytokeratin antibodies, is summari-
zed per type of epithelium. All epithelial cells were stained by the antibodies 
clone 80 and RCK103 (not included in Fig. 3). RCK102 stained all epithelial cells 
with the exception of certain cell layers in squamous epithelium (see below). 
The staining patterns of the other anti-CK antibodies varied and will be descri-
bed in detail. Vimentin positive epithelial cells were not observed. Throughout 
the different epithelia scattered vimentin positive cells were seen, most probably 
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representing Langerhans or inflammatory cells. Desmin positivity was only 
observed in muscle cells (results not shown). 
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Figure 3A-H. Schematic representation of the cytokeratin distribution patterns 
as detected by the different monoclonal antibodies. Filled bars indicate a 
positive reaction, open bars indicate a negative reaction, while a little square 
indicates that only a few ells are positive. A partly filled bar means that only 
part of the cells in the respective layers is positive: a vertically divided bar 
means that both positive and negative areas were seen, an obliquely divided bar 
means that the expression pattern differs in the the individual layers and a 
stippled bar means that a weakly positive reaction was observed. 
Abbreviations: CK=cytokeratin(s); S = superficial (cell) layer; I = intermediate cell 
layers; В = basal cell layer 
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Renal calyx up to trigone 
In one of the specimens of the renal calyx we observed the presence of pseu-
dostratified columnar epithelium lining a renal papilla (Fig. ЗА), adjacent to the 
transitional epithelium of the calyx. All cell layers of this columnar epithelium 
were positive for RCK105 (CK7), M20 (CK8), LP2K (CK19) and only two of the 
CK18 antibodies, i.e. RCK106 and CK18-2. A few basal cells were positive for 
6B10 (CK4; Fig. 4A, upper part) and to an even lesser degree with 1C7 (CK13; 
Fig. 4B, upper part) and 2C8 and RGE53 (CK18; Fig. 4C, upper part). No 
reactivity was observed for LE41 (CK8). 
In transitional epithelium (Fig. 3B and D) all cell layers were positive for M20 
(CK8, Fig. 4D), RCK106 and CK18-2 (CK18) and LP2K (CK19). The other two 
CK18 monoclonal antibodies (RGE53 and 2C8) stained only umbrella cells (Fig. 
4E) with cell extensions reaching down between intermediate cell layers or 
staining sporadically intermediate cells lying directly beneath the umbrella cells. 
All umbrella cells were also positive for LE41 (CK8; Fig. 4F), although cell 
extensions were not found to be stained. Only sporadically umbrella cells were 
positive for 6B10 (CK4; Fig.4G), while almost all baal and intermediate cells 
were heterogeneously positive for 1C7 (CK13; Fig. 4H), especially the lowerin-
termediate cells. Only sporadically all layers except the umbrella cells were 
stained with this antibody (Fig. 4I). Up to the bladder all epithelial layers of the 
transitional epithelium were positive for RCK105 (CK7), but in the bladder areas 
of varying size were negative and alternated with CK7 positive areas (Fig. 4J). 
Trigone 
In the trigone the major part of the transitional epithelium reacted similar to 
bladder transitional epithelium. In the distal part of the trigone (Fig. 3G), i.e. the 
bladder neck, transitions were observed in the staining patterns of antibodies 
6B10 (CK4), 1C7 (CK13) and LE41 (CK8). CK4, which detected only sporadi­
cally in umbrella cells of the tissues described above, was now found in an 
increasing number of cells in this umbrella cell layer (Fig. 5A). More distally in 
the trigone also the intermediate and basal cell layers became increasingly 
26 
positive, although they were stained weaker than the umbrella cell layer (Fig. 
5B). In the area were the umbrella cells became positive for 6B10 (CK4), most 
cells, in all layers of the transitional epithelium, became positive for 1C7 (CK13; 
Figs. 5C and D). On the contrary, the expression of CK8 in the umbrella cells, 
as monitored by LE41, diminished. 
Figure 4A-J. Immunoperoxidase staining patterns of frozen sections from: renal 
papilla and renal calyx for 6B10 (A), 1C7 (B) and RGE53 (C), showing pseudos-
tratified columnar epithelium (C - basal cell layer) lining the renal papilla in the 
upper part and the transitional epithelium (T - basal layer) of the renal calyx in 
the lower part of A-C (L marks the collapsed lumen); transitional epithelium of 
the bladder for M20 (D), RGE53 (E), LE41 (F), 1C7 (H and I) and RCK105 (J); 
transitional epithelium of the ureter for 6B10 (G). Α-D x280, Ε-I x200, J x80 
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Urethra 
(Pseudo)stratified columnar urethral epithelium (Fig. 3F) was homogeneously 
positive for CK4 (Fig. 5E), CK7, CK8 (M20) and CK13. Positive staining with 
anti-CK18 antibodies was only observed with CK18-2 and RCK106, with a 
strong signal in the superficial cells and a variable to negative staining reaction 
in the other epithelial cell layers. Cells in the basal layers were found to be more 
intensely stained by RCK106 (Fig. 5F), than for CK18-2. 
The female external urethral orifice was lined by nonkeratinizing squamous 
epithelium with CK distribution similar to those observed in an area of nonkerati­
nizing squamous epithelium in one sample of a female trigone (Fig. 3C). Such 
squamous epithelium showed an abrupt change in the CK expression pattern as 
compared to the columnar or transitional epithelium. CKs7, 8 (Fig. 5G), 10 and 
18 (Figs. 5H and I) could not be detected in this type of squamous epithelium, 
while CK4 (Fig. 5J) and CK 13 (not shown) were present in all except the basal 
cell layer. In a minority of these squamous areas LP2K (CK19) reacted homoge­
neously positive (Fig. 5K). In most squamous areas this antibody showed a 
homogeneously positive reaction only in basal cell layers, while its reactivity 
was heterogeneous in the higher cell layers (Fig. 5L). RCK 102 showed a 
distinct reaction in basal and lower suprabasal cell layers, while the other layers 
were predominantly negative (Fig. 5M). RCK103 showed a strong staining 
reaction in the basal cells, with a slightly less extense staining reaction in the 
other cell layers (Fig. 5N). Reactivity for (CK10) was found only once in a few 
suprabasal cells (Fig. 50). 
Figure 5A-0. Immunoperoxidase staining patterns of frozen sections from: 
transitional epithelium in distal trigone for 6B10 (A and В); В is further distally 
than A and for 1C7 (C and D); urethral columnar epithelium for 6B10 (E) and 
RCK106 (F); adjacent areas of nonkeratinizing squamous epithelium (at the left 
side of the figures) for M20 (G), RGE53 (H), RCK106 (I), LP2K (K), RCK102 (M) 
and RCK103 (N); nonkeratinizing squamous urethral epithelium for 6B10 (J), 
LP2K (L) and RKSE60 (0). Note both homogeneous (K) and heterogenous (L) 
reactions for LP2K in this latter type of epithelium. A, C, G, Η, Ι, Κ, Μ, N x80; J 
and L хЮО; О x150; В and D x200; E and F x280 
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Fossa navicularis and glans penis 
Between urethral columnar epithelium and the nonkeratinizing squamous 
epithelium lining the fossa navicularis (Fig. 3E) an abrupt change in CK expressi-
on pattern was observed. Proximally in the fossa CK19 was extensively but 
heterogeneously expressed (Fig. 6B). Up to the external urethral orifice reactivi-
ty for CK19 decreased considerably (Fig. 6C). Cells in the intermediate layers 
were heterogeneously positive for RKSE60 (CK10) with an increasing number of 
RKSE60 posotive cells in the distal portion of the fossa (Figs. 6D-E). The 
positive reaction for RCK102 seen in the fossa decreased rather abruptly in the 
upper cell layers when going from the proximal to the distal part (Fig. 6A). The 
expression pattern of the other CKs was similar to that seen in nonkeratinizing 
epithelia in the urethra as described above. However, with respect to the CK4 
expression pattern it should be noted that in most cases 6B10 staining deminis-
hed before the transition into keratinizing squamous glanular epithelium became 
morphologically evident. Initially only basal cells were unstained, while subse-
quently also the intermediate cell layers and finally the superficial layer became 
negative (Figs. 6F and G). CK13 expression showed in most cases an abrupt 
change (Fig. 6H). The keratinizing glanular epithelium (Fig. 3H) expressed CK10 
in all excepted the basal cell layer (Fig. 6I). CK4 was found to be focally 
distributed in the stratum corneum (Fig. 6J). RCK102 showed a positive 
reaction in the basal and lower suprabasal cells (Fig. 6K), while CK13 was 
found occasionally in only a few cells (Fig. 6L). 
Figure 6A-L. Immunoperoxidase staining patterns of frozen sections from: 
nonkeratininzing squamous epithelium at proximal fossa navicularis (left a part 
of the urethra) for RCK102 (A) and LP2K (B); distal fossa navicularis for LP2K 
(C) and RKSE60 (D), the transition between fossa navicularis and glans penis 
lined by keratinizing squamous epithelium (right side) for RKSE60 (E), 6B10 (F 
and G) and 1C7 (H); the glans penis for RKSE60 (I), 6B10 (J), RCK102 (K) and 
1C7 (L). A -Lx80 
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DISCUSSION 
The distribution of cytokeratin (CK) polypeptides was studied immunohistoche 
mically in the epithelial lining of the normal adult human urinary tract, using a 
panel of monoclonal antibodies. This technique allows light microscopic interpre-
tation at the single cell level. 
The panel of monoclonal antibodies recognized separately seven of the 11 CKs 
reported by Achtstätter et al. (1985) to occur in the male urinary tract epithelia. 
A limitation of the immunohistochemical approach is that the antigenic epitope 
recognized by a certain monoclonal antibody can vary in protein structure as 
aresult of of biological activity and malignant transformation. This may result in 
an alteration of the detectability or accessibility of the comopnent under 
investigation, i.e. the antigenic epitope is masked or unmasked. This phenome-
non is well illustrated by the fact that four different CK18 antibodies showed 
two completely different expression patterns in the urinary tract epithelia. 
RGE53 and 2C8 mainly stained the superficial umbrella cells, while all cell layers 
were positive with RCK106 and CK18-2 (compare Ramaekers et al. 1985; 
Nadakavukaren et al. 1984; Achtstätter et al. 1985; Feitz et al. 1986). Also in 
the (pseudo)stratified columnar epithelium of the urethra and the renal papilla 
these two subgroups of CK18 antibodies could be distinguished on basis of 
their reaction patterns. A similar observation was made for the anti-CK8 
antibodies LE41 and M20. These results may possibly be explained by a 
phenomenon recently described by Franke and coworkers (1987), who showed 
that a CK18 dependent antibody Ks18.18 interacted only with its antigen when 
this was present in heterotopic coiled-coil complexes, notably with CK8. It can 
also not be excluded that (de)phosphorylation may play a role in the phenome-
non (Sternberger et al. 1983). 
Apparently the epitopes recognized in CK18 by RGE53 and 2C8, but also by the 
monoclonal antibody CK1, described by Achtstätter et al. (1985), and in CK8 
by LE41, are structuraly or biochemically different in the basal and intermediate 
cell layers as compared to the umbrella cell layer. 
In transitional epithelium other CKs studied showed differences in expression 
depending on the site. This indicates that differences in CK distribution between 
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morphologically identical transitional epithelium. It was striking to note that CK7 
was found heterogeneously distributed in the epithelium of the bladder, inclu-
ding the trigone, whereas it was homogeneously expressed in the renal pelvis 
and ureter. This observation may be the results of epitope masking sa described 
above for CKs8 and 18. It remains to be examined wether or not these differen-
ces in CK7 structure or content are related to functional differences between 
the bladder on one hand and the higher urinary tract on the other hand. Epithelia 
of other hollow organs with a reservoir function, such as the digestive tract, 
seem to lack CK7 completely, while ductal structures (for example bile ducts) 
frequently show the presence of CK7 (Osborn et al. 1986; Ramaekers et al. 
1987a). 
CK4 expression in transitional epithelium was most pronounced in the distal 
trigone and was sporadically found in the more proximal transitional epithelium. 
Gel-electrophoretic data published by Moll et al. (1982) and Achtstätter et al. 
(1985) showed that CK4 was found occasionally only at low levels in transitio-
nal epithelium. In the same distal trigonal area all cell layers including umbrella 
cells were CK13 positive, while more proximally only basal and intermediate 
cells were stained heterogenously. Also in this area CK8 expression in umbrella 
cells, as detected by LE41, diminished. We considered that here the CK expres-
sion in transitional epithelium partially anticipates the morphological transition 
into the columnar urethral epithelium. Our observations for CK4 and CK13 
differed from those reported previously (van Muijen et al. 1986) in that these 
authers found CK4 and CK13 in suprabasal cells. Most probably squamous 
metaplasia has been studied for this study. Our observations of CK13 expressi-
on are partly in accordance with those of Huszar et al. (1986), who reported 
that their antibody Ks8.12, recognizing both CK13 and CK16, in some sections 
did not react well with certain luminal cells, most probably due to the fact that 
the epitope recognized by Ks8.12 was less accessible in these cells. We prefer 
to consider the umbrella cells as a separate cell type with a CK expression 
pattern only partly related to that of the underlying cells. 
A second possible transition zone is observed in the epithelium of the renal 
papilla, consisting of two or three layers of columnar cells without umbrella 
cells. This epithelium lies between the epithelium of the renal collecting tubules 
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(negative for CK4 and CK13, unpublished data) and the transitional epithelium 
of the renal calices (heterogeneously positive for CK4 and CK13). The CK 
distribution in the epithelium of the renal papilla is different from both adjacent 
types of epithelium in the expression of CK4 and CK18 (as recognized by 
RGE53 and 2C8) in several basal cells, contrasting with the expression of these 
two CKs only in umbrella cells for regular transitional epithelium. 
In the columnar epithelium of the urethra, which is histologically classified as a 
pseudostratified or stratified type of epithelium (Ham, 1965; Bloom et al. 1975), 
we observed staining of CK18 only with RCK106 and CK18-2 and of CK8 only 
with M20. These results are in contrast to the gel electrophoretic data of 
Achtstätter et al. (1985), who could not find CKs8 and 18 in the urethra, and 
show the additional value of cytokeratin immunohistochemistry. The presence 
of CK4 and CK 13 in this type of epithelium supports its stratified rather than 
pseudostratified nature (see Sun et al. 1985). The female urethra is mainly lined 
by nonkeratinizing squamous epithelium, while in male only foci of squamous 
epithelium can be found (Bloom et al. 1975). Neither could we demonstrate 
CKs7, 8 or 18 in this type of epithelium, nor significant levels of CK10 expressi-
on in urethral squamous epithelium, with the exception of one sample in which 
a few RKSE60 positive cells were detected. CK4 and CK13 were expressed in 
all suprabasal cells as reported previously (van Muijen et al. 1986). The hetero-
genous CK19 pattern seen in the former nonkeratinizing squamous epithelium 
was also found in the proximal fossa navicular!. In the distal fossa an increase 
of CK10 positive cells was observed and a decrease of CK19 and CK4 reactive 
cells. Normally the glans penis is lined by a keratinizing squamous epithelium 
(Ham, 1965) as observed also in all six male patients examined by us. The CK 
distribution pattern in this type of epithelium was, however, not identical to that 
in epidermis (Huszar et al. 1986; van Muijen et al. 1986; van Muijen et al. 
1987b; Moll et al. 1982). For example, CK4 and CK13 are normally not found 
in adult epidermis, while they are detected in the keratinizing glanular epitheli-
um. Achtstätter et al. (1985) reported that apparently nonkeratinizing squamous 
glanular epithelium contained CK13 and CK19, but also CK1, which is a marker 
for keratinization. When comparing the staining patterns of the CK8 antibodies 
LE41 and M20 with those of RCK102, recognizing CK5 and CK8, one may 
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conclude that the positive reaction for RCK102 in stratified squamous epithelia 
represents the distribution of CK5 in these tissues. 
In summary, we can conclude that monoclonal antibodies to individual cytokera-
tin polypeptides are valuable markers for the detection and characterization of 
the different morphological types of epithelia occurring in human male and 
female urinary tract. Furthermore, within one type of epithelium cytokeratin 
patterns can be related to stage of differentiation. Future studies with these 
antibodies in neoplasms of these epithelia will have to reveal whether cytokera-
tin expression is related to morphology, site of origin or degree of tumor 
progression. 
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ABSTRACT 
The expression of cytokeratin (CK) polypeptides was studied in 59 transitional 
cell carcinomas (TCCs) of the urinary tract of different grade and stage. Using a 
panel of 14 chain-specific monoclonal CK-antibodies we identified immuno-
histochemically 8 different CKs separately, ie, CKs 4, 7, 8, 10, 13, 14, 18,and 
19, while in immunoblotting studies CK5 expression was detected indirectly by 
using the antibody RCK102, recognizing CK5 + 8. 
In the low grade TCCs (G1-G2) the CK distribution was comparable to that in 
normal urothelium, however with a variable expression of CK13 in the different 
tumors and a uniform distribution of CK7. In higher grade TCCs (G3) a decrease 
in CK13 expression was observed, particularly in the areas of muscle invasion. 
Furthermore, the appearance and increasing expression of CK14 (not present in 
normal urothelium or G1 TCCs) with higher grade and stage was striking. With 
tumor progression changes in epitope configurations of CK8 and CK18 were 
detected, as concluded from immunohistochemical assays with the panel of 
monoclonal antibodies for each of these two CKs. In extreme cases this resulted 
in differential staining patterns of the invasive and non-invasive components 
within one tumor. In 7 out 32 of TCCs, some of which showed areas with 
evident squamous differentiation, a decrease in the expression of CK7 and/or 
CK8 was seen. 
We conclude that tumor progression in TCCs is associated with discrete 
changes of CK expression, which can be detected using monoclonal antibodies. 
INTRODUCTION 
Normal epithelia and carcinomas contain cytokeratins (CK) as their main 
intermediate filament constituents. Specific subsets of different CK polypeptides 
are expressed in different epithelia depending on their origin or type of differen­
tiation 'Λ 
With respect to the different types of urothelium and the tumors derived from 
them some reports have already described intermediate filament expression 
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patterns, mainly based on electrophoretic studies or using immunohistochemical 
assays employing a limited number of chain-specific CK antibodies *"7. Recently, 
however, Moll et al 8 have published an extended study on the expression in 
normal and malignant urothelium, while we 9 examined the CK distribution in a 
large series of samples from different localizations in the normal urinary tract. A 
profound heterogenity within these epithelia and within tumors derived there­
from became obvious from these studies. 
Because satisfactory morphological detail can be resolved down to the single 
cell level using immunohistochemical procedures, these are preferable to gel 
electrophoretic analyses, especially in the study of tissues with variable morpho­
logy. The latter certainly applies to the different grades of transitional cell 
carcinoma (TCC): the malignant potential of TCCs is related to the degree of 
architectural and cytologic atypia (grade) and the level of infiltration (stage) 1 0 1 Б. 
As a result TCCs seem very suitable to use in the study of expression patterns 
of CKs in relation to tumor behavior. To provide a solid basis for such a study 
we have recently performed an extensive study of the normal epithelia lining the 
surface of the urinary tract using a large panel of chain-specific monoclonal CK 
antibodies (anti-CKs 4, 7, 8, 10, 13, 18 and 19) 9. In the different types of 
normal urothelia, ie, transitional epithelia and squamous epithelia, different CK 
expression patterns showed a relation to tissue morphology, the specific 
localization of a certain epithelium within this tract, the cell type, or partly to 
the state of differentiation within the epithelium. In the present study the panel 
of polypeptide-specific antibodies was essentially extended and applied to a 
series of 59 TCCs from 48 patients and selected for their differences in 
malignant potential, ie, grade and stage. In this way we intended to examine a 
possible relationship between the cytokeratin expression patterns and the 
biological behavior of the tumor, with special attention to tumor progression, ie, 
increasing grade and stage. The results were compared to CK expression 
patterns in the normal epithelia of the urinary tract. 
MATERIALS AND METHODS 
Tissues. The different types of normal epithelium of the urinary tract used for 
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screening antibody LL002 ( directed against CK 14) were obtained from autop­
sies as described in a previous reporte. Seventeen tissue samples, derived from 
six different patients, included transitional epithelium from renal pelvis and 
ureter (n = 2), bladder (trigone excluded; n = 3), trigone (n = 5; in one specimen 
also an area of nonkeratinizing squamous epithelium was seen) and male 
proximal urethra (n = 2). The other types of epithelia included columnar urethral 
epithelium (females, n= 2; male, n = 1), non-keratinizing squamous urethral 
epithelium (female, n = 1, same specimen as for columnar epithelium) and two 
specimens with keratinizing squamous glanular epithelium. One of these latter 
specimens also contained nonkeratinizing squamous epithelium of the fossa 
navicularis. 
Tumor samples of TCCs were obtained immediately after transurethral resection 
or other surgical procedures. Fifty-five TCCs were resected from the urinary 
bladder, while in four cases TCCs were derived from the renal pelvis. Parts of 
the fresh tissue samples were snap-frozen and stored in liquid nitrogen until use. 
The main part was used for conventional pathological examination. The vast 
majority of the tumors had not been exposed to medical treatment other than 
transurethral resection of possible prior lesions. 
Grading and Staging of the Transitional Cell Carcinomas. Grading and staging 
was performed on conventional paraffin sections. The tumors were graded 
according to the method described by Ooms et al 1 < M 7 to obtain reproducible 
grading results. This method involves the classical WHO light microscopic 
criteria 1S followed by a morphometrical assay, in which the mean nuclear areas 
of 50 basal cells, 50 superficial cells and 50 of the largest nuclei are calculated 
on a graphic tablet (Kontron-MOP videoplan). This morphometrical grade is 
compared with that made by the pathologist. In cases of disagreement the 
slides were reviewed by the pathologist for a final conclusion. 
Staging was performed according to the TNM classification of the International 
Union Against Cancer 1β. In biopsy material the maximal degree of muscle or 
perivesicle infiltration could not be assessed exactly, so that in those cases pT2 
must be interpretated as "at least pT2". 
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Antibodies. The panel of monoclonal chain-specific CK antibodies used in this 
study has been described before e. Table 1 summarizes specifications and 
references of the individual antibodies e' M 2 e . The antibody LL002 was not 
described in our previous study *, but has been shown to react specifically with 
CK 14 in immunoblotting M . The specificity of LL002 for CK 14 is further 
illustrated in the Results section. Furthermore, we have now performed immuno­
blotting studies with antibody 2C8 on bladder cancer samples, showing a 
specific reaction of this antibody only with CK18, as well as 2D-immunoblotting 
studies with antibody M20, proving its specificity for CK8 (see Results). For 
immunoblotting assays the mouse monoclonal anti-vimentin antibody RV202 2\ 
as well as the CK17 antibody E3 " (provided by Dr. S. Troyanovski, Moscow) 
were used. 
Immunohistochemistry and Immunoblotting. The indirect immunoperoxidase 
technique was applied to 4 micron thick cryostat sections in which the peroxi­
dase activity was detected with 3-amino-9-ethylcarbazole 2S. 
For the immunoblotting studies both cytoskeletal preparations from RT4 cells e, 
TR146 cells, and TCCs were used. RT4 cells were extracted with 1 % Triton X-
100 in phosphate buffered saline, containing 0.4 mM phenylmethyl sulphonyl 
fluoride (PMSF), 1 mM EGTA and 1 mM EDTA. Cytoskeletal preparations from 
TCC specimens were made as follows: 20 micron thick frozen sections (about 
15 to 30 sections needed for one two-dimensional gel) were immediately after 
cryosectioning extracted for 15 minutes on ice with buffer containing 1.5 M 
KCl, 0.5% Triton X-100, 5 mM EDTA, 0.4 mM PMSF, and 10 mM Tris.HCI, pH 
7.2. The 2000 rpm pellet (Minifuge; 10 min. at 0° С) was washed several times 
in cold buffer 5 mM EDTA, 0.4 mM PMSF and 10 mM Tris.HCI, pH 7.2 by 4 
min. centrifugation steps at 3000 rpm. The final pellet was dissolved in SDS-
sample buffer and stored at -20° С until use. One- and two-dimensional gel 
electrophoresis and immunoblotting were performed essentially as described 
before 2e. 
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RESULTS 
Characterisation of antibodies M20, 2C8 and LL002 
In an earlier study θ we have characterized antibody M20 by one-dimensional 
immunoblotting assays, which indicated its specificity for СК . However, in 
these studies we occasionally observed a faint reaction in the CK18-region on 
the immunoblots. To exclude cross-reactivity of M20 with CK18 two-dimensio­
nal immunoblotting was performed on RT4 cytoskeletal preparations (Figures. 
1A to D). Our results (Figure 1A) show that M20 reacts with CK8 in two-
dimensional blots and that the faint cross-reactivity in the CK18-region repre­
sents breakdown products of CK8. Reincubation of the two-dimensional blots 
with the antibodies to CK18 confirm this conclusion (Figure IB). Figures 1С and 
ID, which show the results of reincubations of this blot with antibodies to CK7 
and CK19, further substantiate the specificity of M20. Also 2C8 was further 
characterized in this way (Figures. 1E to H), and was shown to react only with 
CK18 in RT4 cell extracts (Figure 1E). Again, reincubation of the immunoblot 
with antibodies specific for CK 19, CK7 and CK8 support this interpretation. To 
illustrate the specificity of antibody LL002 for CK14, we have performed an 
immunoblotting study on CKs of TR146 cells. The results shown in Figures 11 to 
L clearly demonstrate that LL002 reacts with a CK protein migrating at a 
position slightly below CK8 and above CK17. Furthermore, the fact that the 
isoelectric pH of this protein is in between that of CK8 and CK17 proves that 
LL002 recognizes only CK14 in these cells. 
Expression of CK14 in normal epithelia of the urinary tract. 
Antibody LL002 did not stain the transitional epithelium including the prostatic 
part of the urethra (Table 1 and Figure 2A). In columnar urethral epithelium 
several positive areas were found in which especially the basal cells and some 
parabasal cells were stained (Figure 2B). Nonkeratinizing squamous epithelium 
of the trigone and urethra showed some areas with positive basal cell layers and 
sporadically positive intermediate cells (Figure 2C). Nonkeratinizing squamous 
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Figure 1. Characterization of monoclonal antibodies M20 (panels A-D), 2C8 
(panels E-Η) and LL002 (panels l-L) by two-dimensional immunoblotting assays 
on cytoskeletal préparerions of RT4 cells. Note that M20 reacts with CK8 and a 
breakdown product (asterisk, A), which does not comigrate with CK18 (B; 
CK18 detected with RCK106). In С and D the positions of CK7 (detected with 
RCK105) and CK19 (detected with LP2K) are indicated. Also note that 2C8 
reacts only with CK18 (E). The positions of CK19 (F; detected with LP2K), CK7 
(G; detected with RCK105) and CK8 (H; detected with M20) are indicated as 
such. В, С and D, as well as F, G and H show results of reincubation of the 
blots shown in A and B, respectively. For the characterization of antibody 
LL002, TR146 blots were incubated first with RCK106 (detecting CK18; I), 
then with LL002 (J), and subsequently with M20 (detecting CK8; K) and E3 
(detecting CK17; L). Note that the CK spot recognized by LL002 migrates in the 
position of CK14. 
epithelium in the fossa naviculars was almost completely positive in the basal 
and parabasal cell layers (Figure 2D), while the keratinizing squamous epithelium 
of the glans penis was completely positive, except for the stratum corneum 
(Figure 2E). 
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Cytokeratin expression in TCCs 
The results obtained with the immunoperoxidase technique on bladder cancer 
frozen sections are described in the following paragraphs, summarized in Table 
2 and depicted in Figures 2 to 4. 
Of the 59 TCCs examined, 52 showed similar CK expression patterns, while in 
the remaining 7 cases (all G3) a remarkable deviation from these expression 
patterns was observed. Table 2 summarizes our clinicopathologic and immuno-
histochemical data for all TCCs, with these 7 tumors grouped separately at the 
end. This group will be described in a separate paragraph after the prevailing CK 
expression patterns. Frequently within one tumor quantitative differences in 
staining patterns for the individual CKs were observed. These were scored as 
major and minor expression patterns. 
From Table 2 it is obvious that TCCs of all grades and stages show a homoge­
neous expression of CKs detected by RCK105 (CK7; Figure 2F), RCK102 
(CKs5 + 8), M 2 0 (CK8), RCK106 and CK18-2 (both CK18) and LP2K (CK19), 
except for one case with RCK102 (case 27; Figure 2G) and two exceptions for 
RCK106 (Figures 2H,I) and CK18-2 (cases 26 and 27). RKSE60 (CK10) showed 
no staining reaction except for one case (case 35a) where focally RKSE60 
positive cells were seen. 
Expression of cytokeratins 4 and 13 
The CK4 expression did not appear to be related to that of other CKs, especially 
not to CK13. 6B10 (CK4) showed a focal staining reaction in the minority of 
TCCs (Figure 2J). In three cases 6B10 stained superficial cells more extensively 
(Figure 2K) than in the other cases. In two of these cases the superficial cells 
were morphologically identical to umbrella cells, while in the third case the 
superficial cells were part of adenomatoid structures (Figure 2L). Two TCCs 
were almost homogeneously positive for 6B10 (Figure 2M). 
The CK 13 expression could be divided into three patterns with similar staining 
for both СК1Э antibodies (see Table 3). Firstly, an extensive to almost homoge-
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Figure 2. A-E: Immunoperoxidase staining patterns of frozen sections from 
normal epithelia of the adult human urinary tract, incubated with the cytokeratin 
14-antibody LL002 and including urinary bladder transitional epithelium (A), 
columnar epithelium of the urethra (B), nonkeratinizing squamous epithelium of 
the female urethra (C) and of the male fossa navicularis (D), and the keratinizing 
squamous epithelium of the glans penis (E). 
F-R: Immunoperoxidase staining patterns of human transitional cell carcinomas 
showing the typical pattern of RCK105 (F, case 26). Furthermore are shown the 
occasionally occurring patterns of RCK102 (G) and RCK106 (H,l), from case 27 
(G,H), and case 26 (I), variable patterns of 6B10 (J-M, cases 26, 32, 18 and 
33), two typical patterns of 2D7 (N,0, cases 32 and 8, respectively) and typical 
patterns of LL002 (P,R, cases 15, 28a and 37, respectively). 
Magnifications: Α-F and K-R, X 100-120; G and Η, X 40; I X 350. 
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neous staining reaction, with exception of umbrella cells (Figure 2N), and 
continuous staining of the basal and parabasal cell layers, dominating in most 
G1 and G2 tumors; second, a positive staining reaction limited to small focal 
areas with basal and parabasal cells positive (Figure 20) , dominating in superfi-
cial G3 tumors; third, no staining at all, occurring in deeply infiltrating G3 TCCs 
(not shown). In the noninfiltrating part of G3pT2 TCCs we observed relatively 
frequent extensive CK13 expression in contrast to the superficial, ie, pTa and 
pT1, G3TCCS (Table 3). 
In case 17, two asynchronous G2 samples (interval, 3.5 months) showed 
differences in their staining pattern, with one sample extensively positive and 
the other focally positive. A similar phenomenon was observed in case 36, 
although the second sample (interval, 19 months) was obtained after radiothera-
py-
Table 3. Degree of immunohistichemical expression of CK13 in different steps of tumor 
progression of transitional cell carcinoma (n = 52) 
Steps of tumor 
progression 
Grade and Stage 
G1pTa 
G2pTa 
PT1 
G3pTa/1 
pTa/1(2)" 
PT2 
Number of 
TCCs studied 
11 
14 
2 
12 
4 
9 
Degree of immunohistochemical 
Extensively 
positive 
7 
11 
1 
4 
3 
3 
Focally positi-
ve 
4 
3 
1 
8 
1 
3 
expression 
Negative 
0 
0 
0 
0 
0 
3 
* In frozen sections of these four cases only the pTa/1 component was 
observed, while the whole neoplasm was staged as pT2 on basis of paraffin embedded 
material. 
Expression of cytokeratin expression 14 
Table 2 indicates that with increasing degree of malignancy, an increasing 
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number of TCCs showed LL002 reactivity. In the lower grade tumors the 
staining was confined to basal cells (Figure 2P). In higher grade tumors a 
tendency of suprabasal cell staining was seen (Figure 2Q) and in two cases of 
G3pT2 TCCs all tumor cells were positive for LL002 (Figure 2R). In three TCCs 
CK14 positive cells were only found in the infiltrating tumor component, while 
the noninfiltrating part was negative (not shown). 
Expression of different CK8 and CK18 epitopes 
As mentioned before, two antibodies to CK18 (RCK106 and CK18-2) and one 
antibody to CK8 (M20) showed a homogeneous staining in the 52 TCCs 
independent of stage and grade (Figures 3A,B). Fewer cells were positive with 
antibody RGE53 (CK18), which gave variable intense staining with a preference 
for the superficial cell layers in G1 and G2 tumors (Figures 3C,D). With antibody 
2C8 (CK18), as well as with LE41 (CK8), a significantly different staining 
pattern was observed as compared to the other CK18 and CK8 antibodies. Both 
antibodies strongly stained umbrella cells or superficial (umbrellalike) cells in all 
noninfiltrating areas of TCCs, with 2C8 showing reactivity in more umbrella 
cells than LE41 (Figure 3E). Next to this pattern both antibodies showed 
localized-to-extensive staining reactions in the other cell layers of a number of 
TCCs. These staining reactions were generally weak and only in a few cases 
was a predominantly positive pattern seen (Figures 3F,G). However, in G3 TCCs 
antibody 2C8 showed extensive positivity in the majority of these tumors 
(Figure 3H). As seen in Figures 3I to P, the invasive parts, whenever present in 
the TCCs, showed variable numbers of strongly positive cells with both antibo-
dies. This was also the case in those tumors in which the noninfiltrative part 
was predominantly negative (Figures 3I to K). Again, also in these infiltrating 
areas, 2C8 stained more cells than LE41; LE41 was completely negative 
staining on two deeply infiltrating tumors (cases 37 and 38). The infiltrating 
tumor cells bordering the stroma were found to be strongest positive (Figure 
3N); occasionally this was seen also in the noninfiltrating part (arrows, in 
Figures 30,P) especially in the vicinity of infiltrating cells. 
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Figure 3. Immunoperoxidase staining patterns of frozen sections of transitional 
cell carcinomas showing typical staining patterns for the different cytokeratin 8-
and 18-antibodies, including M20 (A, case 26), RCK106 (B, case 6), RGE53 (C, 
case 6; D, case 5), 2C8 (E, case 6; G, case 20b; H, case 25c; I and J, both 
case 23; L, case 36b; 0, case 31a) and LE41 (F, case 6; K, case 23; M, case 
36b; N, case 34; P, case 31a). Note in I and J positive staining in the invasive 
tumor compartment for 2C8, while the noninvasive part is predominantly 
negative. A similar observation for LE41 is depicted in K. Note also focal 
positive staining for 2C8 and LE41 in basal cells of the noninvasive part in О 
and P, respectively. 
Magnifications: A-Η and L-P, X 100-120; I X 35; J X 150, Κ X 175. 
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G3 carcinomas with a "deviating " CK expression pattern. 
Seven G3 carcinomas differed considerably in their CK expression pattern from 
the 
other 52, especially characterized by a reduced expression or absence of CK7 
and CK8 (as detected by M20). Hematoxylin and eosin-stained paraffin sections 
of these tumors revealed large tumor cells that were often strongly eosinophilic. 
In three carcinomas resemblance to nonkeratinizing squamous cells was evident 
(Figure 4A). Although no consistent relationship between morphology and the 
varying expression patterns of the other CKs (Table 2) was observed htere was 
a proportional increase in the incidence of staining with RKSE60 (CK10) within 
this group (3 of 7 tumors; Figure 4D). In two tumors several scattered CK 10 
positive cells were found and in the third tumor the expression was patchy. In 
six tumors CK7 expression (RCK105) was significantly decreased (Figure 4B) or 
lost, and in four cases CK8 (as detected by M20) was diminished. In three of 
the latter TCCs the other CK8 antibody did not stain at all. CK18 (as detected 
by RCK106 and CK18-2) was diminished in two cases (Figure 4C). CK10 
expression was increased and present in three tumors (Figure 4D). The expres-
sion of CK4 and CK 14 (Figure 4E) seemed to be increased, while expression of 
CK 13 (Figure 4F) and CK 19 appeared unchanged as compared to the other 52 
TCCs. 
Immunoblotting studies 
Immunoblotting studies were performed on a selected series of bladder cancers, 
including one Gl , two G2s and four G3 TCCs. One of the G3 tumors showed a 
squamoid differentiation. The results of the assays are depicted in Figure 5 and 
do, in general, confirm our ¡mmunohistochemical studies. They add biochemical 
support for the presence of CK5 in some TCCs (lanes 2 and 7 of Figure 5C). 
This individual cytokeratin polypeptide could not be demonstrated to occur in 
certain samples on basis of immunohistochemistry, because RCK102 recognizes 
both CK5 and CK8. 
These immunoblotting studies detected CKs 7 (Figure 5F), 8 (Figure 5C), 18 
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(Figure 5E) and 19 (not shown) in all seven cases, independent of grade and 
stage, while CK13 (Figure 5D) was not detected in significant amounts in two 
G3 TCCs. CK4 (Figure 5A) was only found in one G3 tumor. CK14 was 
detected next to CK5 in the TCC with squamoid differentiation (Figures 5B,C; 
lane 7) and in one of the other G3 tumors (Figure 5B, lane 6). In addition CK5 
was detected in one of the G2 TCCs. The immunoblotted protein bands, 
migrating below the main band in lane 7 of Figure 5B and in Figure 5F represent 
degradation products of CK14 and CK7, respectively. 
Figure 4 . A: Transitional cell carcinoma (case 44) with extensive squamous 
metaplasia, shown in an H&E stained routine paraffin section. 
B-F: Immunoperoxidase staining patterns of frozen sections of grade 3 transitio­
nal cell carcinomas showing deviating keratin expression patterns with antibo­
dies RCK105 (B, case 45), RCK106 (C, case 45), RKSE60 (D, case 43), LL002 
(E, case 45) and 2D7 (F, case 43). 
Magnifications: Α-C, E and F X 100-120 ; D X 40. 
Two-dimensional immunoblotting studies confirmed the identity of the cytokera-
tin polypeptides detected in the one-dimensional immunoblotting assays using 
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polypeptide-specific antibodies. Figures 5G to I show the identification of 
cytokeratins 18 and 19 in a G1 TCC, and show their position in relation to 
vimentin. These results do also confirm our findings described above that 
antibody 2C8 is specific for CK 18. 
DISCUSSION 
The expression of different cytokeratins was studied in relation to tumor 
progression in TCC. In the low grade carcinomas the CK distribution pattern is 
in agreement with that in normal transitional epithelium β (Table 1), with the 
exception that CK13 was nonuniformly distributed in the basal compartment of 
the tumors and that CK7 was homogeneously positive in in TCCs independent 
of localization in either the upper or lower urinary tract. In the higher grade 
malignancies the following observations were most striking: 1) a decrease in 
CK13 expression with increasing grade and stage, 2) the appearance of CK14, 
3) changes of CK8 and CK 18 epitope configurations related to tumor stage and 
(to a lesser degree) to grade, and 4) decrease of expression of CK7 and CK8 in 
relation to squamous metaplastic changes. 
In a considerable number of G1 TCCs and G2 TCCs expression of CK13 was 
reduced as compared to normal urothelium, resulting in tumors that were only 
focally positive. This phenomenon was neither associated with site, rate of 
recurrence or other follow-up data, nor with the expression of other CKs. For 
example, some recurrent tumors showed different expression patterns of CK 13 
as compared to the previous lesions. In G3 carcinomas a pronounced decrease 
of CK13 expression was found in the part infiltrating the muscle. Moll et al 8 
also have described a decrease of CK13 expression with increasing grade and in 
metastases. However, in contrast to our findings all low grade carcinomas, that 
these authors examined, were found to have high CK13 levels. 
Although CK4 has been proposed to occur in CK filaments in combination with 
CK 13 2β, the expression pattern of CK4 is not related to that observed for 
CK13. 
The expression of CK14 in 5 of the 17 G2 carcinomas suggests a relation of 
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Figure 5. Α-F: One-dimensional immunoblotting study on a G1 ТСС (lane 1; 
case 1a), two G2 TCCs (lanes 2 and 3; cases 22 and 21, respectively) and four 
G3 TCCs (lanes 4-7; cases 27, 29a, 26 and 46, respectively) incubated with 
6B10 (A), and subsequently with LL002 (B) and RCK102 (C), or 1C7 (D) and 
subsequently with 2C8 (E), or only RCK105 (F). The individual cytokeratin 
polypeptides, which are recognized by the diverse monoclonal antibodies are 
indicated. 
G-l: Two-dimensional immunoblotting study on a TCC (case la), subsequently 
incubated with antibodies 2C8 (G), LP2K (H) and RV202 (I), detecting CK18, 
CK19 and vimentin, respectivily, which are indicated as such. 
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expression of this protein with tumor progression in TCC. It was not detected in 
normal transitional epithelium, either by our immunohistochemical studies or 
according to gel electrophoretic data of Achtstätter et al 4 and Moll et al 8. In 
this study we have shown that it is also not detected in Gl TCCs by antibody 
LL002. Of the deeply infiltrating tumors some were extensively CK14 positive, 
while most of the other G3 tumors showed focal positivity. Our data are, howe-
ver, not readily interpreted by a simple relation between CK 14 expression and 
the clinicopathological parameters of tumor progression. For example, 7 of 25 
G3 TCCs were negative and of the 10 TCCs showing muscle infiltration 3 were 
completely negative in these areas. 
CK 14 reactivity was confined to the basal and parabasal cells in the nonkeratini-
zing squamous epithelium of the normal adult urinary tract. CK14 was homoge-
neously expressed in all cells of the keratinizing squamous epithelium of the 
glans penis, although the stratum corneum was negative. These observations 
are in line with CK14 expression observed in TCCs having large eosinophilic 
cells and squamous differentiation. Cintorino et a l 7 have reported that antibody 
SK2-27, recognizing CKs14, 16, and 17 reacted focally in normal transitional 
epithelium and in G1 and G2 TCCs. In squamous epithelium and in G3 TCCs, 
this antibody reacted homogeneously with all cells. Moll et al 8 reported that 
the antibody KA1, considered by Jarasch et al Μ to be specific for CKs5 and 
14, and antibody IVD3A9, most likely directed against CK14, both react with 
basal cells in normal urothelium and more heterogeneously in G1 and G2 TCCs. 
Surprisingly, G3 TCCs were described to be CK14 negative. Future studies will 
have to reveal whether or not epitope-masking phenomena may explain the 
discrepancy between these findings and our findings reported above. That 
epitope masking may play a role in CK 14 immunohistochemistry is illustrated by 
our findings in case 26 in which immunoblotting shows the presence of CK14 
(Figure 5B, lane 6), while in immunohistochemistry no staining is observed with 
LL002. 
In our studies several different antibodies to CK8 and CK18 were used. Since 
these antibodies show two different staining patterns in normal urothelium 9, we 
were interested in their reactions with TCCs. On one hand an extensive reaction 
pattern in all cell layers is obtained with antibodies M20 (CK8), RCK106 and 
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CK18-2 (CK18), and on the other hand a more restricted umbrella-cell-related 
pattern is seen with LE41 (CK8), RGE53 and 2C8 (CK18) e · 9 . Cinturino et al 7 
have described the umbrella-cell-related staining pattern for their antibody SK60-
6 1 , which they consider to be specific for CKs8 and 18, while Achtstätter et al 
4
 showed a similar reaction for antibody CK1, specific for keratin 18. In G1 
TCCs LE41 and 2C8 preferentially stained superficial, ie, umbrella-like cells, 
while RGE53 reacted more extensively in our recent immunoperoxidase studies 
than reported in previous immunofluorescence studies e, probably as a result of 
the use of a more sensitive technique. The intensity and extent of the staining 
reaction of RGE53 in the intermediate and basal cell layers was, however, still 
less than that of the two other CK18 antibodies, RCK106 and CK18-2, which 
stain virtually all TCC cells, independent of stage and grade. An increase of the 
number of cells positive for 2C8 and even for LE41, although to a lesser extent, 
in superficial G3 TCCs is observed as compared to the G1 and G2 carcinomas. 
It is striking that the exposure of the 2C8 epitope is observed to a lesser degree 
in the superficial part of the deeply (pT2) infiltrating tumors. A prominently 
positive reaction for 2C8 is observed in the infiltrating component of G2 and G3 
tumors. Frequently the major part of the 2C8 and LE41 positive cells were those 
bordering at the stroma. In the noninfiltrating part of three TCCs, expression of 
the CK8 and CK18 epitopes as detected by LE41 and 2C8, respectively, was 
mainly observed in a few basally located cells clusters. Similary, Cintorino et al 7 
reported on one G2 tumor in which their antibody SK60-61 stained the deeper 
invasive portions with higher intensity, while in three infiltrating G3 TCCs these 
authors found an extensive reaction for SK60-61. The biological significance of 
this phenomenon of CK8 and CK18 epitope unmasking or epitope formation is 
unknown. One explanation may be that the three-dimensional organization of 
the heteropolymer filaments formed by CK8 and CK18 changes during tumor 
progression, as it does during the process of normal differentiation in the 
urothelium. It is interesting to note that the umbrella cells, which need a flexible 
cytoplasmic architecture to cope with the morphologic deformation during 
urinary bladder extension, show a reaction pattern with the CK8 and CK18 
antibodies, which also recognize the invasive TCC cells. One might speculate 
that a flexible cytoskeletal organization is a prerequisite for the invasive proper-
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ties of these latter cells. One might further speculate that the noninvasive but 
strongly 2C8- and LE41-positive basal cells may be ultimately capable of 
stromal infiltration. 
Another explanation of these antibody discrepancies may be that they show 
different affinities for their respective epitopes. Indications for such an interpre-
tation of apparent cell specificity of CK8 and CK18 antibodies are obtained from 
immuno(histo)chemical studies in other tissues. These experiments rank the 
antibodies in order of strength to a degree: LE41 < < M20 and 2C8 < RGE53 
< CK18-2 < RCK106. As a result, a higher concentration of CK8 and CK18 in 
umbrella cells than in other cell types alone might explain the observed staining 
differences. This argues that weaker antibodies are sometimes more useful than 
stronger antibodies because the allow the detection of quantitative differences. 
Studies on normal epithelia suggest a close correlation between morphologic 
characteristics and CK-expression patterns. In cancers CK expression patterns 
are also related to the type of differentiation rather than to that of the cell origin 
2e
. In the present study we find support for this view in our results with seven 
TCCs showing a deviating CK composition. Morphologically the tumor cells of 
most of these cases appeared to have a large and compact eosinophilic cyto-
plasm, suggesting early squamous differentiation. Areas of squamous differenti-
ation were evident in three cases. Related to these observations is the fact that 
six of the seven TCCs showed a loss or absence of CK7 and in four cases a 
diminshed expression of CK8. We expected also CK18 to be diminished in all 
these cases as for example, was reported for squamous areas in a Brenner 
tumor 31, but by immunohistochemistry this was only obvious in two cases. 
Interestingly, these two particular cases showed extensive CK14 positivity in 
the tumor cells, a further indication of potential squamous differentiation 
because CK14 is one of the fundamental hallmarks of keratinocytelike cells and 
is absent from simple epithelial cells. CK10, a marker for keratinization was 
expressed relatively frequently in the deviating TCCs. Recently other authors 7' '• 
3234
 also described differences of CK expression patterns in urothelial cancers 
between transitional cell differentiation and other types of (frequently squa-
mous) differentiation. Most of these immunohistochemical data were obtained 
with nonmonospecific anticytokeratin antibodies 7 · 3 2 ' 3 4 . 
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We can state that CK expression in transitional cell carcinomas of the human 
urinary tract shows to a certain extent, correlations with morpologic features 
(squamous differentiation), the malignant potential (grade/ stage) and with the 
specific tumor compartment ( infiltrating or noninfitrating part), ie, aspects of 
tumor progression. As a result, a selected panel of CK antibodies may become a 
useful tool in future biologic studies of bladder cancer, for example, in defining 
genetic aberrations in specific tumor cell populations. 
Acknowledgements 
The authors thank Kiek Verrijp, Helma Kuijpers and Gert Schaart for their 
excellent technical assistance in the preparation and specificity testing of the 
monoclonal antibodies and the immunoblotting assays. Dr. S. Troyanovski (Mos­
cow) is kindly acknowledged for providing antibody E3. We are grateful to Dr. 
R. Moll (Mainz) for critical discussions of this manuscript. 
References 
1. Moll R, Franke WW, Schiller DL, Geiger В, Krepier R: The catalog of human cytokeratins: 
patterns in normal epithelia, tumors and cultured cells. Cell 1982, 3 1 : 11-24. 
2. Tseng SCG, Jarvinen MJ, Nelson WG, Huang J-W, Woodcock-Mitchell J, Sun T-T: 
Correlation of specific keratins with different types of epithelial differentiation: monoclonal 
antibody studies. Cell 19Θ2, 30: 361-372 
3. Quinlan RA, Schiller DL, Hatzfeld M, Achtstätter, Moll R, Jorcano J J, Magin TM, Franke 
WW: Patterns of expression and organization of cytokeratin intermediate filaments. Ann 
NY Acad Sci 1985, 455: 282-306 
4. Achtstätter Τ, Moll R, Moore В, Franke WW: Cytokeratin polypeptide patterns of different 
epithelia of the human male urogenital tract: an immunofluorescence and gel electrophore-
tic study. J Histochem Cytochem 1985, 33: 415-426 
5. Feitz WFJ, Beck HUM, Smeets AWGB, Debruyne FMJ, Vooijs GP, Herman CJ, Ramaekers 
FCS: Tissue specific markers in flow cytometry of urological cancers: cytokerains in 
bladder carcinoma. Int J Cancer 1985, 36: 349-356 
6. Ramaekers F, Huysmans A, Moesker O, Schaart G, Herman С, Vooijs Ρ: Cytokeratin 
expression during neoplastic progression of human transitional cell carcinomas as detected 
by a monoclonal and a polyclonal antibody . Lab Invest 1985, 52: 31-38 
7. Cintorino M, Del Vecchio MT, Bugnoli M, Petracca R, Leoncini Ρ: Cytokeratin pattern in 
62 
normal and pathological bladder urothelium: immunohistochemical investigation using 
monoclonal antibodies. J Urol 1988, 139: 428-432 
8. Moll R, Achtstatter T, Becht E, Balcarova-Stander J, Ittensohn M, Franke WW: Cytokera-
tins in normal and malignant transitional epithelium. Maintenance of expression of 
urothelial features in transitional cell carcinomas and bladder carcinoma cell culture lines. 
Am J Pathol 1988, 132: 123-144 
9. Schaafsma HE, Ramaekers FCS, van Muijen GNP, Ooms ECM, Ruiter DJ (1989) Distributi-
on of cytokeratin polypeptides in the adult human urinary tract. Histochemistry 91:151-
159 
10. Koss LG: Tumors of the urinary bladder, Atlas of tumor pathology, 1975, 2nd Series, Fase. 
11, Wasington DC, Armed Forces Institute of Pathology. 
11. Anderström С, Johansson S, Nilsson S (1980) The significance of lamina propria invasion 
on the prognosis of patients with bladder tumors. J Urol 124: 23-26 
12. Lutzeyer W, Rubben H, Dahm H: Prognostic parameters in superficial bladder cancer: an 
analysis of 315 cases. J Urol 1982, 127: 250-252 
13. Kern WH: The grade and pathologic stage of bladder cancer. Cancer 1984, 53: 1185-
1189 
14. Jordan AM, Weingarten J, Murphy WM: Transitional cell neoplasms of the urinary bladder: 
can biologic potential be predicted from histologic grading? Cancer 1987, 60: 2766-2774 
15. Abel PD, Hall RR, Williams G: Should pT1 transitional cell cancers of the bladder still be 
classified as superficial? British J Urol 1988, 62: 235-239 
16. Ooms ECM, Kurver PHJ, Veldhuizen RW, Boon ME: Morphometric grading of bladder 
tumors in comparison with histologic grading by pathologists. Hum Pathol 1983, 14, 140-
143 
17. Ooms ECM, Blok APR, Veldhuizen RW: The reproducibility of a quantitative grading system 
of bladder tumors. Histopathology 1985, 9, 501-509 
18. Mostofi FK, Sobin LH, Torloni H: Histological typing of urinary bladder tumors. In: Internati­
onal Histological Classification Of Tumours 10. World Health Organization, 1973, Geneva. 
19. Hermanek P, Sobin LH: TNM Classification of Malignant tumours. International Union 
Against Cancer, 1987, fourth edition, pp 8, 133-134 
20. van Muijen GNP, Ruiter DJ, Franke WW, Achtstatter Τ, Haasnoot WH В, Ponec M, Warnaar 
SO: Cell type heterogenity of cytokeratin expression in complex epithelia and carcinomas 
as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13. Exp 
Cell Res 1986, 162: 97-113 
2 1 . Ramaekers FCS, Huijsmans A, Schaart G, Moesker O, Vooijs GP: Tissue distribution of 
cytokeratin 7 as monitored by a monoclonal antibody. Exp Cell Res 1987, 170: 235-249 
22. Lane EB: Monoclonal antibodies provide specific intramolecular markers for the study of 
epithelial tonofilament organization. J Cell Biol 1982, 92: 665-673 
23. Broers JLV, Carney DN, Klein Rot M, Schaart G, Lane EB, Vooijs GP, Ramaekers FCS: 
63 
Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell 
lines: a biochemical and immunochemical analysis using a panel of monoclonal and 
polyclonal antibodies. J Cell Sci 1986, 83: 37-60 
24. Ramaekers F, Huijsmans A. Moesker 0 , Kant A, Jap P, Herman C, Vooijs P: Monoclonal 
antibody to keratin filaments, specific for glandular epithelia and their tumors: use in 
surgical pathology. Lab Invest 1983, 49: 353-361 
25. Lane EB, Bartek J, Purkis PE, Leigh IM: Keratin antigens in differentiating skin. Ann NY 
Acad Sci 1985, 455: 241-258 
26. Purkis PE, Steel JB, Mackenzie 1С, Nathrath WJB, Leigh IM, Lane EB: Antibody markers of 
basal cells in complex epithelia. J Cell Sci, 97: 39-50 
27. Guelstein VI, Tchypysheva TA, Ermilova VD, Litvinova LV, Troyanovsky SM, Bannikov GA: 
Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human 
mammary gland, benign tumors, dysplasias and breast cancer. Int J Cancer 1988, 42: 
147-153 
28. Broers JLV, Ramaekers FCS, Klein Rot M, Oostendorp Τ, Huysmans A, van Muijen GNP, 
Wagenaar SSc, Vooijs GP: Cytokeratins in different types of human lung cancers as 
monitored by chain-specific monoclonal antibodies. Cancer Res 1988, 48: 3221-3229 
29. Sun T.-T., Tseng SCG, Huang AJ.-W., Cooper D, Schermer A, Lynch MH, Weiss R, 
Eichner R: Monoclonal antibody studies of mammalian epithelial keratins: A review. Ann 
NY Acad Sci 1985, 455, 307-329 
30. Jarasch ED, Nagle RB, Kaufmann M, Maurer С, Böcker WJ (1988) Differential diagnosis of 
benign epithelial proliferations and carcinomas of the breast using antibodies to cytokera-
tins. Hum Pathol 19: 276-289 
31 . Lifschitz-Mercier B, Czernobilsky B, Shezen E, Dgani R, Leitner 0, Geiger В: Selective 
expression of cytokeratin polypeptides in various epithelia of human Brenner tumor. Hum 
Pathol 1988, 19: 640-650 
32. Fukushima S, Ito Ν, El-Bolkainy MN, Tawfik ΗΝ, Tatemoto Y, Mori M. Immunohisto-
chemical observations of keratins, involucrin and epithelial membrane antigen in urinary 
bladder carcinomas from patients infected with Schistosoma haematobium. Virchows Arch 
(Pathol Anat) 1987, 4 1 1 : 103-115 
33. Tungekar MF, Gatter КС, Al-Adnani MS. Immunohistochemistry of cytokeratin proteins in 
squamous and transitional cell lesions of the urinary tract. J Clin Pathol 1988, 4 1 : 1288-
1296 
34. Asamoto M, Fukushima S, Tatemoto Y, Yamada K, Fukui S, Mori M. Immunohistochemical 
expression of keratin proteins in urinary bladder carcinoma. Pathol Res Pract 1989, 184: 
194-201 
64 


CHAPTER IV 
Cytokeratin expression patterns in 
metastatic transitional cell carcinoma of the 
urinary tract: an immunohistochemical study 
comparing local tumor and autologous metastases 
H.E.Schaafsma1,2, F.C.S.Ramaekers3, G.N.P.van Muijen1, 
H.Robben1, E.B.Lane4, I.M.Leigh6, E.C.M.Ooms6, 
J.A.Schalken7, R.J.A.van Moorselaar7, D.J.Ruiter1 
1 ) Department of Pathology, University Hospital of Nijmegen, the Netherlands 
2) Department of Pathology, Canisius-Wilhelmina Hospital, Nijmegen, the 
Netherlands 
3) Department of Molecular Cell Biology, University of Limburg, Maastricht, 
the Netherlands 
4) Cancer Research Campaign Laboratories, Department of Biochemistry, 
University of Dundee, Dundee, United Kingdom 
5) Imperial Cancer Research Fund Skin Tumor Laboratory, The London Hospital, 
Whitechapel, London, United Kingdom 
6) Department of Pathology, Westeinde Hospital, the Hague, the Netherlands 
7) Department of Urology, University Hospital of Nijmegen, the Netherlands 
Published in: American Journal of Pathology 1991, 139:1389-1400 
ABSTRACT 
The cytokeratin (CK) expression patterns of local, ie, primary or recurrent, high-
grade-malignant transitional cell carcinomas (TCCs) of the human urinary tract 
and autologous lymphogenic and hematogenic metastases (n = 33) were 
compared. Special attention was paid to CK expression in the tumor invasion 
front and other areas where tumor-stroma interaction occurred to visualize cell 
populations with a metastatic phenotype. For this purpose polypeptide-specific 
monoclonal antibodies to CKs4, 7, 8, 10, 13, 14, 16, 17, 18 and 19 were 
used, employing the immunoperoxidase method. 
Results show that: 
- 1 - An increased expression of CK8 and CK18 is seen in the TCC tumor cells at 
the interface with peritumoral stroma in the tumor invasion front and with 
intratumoral stroma ("interface phenomenon"). Other than reflecting a quantita-
tive change, this phenomenon might be explained by unmasking of CK8 and 
CK18 epitopes occurring in these regions. 
-2- Although in general the expression of CK13 in local TCC is decreased with 
increase of histopathologic parameters for progression, ie, grade and stage, an 
extensive proportion of CK 13 positive tumor cells can still be found in some 
TCCs, even in metastases. 
-3- Morphologically recognizable types of aberrant differentiation in TCC, ie, 
pseudosarcomatous or squamous differentiation and marked loss of differentiati-
on, show altered expression of many of the CKs studied. 
INTRODUCTION 
The cytokeratin (CK) protein family, which composes the main type of interme-
diate filaments in normal and neoplastic epithelial cells, consists of at least 20 
different polypeptides (numbered 1 to 201"3) not including the hair cytokeratins4. 
Certain combinations of these CK polypeptides are synthesized in specific types 
of epithelium. Under certain circumstances, such as metaplasia6, hyperprolifera-
tione, or neoplastic growth and progression, the CK expression pattern of a 
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certain epithelium can change. Although initial studies showed that neoplasms 
retain the CK pattern of the normal epithelium from which they are derived1·3 
and CK typing could therefore be useful in determining the site of origin of a 
metastasis, deviating CK expression patterns in preneoplastic lesions7 and 
cancers of different organ systems have recently been reported8"11. 
Cytokeratins not expressed in the normal state of a certain epithelium can 
appear in cancers. Also a correlation between altered CK expression patterns 
and the degree of tumor cell anaplasia has been reported8"12. Recently we8 and 
others10 showed that during tumor progression of local transitional cell carcino-
mas (TCCs) a decrease of CK 13 can be seen in the tumor cells, whereas in 
contrast CK14 became detectable using certain antibodies. Furthermore mainly 
the invasive TCC compartment showed an apparently altered CK cytoskeleton 
structure, as detected with monoclonal antibodies to different epitopes of CK8 
and CK18. We interpreted these findings as an adaptation of the cytoskeleton 
to a more flexible and motile cell phenotype. This assumption was supported by 
our observations that umbrella cells in the urinary bladder, which have to be 
flexible during expansion of the organ, showed the same reaction pattern as 
compared to the invasive TCC cells with the different CK8 and CK18 antibo-
dies. 
In the present study, we examined the CK expression patterns in lymphogenic 
and hematogenic metastases of TCC of the urinary tract from 17 patients as the 
ultimate end point of TCC progression. In 10 out of the 17 cases, the CK 
staining reaction of local tumor and metastasis could be compared, allowing us 
to recognize possible alterations in CK expression between these stages. We 
also considered the possibility that metastatic cells might be selected from a 
pool of primary tumor cells with a particular CK expression pattern; for example, 
those cells that exhibited specific CK8 and CK18 epitopes in the primary tumor, 
could be studied. Particular attention was paid to the specific location of the 
tumor cells, especially in the tumor invasion front and other areas where tumor-
stroma interactions occur. 
MATERIALS AND METHODS 
Tissues. The 33 tumor samples (Table 1 ) were snap frozen and stored in liquid 
nitrogen immediately after surgery or during autopsy. No overlap between this 
series of tumor samples and those described previously8 exists. Approximately 
Ъ-μ thick cryostat sections were made and stained by the indirect immunope-
roxidase procedure, essentially as described previously8, but using 3-3'-diamino-
benzidine tetrahydrochloride (DAB) as chromogen for the detection of peroxida­
se activity. 
A more extensive panel of monoclonal CK antibodies was used than in our 
previous study8, most of which are monospecific for individual CKs. To obtain a 
reference for the staining patterns of these additional antibodies, normal 
urothelium and a series of at least 15 local TCCs of different stage and grade 
were stained. These specimens were taken from the tissue bank described in 
two previous reports8-13. 
Metastatic and local high-grade malignant TCC specimens (n = 33) from the 
bladder or the upper urinary tract were examined. These included 23 TCC 
metastases from 17 different patients and 10 corresponding local TCCs, which 
were primaries or recurrences in the urinary tract. Samples from four patients 
were obtained at autopsy (see Table 1). 
Antibodies. The panel of monoclonal CK antibodies used in this study includes 
most of the reagents described before8 and reacting specifically with CKs4, 7, 
8, 10, 13, 14, 18 or 19. Their reaction patterns in normal transitional epithelium 
are included in Table 2. In addition the following antibodies were used: 
- The mouse monoclonal antibody LL00114 specific for CK14, reacts similar to 
antibody LL002 in normal urothelium and local TCC8. 
- The mouse monoclonal antibody RCK107, specific for CK1418 reacts immuno-
histochemically more extensively than LL001 and LL002, by staining basal cells 
heterogeneously both in normal transitional epithelium and in G1 TCCs. In 
squamous metaplastic urothelium, all cells are positive except for basal and 
some parabasal cells. 
- The mouse monoclonal antibody KA1, reacting with the CK5/14 complex18, 
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ГвЫ 1. Clinical data and morphological characteristics of TCCs used in this 
study (local TCCs and metastases). 
Case - Site 
'Classical' TCC 
1- BLADDER 
LUNG 
2- BLADDER 
LIVER 
3- BLADDER 
LIVER 
4- BLADDER 
LYMPH NODE 
5- BLADDER 
LYMPH NODE 
6- RENAL PELVIS 
LYMPH NODE 
7- RENAL PELVIS 
LYMPH NODE 
Interval 
between the samples 
(months) THERAPY 
2 
V, 
VA 
Cystectomy 
I t t 
Nephrectomy 
Nephrectomy 
-
Bladder radio­
therapy 
-
Radiotherapy & 
chemotherapy 
Chemotherapy 
-
-
Special Invasion front present 
morphologic in the sample 
aspects Y/N 
Y 
N 
Y 
Ν 
Ν 
Y 
Y 
Y 
Necrosis (bladder) Ν 
Severe polymorphism and Y 
tumor giant cells 
Y 
N 
Large eosinophylic cyto- N 
plasm Y 
8- LYMPH NODE' 
9- LYMPH NODE1 
10- LYMPH NODE1 
11- LIVER2 
LUNG 
2 LYMPH NODES 
Chemotherapy 
Autopsy 
Basaloid aspect of the 
cells 
12- LYMPH NODE3 
Carcinomas "deviating" morphologically from classical TCC 
N 
Y 
Y 
Y 
Ν 
Y/Y 
13- LYMPH NODE1 
14- BLADDER 
2 LYMPH NODES 
LIVER 
15- BLADDER NECK 
LIVER 
PITUITARY GLAND 
16- LUNG1 
17- BLADDER 
ABDOMINAL WALL 
ootnotes: 1) primary 
3 
Autopsy 
Autopsy 
Autopsy 
26 
in ureter 
-
Bladder 
radiotherapy 
Chemotherapy 
Both after 
chemotherapy 
Pseudosarcomatous carci­
noma 
Undifferentiated carcinoma 
with giant cells 
Oat cell-like, but neuro-en­
docrine marker N-CAM 
and electronmicroscopy 
are negative 
Extensive squamous me­
taplasia 
Extensive squamous me­
taplasia 
N 
N 
Y/Y 
Y 
Y 
Y 
Y 
Ν 
Ν 
Ν 
2) primary in renal pelvis 
3) primary in bladder 
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stains virtually all basal and several suprabasal cells of normal transitional 
epithelium, whereas squamous metaplastic urothelium is homogeneously positive. 
In most G1 and G2 TCCs in a series of 55 tumors (predominantly the same series 
as described earlier8), basal and several parabasal cells are positive, whereas a 
considerable part of the G3 TCCs is negative. 
- The mouse monoclonal antibody Ks8.12, described to be reactive with CKs13 
and 1617 as well as with CK1516·18, was purchased from Sigma Chemical Co. 
through Brunschwig Chemie, Amsterdam, the Netherlands. In normal transitional 
epithelium, all cells, except for the umbrella cells, are positive. In a series of 59 
TCCs8, this antibody reacted similarly to, although slightly more extensively than, 
our CK13 antibodies 1C7 and 2D7. 
- The mouse monoclonal antibody LL025, specific for CK1615, does not react 
with normal transitional epithelium and only weakly in squamous metaplastic 
urothelium, with negative reaction in basal and some parabasal layers. In a series 
(a part of the series described previously8) of 15 TCCs (G1-3) sporadic positive 
tumor cells were observed only in three out of nine G3 TCCs. 
- The mouse monoclonal antibody E3, reacting with CK17'820, stains normal 
transitional epithelium heterogeneously, usually reacting with a minority of the 
basal cells, although in some samples all cell layers were reactive, with the most 
intense reaction on sporadic umbrella cells. In squamous metaplasia, extensive 
staining is observed in all but the basal and some parabasal cell layers. In 15 local 
TCCs (a part of the series described previously8), basal cells were stained most 
intensely, whereas suprabasal cells were stained with variable intensity. In all 
grades, but especially in G3 TCC, homogeneously positive cases were found as 
well as less extensively stained tumors. One TCC of the "deviating" tumors, 
described in our previous report8, was negative with E3. 
- The mouse monoclonal antibody KA5, recognizing CKs1, 9 and 1021, does not 
stain normal transitional epithelium, whereas squamous metaplasia shows 
extensive staining except for basal and some parabasal cell layers. In a series of 
55 TCCs8 (G1-3) most of the cancers are negative and only a few cases show 
sporadic positive cells. 
- The mouse monoclonal antibody CAM5.2, specific for СК 5, reacts similarly to 
M20, another anti-CK8 antibody8. With this antibody both normal transitional 
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epithelium and the 15 TCCs mentioned above were homogeneously positive. 
Squamous metaplastic urothelium is negative. With respect to CAMS.2, it should 
be kept in mind that this antibody reacted weakly with purified CK722 (unpublis-
hed results from CM Alexander, PC Stasiak and EB Lane6). 
- The mouse monoclonal antibody RV202, is directed against vimentin13. 
RESULTS 
The CK expression patterns seen in the series of TCC metastases from 17 
patients, including 10 cases with corresponding local tumors, are summarized in 
Table 2 and depicted in Figures 1 to 4. Morphologically the TCCs could be 
subdivided into two groups, one with features of classical TCCs and the other 
group with a morphology deviating from classical TCC. 
CK EXPRESSION IN "CLASSICAL " TCCs AND THEIR METASTASES. 
In 12 cases ( with 22 specimens), the lesions were morphologically typical 
transitional cell carcinomas. 
No consistent differences in the expression patterns of the different CKs were 
found when the local TCC and hematogenic or lymphogenic metastasis were 
compared. The vimentin antibody did not stain tumor cells, and the broad-
spectrum epithelial marker RCK102 stained all cases extensively, as did LP2K (to 
CK19). The reactivity patterns of the other antibodies reacting with individual 
CKs can be summarized as follows: 
Cytokeratin 7. 
Homogeneous positive reaction was observed in the 22 specimens of both local 
and metastatic TCC, indicating a complete conservation of CK7 during malignant 
progression. 
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Cytokeratíns 8 and 18. 
The different CK8 and CK18 antibodies showed different staining patterns. LE41 
stained fewer tumor cells than the other two CK8 antibodies CAM5.2 and M20. 
The CK 18 antibody 2C8 stained fewer tumor cells than RGE53, which in its turn 
stained less extensively than the other CK18 antibodies CK18-2 and RCK106. As 
a result of the different degree of staining (both qualitatively and quantitatively), 
particular staining patterns emerged, which can be described as follows (Figures 
1 and 2a-h): 
1 ) Peripherally located carcinoma cell clusters within a tumor lesion were more 
intensely and extensively stained than the more centrally located cell clusters 
(Figures 2a-c). This staining pattern was most prominent with LE41 and 2C8 in 
cases 3 (liver), 4 (lymph node), 5 (lymph node), 6 (renal pelvis), 8, 9, 14 (lymph 
node) and 15 (pititary). 
2) Peripheral individual tumor cells within a given tumor cell cluster ("basal" cells) 
reacted more frequently and more strongly than those located more centrally 
с 
te = tumor cell cluster 
ts = tumor stroma. 
Figure 1. Schematic representation of the "interface phenomenon" in TCC based 
on CK8 and/or CK18 staining. It is characterized by preferential staining of 
carcinoma cells located at the interface with stroma, especially in the invasion 
front. This results in a gradient in expression from the invasion front to the center 
of the tumor. The degree of staining (A local expression, В moderate extensive 
expression, С extensive expression) depends on the antibody used as well as 
tumor qualities. 
tumor nodule 
ö ν 
Abbreviations : 
co 
A 
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within the cluster, depending on which antibody was used (Figures 2d,e) and on 
the localisation of the cluster in the whole tumor lesion (see above). This staining 
pattern was most prominent with LE41 and 2C8 and in a lesser degree with 
RGE53 and was observed only a few times with the other, more extensive 
staining antibodies (cases 3 [bladder], 9 and 11 [lung and lymph node]). In cell 
clusters with minimal CK8 and CK18 expression, staining was often observed to 
be polarised within the cell, located at the stromal side of individual basal cells 
(Figures 2f,g). 
3) In small tumor clusters, relatively more cells seemed to be positive than in 
larger tumor cell groups (Figure 2h). 
Figure 2. Immunoperoxidase staining patterns of frozen sections of local transitio­
nal cell carcinomas or metastases, showing typical staining patterns for the 
different CK8- and CK18-antibodies, illustrated for 2C8 (A, case 4 - lymph node 
metastasis), CK18-2 (B, same case as in A), RCK106 (C, case 9), RGE53 (D, 
case 3 - bladder), LE41 (E, case 6 - lymph node), RGE53 (F, case 3 - bladder), 
2C8 (G, case 3 - bladder) and RCK106 (H, case 9). Magnifications A-C,H x50; D-
F x200; G хЗОО. 
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These distribution patterns were observed consistently, and they hold true for the 
local TCC as well as the metastases. In some cases the phenomenon described 
above was less prominent when a diffuse strong staining reaction was observed 
even with the generally "less extensive" staining antibodies (LE41, 2C8 and 
RGE53). In fact, the expression of CK8 and CK 18 appeared to be conserved 
throughout the final steps of malignant progression. 
Cytokeratin 4 and 13. 
Expression of CK 13, as recognized by the antibodies 1C7 and 2D7, was low in 
10 out of the 12 cases and only sporadically positive cells were found in most of 
these local and metastatic tumors (Figure 3a). In the remaining two cases, 
numbers 7 and 11, all 6 specimens, including one local TCC were extensively 
positive for both CK13 antibodies (Figures 3b,c). 
Expression of CK4 (Table 2) was also very low in most cases and was found to 
be associated with the degree of CK13 expression. The two cases that were 
extensively positive f or CK 13 showed a slightly higher expression level for CK4 
as compared to the other 10 cases (Figure 3d). 
Cytokeratin 16. 
CK16 (Table 2), as recognized by LL025, was mostly found to be focally expres-
sed in a few dispersed cells in a minority of the local and metastatic tumors 
(Figure 3e). The antibody Ks8.12, which recognizes CK13, CK16 and CK15, 
stained the TCCs more extensively than the monospecific CK13 and CK16 
antibodies taken together, suggesting the presence of some CK15. In 3 cases 
that were all negative with the two specific CK 13 antibodies, and of which only 
one showed some positive reaction with the monospecific CK16 antibody LL025, 
there was positive staining with Ks8.12. 
Cytokeratin 17. 
The expression of CK 17 (Table 2) was variable between the samples, even within 
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Figure 3. Immunoperoxidase staining patterns of frozen sections of local transitio-
nal cell carcinomas or metastases, including 2D7 (A, B, C, respectively case 4 -
lymph node, case 7 - lymph node, case 11 - liver), 6B10 (D, case 11 - liver), 
LL025 (E, case 6 - kidney), E3 (F, G, H, case 7 -lymph node, case 6 - kidney and 
case 10, respectively). Magnifications B-D,F,H x50; A,G x75; E x100. 
individual cases (Figures 3f-h). Extensively positive cases were found next to 
cases that showed sporadic positivity in the high-grade malignant local TCC as 
well as in metastases. 
Cytokeratins 1, 9 and 10. 
Only sporadic staining was observed in some tumor cells with antibodies RKSE60 
and KA5, used to recognize cytokeratins expressed in keratinizing differentiation. 
Their expression appeared unrelated to expression of other CKs (Table 2). 
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Cytokeratin 14. 
The three monoclonal antibodies that specifically react with CK 14 (Table 2) all 
gave similar staining patterns when the local and metastatic TCCs were compa-
red. They preferentially stained the basal and parabasal cells (ie, cells at the 
interface with the stroma) with occasional staining in virtually all tumor cells. 
Antibodies LL001 and LL002 reacted similarly. The antibody RCK107 stained 
more cases than the former two, and its reaction pattern was more extensive, in 
that it stained more cells. Antibody KA1, reacting with both CK14 and CK5, 
reacted in a pattern that was neither related to the CK14-specific antibodies nor 
to any of the other CK antibodies. 
CK EXPRESSION IN CARCINOMAS "DEVIA TING "MORPHOLOGICAL!. Y FROM 
CLASSICAL TCC. 
The 5 nonclassical TCCs included 1 ) a (pseudosarcomatous) spindle cell carcino-
ma (case 13), 2) an undifferentiated TCC with tumor giant cells and local spindle 
cell differentiation (case 14), 3) a poorly differentiated carcinoma with small 
basophylic cells (case 15) and 4) two cases of TCC with varying degrees of 
squamous differentiation (cases 16 and 17). 
In this heterogeneous group of tumors striking differences are observed in CK 
expression in comparison to the classical TCCs. In the pseudosarcoma (case 13), 
only vimentin was homogeneously positive expressed. CK8 and CK18 were 
heterogeneously extensive expressed with a gradient pattern for the different 
antibodies, whereas only LE41 gave a negative staining result. The CK8 and 
CK18 did not show zonal differences in staining intensities. A limited expression 
was found for CK 19. Antibody RCK102 reacted extensively positive. 
In case 14 (Figure 4a) the bulk of the tumor showed a comparable reaction 
pattern to the classical TCCs (for example, Figure 4b), with the exception of a 
variable but mostly extensive vimentin staining reaction (Figure 4c). The giant 
cells showed a staining pattern similar to that of the other tumor cells. In only 
one sample from this case was a relationship seen between CK8 expression (with 
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Figure 4. (A) "Undifferentiated" carcinoma of the bladder, shown in a H&E-
stained section (case 14). (B-G) Immunoperoxidase staining patterns of frozen 
sections of local and metastatic urinary tract carcinomas, morphologically 
deviating from the typical transitional cell carcinoma. The sections were incuba­
ted with antibodies LP2K (B, case 14 - bladder), RV202 (C, case 14 - bladder), 
and LP2K (D), 2D7 (E), LL002 (F) and LL025 (G) from case 17 (bladder). Magnifi­
cations D-G x50; Α-C x230. 
LE41 in a lymph node) and the peripheral location of tumor cells (see above). 
The expression pattern of case 15 did not substantially differ from that of the 
classical TCCs, except for a decreased expression of CK18. 
Cases 16 and 17, both with squamous differentiation, showed almost complete 
absence of CK7 expression, an extensive decrease of CK 18 and a slight decrease 
in CK8, predominantly detected with LE41, as compared to the classical TCCs. 
CK19 was focally less extensively expressed (Figure 4d). Incase 16, extensive 
expression of CK4 and CK13 (Figure 4e) was observed, and in both cases 16 and 
17, extensive expression of CK14 (Figure 4f) and CK16 (Figure 4g) also were 
found, whereas CK10 and CK17 antibodies did not stain significantly more cells 
than in all other TCCs. 
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DISCUSSION 
Several rules for the distribution of the various cytokeratins and their combinati-
ons have been described for adult human epithelial tissues, both in the normal 
tissues and benign as well as malignant tumors23. For example, CKs 4 and 13 are 
related to epithelial stratification, whereas CKs7,8,18 and 19 are described to 
be merely associated with glandular differentiation1·3·24. After examination of 
extensive series of normal and malignant epthelial tissues, however, several 
exceptions to these general rules were reported9·12. For example, our immuno-
histochemical studies on urothelium13 and cancers derived there from8 showed 
alterations in cytokeratin expression related to tumor progression. Another 
complicating factor is introduced by a diversity in reaction patterns of individual 
monoclonal antibodies all reactive with the same CK protein. Furthermore 
different tumor compartments showed differences in their cvtokeratin expression 
patterns, whereas the morphologic phenotype also influences the intermediate 
filament composition of cells. In the present study, we compared the cvtokeratin 
expression patterns in local high-grade malignant TCCs, ie, a primary tumor or a 
local recurrence, to those in TCC metastases, with special emphasis on aberrati-
ons as described above. 
Increased expression of cytokeratins 8 and 18'mareas of tumor-stroma interac-
tion. 
From the results presented here, the increased detectability of CK8 and CK 18, 
reported earlier by us to occur during malignant progression of TCC8,25 can be 
placed in a new perspective. By the use of our panel of specific CK8 and CK18 
antibodies, which show different reaction patterns in normal and malignant 
urothelium8·13, given tumor areas were positive for a set of CK8 and CK18 
antibodies, whereas on the same area another set of such antibodies gave 
negative results. The use of this panel of antibodies showing different degrees of 
reactivity with CK8 and CK 18 allows a crude histochemical titration of antigen 
accessibility, if not protein quantity. Quantitation at the cell level is generally not 
possible with the immunoperoxidase detection because the method depends for 
82 
its sensitivity upon a saturation amplification reaction. Furthermore we observed 
regional differences in the staining intensity of TCCs with the antibodies. We 
often noticed the most intense reaction in tumor cells in close proximity to 
stroma and in the periphery of the tumor nodule, ie, the invasion front. At one 
extreme, in several cases antibodies LE41 and 2C8 showed exclusive reactivity 
with cells in these peripheral areas. Similar observations were made in the 
invasion front of otherwise CK8- and CK18-negative non-urological squamous cell 
carcinomas (Schaafsma, to be published) and in epidermal neoplasia™. Cintorino 
et al27 also commented upon more intense staining reaction at the front of a 
deeply infiltrating TCC. We interpret this staining pattern as an "interface 
phenomenon", as we think that the expression in the tumor cells is influenced by 
their micro-environment, ie, the stroma. Therefore the tumor cells at the interface 
with the stroma show the most prominent changes in expression. 
We would suggest that either these different antibodies recognize different 
configurations of the CK8 and CK18 antigens or that these areas contain higher 
amounts of these proteins. The suggestion made in our previous report8 that 
reactivity with LE41 or 2C8 of high-grade malignant TCC cells in local tumors 
might detect a potentially metastatic clone, is not supported by our current 
findings in TCC metastases. The fact that the metastatic lesions showed similar 
regional distribution patterns of CK8 and CK18 epitope configurations is more in 
line with the idea of stromal components influencing the phenotype of adjacent 
tumor cells. The reason for not appreciating this phenomenon in our earlier study 
lies in the fact that in the previous study, small fragments of transurethral tumor 
resections were used, making orientation very difficult. We did, however, observe 
and report the more extensive reaction in the infiltrative tumor compartment as 
compared to the exophytic growing high-grade malignant componenf. Extensive 
CK8 and CK18 expression, as observed in umbrella cells of normal transitional 
epithelium, as well in tumor areas in close proximity to stromal cells could be a 
result of related phenomena. In both situations the CK8/18 positive cells "seal 
off" the epithelium from its environment. Further studies are in progress to 
examine the cell biological background of these observations. In our experiments 
we will explore two possible explanations. One is the possible relationship 
between CK8/18 expression, characteristic of secretory or glandular cells, and a 
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possible secretory function of the TCC cells at the stroma border, ie, specializa-
tion of tumor cells. The second possibility is that a relation exists between the 
quantitative and qualitative changes in the cytoskeleton of these cells and the 
loss of differentiation in neoplasms11 or immaturity in embryological tissues28, 
resulting in increased flexibility of the cytoplasm, as might be needed for cell 
migration. 
Cytokeratin 13 can be expressed extensively in TCC metastases. 
Our earlier observations8,13 and those of Moll et al10 showed that with progression 
of TCC (GIpTa to G3pT2), CK13 expression decreased in the tumor cells. 
Therefore we assumed to find low CK13 expression levels in TCC metastases. In 
an extended series of metastatic TCCs, this hypothesis was only partly confirmed 
by the present study. The 23 metastases examined showed CK13 expression 
similar to that described for high-grade malignant local TCCs9. Of the 10 cases in 
which the reaction patterns could be directly compared to those in the matching 
local cancer, nine cases showed a similar staining pattern in both tumor stages. 
For example, in three cases (cases 7,11 and 17), where the local TCC showed 
an extensive CK13 expression, this was also found in the metastases. In other 
cases (except one), where the local tumor showed low CK13 levels, the metasta-
sis also showed a very limited reaction with the CK13 antibodies. Case 15 
showed extensive CK 13 reactivity in the local tumor but loss of this reactivity in 
the metastases. Only in one case (no. 17) could squamous metaplasia explain the 
extensive CK13 expression in this otherwise typical high-grade malignant TCC. 
Moll et al10 descibed absence of CK13 in their series of five TCC metastases 
except for one case, which also showed squamous metaplasia. In our series the 
extensive CK13 expression of two cases (cases 7 and 11 ) remained unexplained, 
although in one case the cytoplasm of the tumor cells was relatively large and 
eosinophilic as seen by hematoxylin and eosin (H&E) staining, which might 
indicate early stages of squamous differentiation. It should be noted, however, 
that carcinomas of the squamous phenotype do not necessarily contain CK13. 
For example. Broers et al11 reported a decrease in CK13 expression upon dediffe-
rentiation of squamous cell carcinomas of the lung, resulting in 50% CK 13 
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negative cases in poorly differentiated squamous carcinomas. Kuruc et al29 
showed that CK13 is not expressed in squamous cell carcinomas of the skin, alt-
hough this had been expected on basis of results of Nischt et aP° and because of 
its transient expression in certain stages of fetal skin development'. Our prelimi-
nary studies in head and neck mucosal squamous cell carcinomas are in line with 
these observations, in that CK 13 is not a major component in these tumors (to be 
published). 
Cytokeratin 16 as an indicator of squamous differentiation 
CK16 has been reported to be related to hyperproliferation in stratified epithelial 
cells63233, but it has also been correlated with a basal cell phenotype in certain 
malignancies16. As expected, we did not find a significant reaction in normal 
transitional epithelium for CK16. In squamous metaplasia in the bladder, howe-
ver, CK16 expression was found in most suprabasal cells. In both local bladder 
cancers as well as in the metastases, CK16 (as recognized by LL025) was only 
found sporadically in scatterd cells, except for the two cases with squamous 
metaplasia, which displayed more extensive positive reactivity. Our immunohisto-
chemical observations concerning CK16 are generally in line with gel electropho-
retic data10-34. The results suggest a relation of CK16 with squamous differentia-
tion, rather than with proliferative state, at least in the bladder. This assumption 
may be supported by the observation that the metastasis of case 7 also showed 
a relatively high CK16 level. In this case, CK16 expression might be related to the 
expression of CK13, a marker for stratified, squamous epithelium which is not 
keratinizing. In this particular case, however, morphological characteristics for 
such a type of differentiation were not found, although a suggestion was present 
in the extensive eosinophilic cytoplasm of some cells. 
Antibody Ks8.12 showed a more extensive staining pattern than we would 
expect from the combined results of antibodies 1C7, 2D7 and LL025. Recent 
reports now suggest that this antibody reacts with CK15 1 fMe as well as the 
earlier described CK 13 and CK16 reactivity. Data presented here therefore point 
to the expression of CK 15 particularly in TCCs with "deviating" morphology, but 
not or to a much lesser extent in the typical TCCs. This might also explain why 
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expression of CK15 in ТСС was not reported earlier 
Cytokeratin 7 as marker for transitional cell differentiation 
In normal transitional epithelium, CK7 is expressed homogeneously in the upper 
urinary tract but heterogeneously in the lower part13. This is observed with two 
independent monoclonal antibodies to CK712. In TCCs, also those in the bladder, 
the expression of CK7 is in general homogeneous. In the differential diagnosis of 
carcinomas, CK7 can be used as an indicator for urothelial differentiation12, 
especially in male, where it can distinguish urothelial malignancies from, for 
example prostate cancer, renal cell carcinomas etc.. We must keep in mind, 
however, that the expression of CK7 can be found to be decreased, particularly 
when squamous differentiation is present8. 
Cytokeratin 17 
Using our immunohistochemical procedure, the expression of CK 17 appears to be 
less extensive in normal urothelium than in local TCC and metastases. No relation 
was observed between advanced stage and increased CK17 expression, because 
a number of advanced cancers with only limited expression of CK17 were also 
found. No morphological explanation or relation to expression patterns of other 
CKs could be found in these TCCs with limited CK17 expression. It was striking 
that, in the two TCC cases with squamous metaplasia, no increase of CK17 
expression could be seen, although extensive CK17 expression was found in 
normal squamous metaplastic urothelium. Our immunohistochemical results 
appeared to be in line with the gel electrophoretic data of Moll et al10. 
Cytokeratin 14 
In this study, the panel of CK14 antibodies was extended from our earlier study. 
Two different sets of results were obtained. LL001 and LL002 were both 
negative in normal transitional epithelium; conversely, RCK107 was reactive with 
several basal cells in normal urothelium. This difference also was present in the 
RR 
cancers, frequently with more staining by the latter antibody. In general, LL001 
and LL002 reacted similarly. In our previous study9, an increase of CK 14 expres-
sion was noted in parts of the tumors during tumor progression. We reported that 
this increase was not consistently present in tumors infiltrating muscle. From the 
results of the present study, we could even state that there is no relation of 
CK 14 expression and the metastatic potential of TCC. Extensive CK14 expressi-
on was found only in one case of the two TCCs with squamous metaplasia. No 
constant relation between increase of CK14 and CK13 expression was detected. 
The antibody KA1, described as recognizing complexes of CK5 and CK14, 
reacted extensively in basal cells of normal transitional epithelium and in the 
majority of G1 and G2 TCCs studied in our series. These results are in accord 
with data of Moll et al10. No consistent pattern of CK expression was noted with 
increasing degree of malignancy for this antibody. 
Independent of morphological characteristics, the expression patterns of individu-
al CKs observed in this series of TCCs showed interrelationships only for CK8 and 
CK18 and to a minordegree between CK4 and CK13; some crude quantitative 
relation appeared to exist between CK17 and CK14 if CK14 expression was 
determined with antibody RCK107. 
Conclusions. We conclude from the present and previous studies that for human 
urothelium, CK expression is not fully conservative during neoplastic progression. 
Expression patterns in TCC depend on morphological characteristics and type of 
differentiation, the degree of anaplasia, and on interactions with the microenvi-
ronment. 
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ABSTRACT 
The immunohistochemical expression patterns of cytokeratins 8 and 18 and of 
vimentin were examined in frozen sections of 120 human mucosal squamous 
cell carcinomas with special emphasis to the topological distribution in the 
tumour. This was done in order to evaluate in squamous cell carcinoma a 
particular expression pattern observed recently by us in transitional cell carci­
noma of the urinary tract and designated as "interface phenomenon". This 
phenomenon implying maximal expression of cytokeratins 8 and 18 at the 
tumour front and to a lesser extent also in areas of intratumorous stroma con­
tact, was also found in about 50% of the squamous cell carcinomas examined. 
It was also found for vimentin, which contrasted with transitional cell carcino­
ma. The percentages of occurrence of the phenomenon varied for the different 
sites of origin of the tumour. Tumour grade did not influence the results. These 
findings further supported the idea that invasive carcinoma cells interacting with 
the stromal micro-environment display a characteristic intermediate filament 
phenotype that deviated from the pattern expected on the basis of their 
direction of differentiation. These changes might reflect a phenotype involved in 
invasive, migrating, and proliferating activities. 
INTRODUCTION 
In early studies of intermediate filament protein expression, cytokeratin and 
vimentin were considered as typical for epithelial and mesenchymal differentiati­
on, respectively \ However, an increasing number of reports indicated coex-
pression of vimentin and cytokeratins in nonneoplastic and neoplastic epithelium 
(for reviews see 2 Э) thus complicating these initial expectations. Even coexpres-
sion of cytokeratin in mesenchymal tissue was observed 3-4. With respect to the 
different cytokeratin polypeptides occurring in specific combinations within the 
different epithelia 6, the early reports also suggested a strong preservation of 
the original combination of cytokeratins in a specific epithelium during malignant 
transformation 6. However, when comparing the normal situation to a diversity 
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of biological in vivo and in vitro situations such as hvperproliferation e, premalig-
nancy 7, neoplastic growth 81° or tissue culture 11, changes in cytokeratin 
expression patterns were also observed. 
The original "rules" of vimentin and cytokeratin expression are still helpfull, 
although new insights have shown the situation to be more complex. For exam­
ple, cytokeratin 7 is, as a rule, expressed in many simple epithelia and remains 
predominantly restricted to adenocarcinomas 12. It is only sporadically and 
focally expressed in squamous cell carcinomas 12,1Э. On the other hand, cy to ke­
ratins 8 and 18, also considered as specific for simple epithelia in earlier studies 
s
·
1 4
, are found variably in squamous cell carcinomas s e ·1 3 ·1 6. A positive correlati­
on between increased expression of cytokeratin 8 and 18 and an increase in the 
histological grade of anaplasia s had been reported. Only recently, a relationship 
of cytokeratins 8 and 18 expression with location of carcinoma cells at the 
tumour invasion front or in other areas of stroma interaction 1 β · 1 7 had been 
noticed. An increased expression of vimentin in carcinomas was found to be 
related to parameters of malignant potential such as grade, growth fraction, 
hormone independency and survival rate 1β~22. Encouraged by these data we 
have studied such topographical expression patterns in carcinomas, in particular 
those with expected low amounts of cytokeratin 8, 18 and vimentin, i.e. 
squamous cell carcinomas 5. 
MATERIALS AND METHODS 
Tissues. One hundred and twenty fresh tumour samples of squamous cell carci­
nomas from different mucosal sites were obtained after surgery (Tables 1 and 
2). A small sample from the specimen was snap frozen in liquid nitrogen and 
stored until further use. From the head and neck region we collected 80 
samples of non-irradiated, squamous cell carcinoma lesions (from 61 different 
patients) including 65 primary tumours and 15 samples from lymph node meta­
stases. 
Forty squamous cell carcinoma samples were derived from the vulva, 
oesophagus and lung. 
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Spindle cell carcinomas were not included in this series. 
Samples were preferentially taken from the transition zone between tumour and 
surrounding tissue. The pathology diagnosis was made on routinely processed 
tissue samples. The carcinomas were graded according to WHO criteria 23. 
Immunohistochemistry. The indirect immunoperoxidase technique was applied 
to approximately 5 micron thick parallel cryostat sections essentially as descri-
bed before e. The panel of monoclonal antibodies consisted of the chain-specific 
anti-cytokeratin 8 antibodies Cam5.2 1B·24·26 and M20 4e, the anti-cytokeratin 18 
antibodies 2C8 8, RGE53 u , CK18-2 " and RCK106 ", and the anti-vimentin 
antibody RV202 ". The slides were assessed by one experienced pathologist. 
The degree of cytokeratin staining was scored as - (negative), ± (limited 
staining, i.e. less than 50% of the cells were positive) or + (extensive staining, 
i.e. more than 50% of were positive). In some occasions a sporadical positivity 
was mentioned separately representing less than 1 % positive cells. Vimentin 
staining was scored in only two divergent groups, one showing extensive 
positivity (more than 75% of the carcinoma cells were positive) and the other 
showing focal positivity (less than 25% of the cells were positive). 
RESULTS 
Expression of vimentin. (Table 1 and Figure 1 ) 
In each carcinoma several scattered positive cells could be detected, which we 
considered to represent lymphoid cells, and were therefore left out of con-
sideration. Most of the carcinomas examined were predominantly negative for 
vimentin. In 58 (48%) samples vimentin positive carcinoma cells were found. 
Two types of vimentin staining patterns of the tumour cells could be observed 
(see Table 1). The first pattern consisted of a randomly extensive staining of 
(large) areas of the carcinoma (Figures 1a-d). The second pattern was formed 
by (small) positive cells clusters of basal and parabasal cells, located preferen-
tially in extensions protruding from the tumour cell clusters (Figures 1e-g). The 
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Table 1 : Vimentin staining patterns in mucosal squamous cell carcinomas. 
tumour site, grade and number 
of cases 
FLOOR of MOUTH G1 n = 3 
G2n = 7 
G3n = 4 
TONGUE G1 n = 5 
G2n = 10 
G 3 n = 3 
TONSIL G1 n = 4 
G2n = 5 
G3n = 2 
LARYNX G1 n = 10 
G2n = 8 
G3n = 19 
LUNG Gl n = 9 
G2n = 10 
G3n = 8 
OESOPHAGUS G2n = 3 
G3n = 3 
VULVA G1 η = 2 
G2n = 5 
EXTENSIVE 
staining * 
-
4 
2 
1 
-
1 
-
-
LIMITED 
staining · · 
2 
3 
3 
3 
4 
3 
2 
1 
2 
3 
6 
1 
3 
4 
3 
1 
1 
5 
total number 
of positive 
cases 
(percentage) 
8 (57%) 
13(72%) 
7 (64%) 
11 (30%) 
9 (33%) 
4 (66%) 
6 (86%) 
* Extensive positivity in more than 75% of the tumour cells 
** Focal positivity in less than 25% of the tumour cells, especially in which cells 
located in small tumour cell clusters and protrusions were stained. 
number of vimentin positive cases was approximately the same in samples 
containing the most peripheral part of a tumour as compared to samples contai­
ning centrally located portions. The smallest cell clusters that showed strong 
vimentin staining were most frequently found in the outer rim of the con­
glomerate. The number of vimentin positive epithelial cells in the protrusions 
varied, ranging from a few cells to many cells in most of the buddings. The fre­
quency of vimentin positive cases differed between carcinomas from different 
sites of origin (Table 1). The 15 metastases from the head and neck carcinomas 
showed equal vimentin expression levels as their primary lesions. No relation 
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was found between the presence of vimentin expression and the degree of kera-
tinization or other parameters of tumour grade. 
Figure 1. Immunoperoxidase staining in frozen sections of mucosal squamous 
cell carcinomas. Extensive vimentin staining is shown in A and C, while in 
parallel sections (B stained with M20; D stained with CAM5.2) the carcinoma­
tous area (in С and D small arrows are placed inside a cluster of carcinoma 
cells) also shows expression of cytokeratin 8. Note in parallel sections С and D 
that adjacent squamous epithelium (large arrow) is negative for cytokeratin 8 
(CAM5.2) and vimentin. 
Ε-G: Preferential vimentin expression in the tumour front (E; front at the left 
side, see small arrows) and tumour buds (F and G) 
Magnifications: А,В 75X; C,D 150X; E 125X; F 250X; G 500X. Tumour origin: 
tongue (Α-D), tonsil (E), lung (F), vulva (G). 
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Expression of cytokeratins 8 and 18 (Tables 2 and 3; Figure 2) 
Expression According to Cell Types 
Both cytokeratins 8 and 18 were frequently (in 90% of the cases) expressed in 
the squamous cell carcinomas examined (Table 2). Their distribution pattern 
was heterogeneous, while the number of positive cells varied considerably 
between different cases and between different regions within the same tumour. 
Cytokeratins 8 and 18 were found to be preferentially expressed in the perip-
heral (basal) cells of the tumour cell clusters, often extending into the parabasal 
region. In some cases all cells of a tumour cell cluster were found to be positive. 
Occasionally a rim of cytokeratin staining was found only at the stromal side of 
basal cells (Figures 2a,b). 
In sporadic cases (6 out of 120 samples) cytokeratin 8 and 18 staining was 
found focally in the suprabasal cell layers (Figure 2c) or only in the layers 
bordering cornifying cells (Figure 2d), while the other layers were predominantly 
negative. 
Expression According to Tumour Area 
When surveying the architecture of the tumour it became evident that 
cytokeratin 8 and 18 expression was often found in the area of the tumour front 
with the surrounding tissue. This phenomenon was observed in about half of 
the 74 samples, in which the outer rim of the tumour was present (see Table 3 
and Figures 2e-g). The basal and parabasal cells at the tip of the protruded cell 
clusters often showed the highest expression levels. This phenomenon was 
observed in tumours of different grade and degree of keratinization. 
Cytokeratin Gradients as Detected by Different Antibodies 
The 2 anti-cytokeratin 8 antibodies Cam5.2 and M20, produced similar staining 
patterns, although Cam5.2 staining patterns were generally slightly stronger 
and/or more extensive than those for M20. In 8 head and neck carcinomas, 
however a significantly lower staining level or even a negative result was seen 
with M20 (Figure 3), while Cam5.2 stained more extensively. 
The four different anti-cytokeratin 18 monoclonal antibodies also showed 
quantitative differences with respect to the proportion of positive tumour cells 
(Figures 2h-j and Figure 3). Firstly, the antibodies RCK106 and CK18-2 stained 
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Table 2: Cytokeratin 8 and 18 levels as detected by antibodies CAM5.2 and 
RCK106, respectively, in mucosal squamous cell carcinomas and scored to 
tumour grade, irrespective of tumour area. 
tumour site, grade and 
number of cases 
FLOOR of G1 n = 3 
MOUTH G2n = 7 
G 3 n = 4 
TONGUE G1 n = 5 
G2n = 10 
G3n = 3 
TONSIL G1 η = 4 
G2n = 5 
G3n = 2 
LARYNX G1 η=10 
G2n = 8 
G3n = 19 
LUNG G1 n = 9 
G2n = 10 
G3 n = 8 
OESOPHAGUS G2n = 3 
G3n = 3 
VULVA G1 n = 2 
G2n = 5 
EXTENSIVE 
staining 
8' + 
18 + 
1 
4 
2 
1 
2 
2 
10 
6 
7 
4 
1 
8 + 
18± 
1 
2 
1 
1 
3 
1 
2 
8 ± 
18 + 
1 
1 
3 
1 
1 
LIMITED 
staining 
8 ± 
18± 
1 
2 
1 
2 
3 
1 
1 
4 
1 
4 
4 
2 
1 
1 
2 
2 
1 
8 ± 
18-
1 
1 
1 
1 
1 
8-
18± 
1 
1 
1 
2 
1 
1 
1 
1 
1 
1 
1 
NEGA­
TIVE 
1 
2 
1 
1 
2 
2 
2 
1 
• cytokeratin number. 
Extensive staining and + indicate that more than 50% of the (basal and parabasal) 
cells are positive. 
Limited staining and ± indicate that less than 50% of the (basal and parabasal) cells 
are positive. 
Negative and - indicate that no specifically stained cells are found. 
similarly and most extensively, although RCK106 reacted slightly more exten­
sively than CK18-2. Secondly, RGE53 showed less extensive staining patterns 
and lower numbers of positive cases as compared to RCK106 and CK18-2. 
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Figure 2. Immunoperoxidase staining in mucosal squamous cell carcinomas for 
cytokeratins 8 and 18, employing different monoclonal antibodies. Note the 
linear staining at the stromal side of peripherally located carcinoma cells as 
shown in A and В with antibody CAM5.2 . С shows a random staining pattern 
with M20, while in D only the cell layer directly beneath the keratinized cells is 
stained with CAM5.2. 
Ε-G: Most staining is shown in the tumour front (at the left side of the figures) 
with antibodies CK18-2, RCK106 and M20, respectively. 
Η-J: Gradient pattern for cytokeratin 18 in a pulmonary squamous cell carcino­
ma displaying most staining with RCK106 (H), slightly less staining with RGE53 
(I), while in a detail of the same area as shown in H and I only weak staining is 
seen with 2C8 (J, arrows). Note strong staining of residual alveolar cells in J . 
Magnifications: A,B 200 X; C,D 100 X; E-l 60 X; J 120 X. 
Origin of tumours: larynx (A,B,C,G), floor of mouth (D,E), tonsil (F), lung (H-J). 
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Finally, the least staining was observed with 2C8. As a result the 2C8 positive 
areas were increasingly overlapped by RGE53, CK18-2 and RCK106 positive 
areas. Basically, the results taken together indicate that a so-called "gradient-
pattern" exsists for the extent of staining by the anti-cytokeratin 8 β '1 β and 18 
antibodies. 
Cytokeratin 8 versus 18 
The tumour staining patterns for cytokeratin 8 and 18 were generally related to 
each other. Overlap of the staining patterns was, however, not complete. Fre­
quently the positive areas were distributed differently or their staining levels 
varied (Table 2). 
EXTENSIVE iHÜ L IMITED D i SPORAD I CAL LZZ NEGAT I VE 
tongue larynx oesophagus 
Figure 3. Levels of cytokeratin 8 and 18 expression in mucosal squamous cell 
carcinomas (G1-3) of different sites of origin, as monitored by the 6 different 
monoclonal antibodies used. 
Extensive positivity: more than 50% of the cells are stained. 
Limited positivity: less than 50% of the cells are stained. 
Sporadical positivity: only very few (less than 1 %) cells are positive. 
Negative: no specific staining of tumour cells is seen. 
The 6 individual bars per tumour type represent the results of the 6 antibodies, 
i.e. 1: CAM5.2, 2: M20, 3: RCK106, 4: CK18-2, 5: RGE53 and 6: 2C8. 
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Tumour Staining Levels According to Site of Origin 
The expression levels of both cytokeratins 8 and 18 as well as vimentin varied 
between the tumours from different sites of origin (Table 1 and Figure 3). 
Pulmonary squamous cell carcinomas showed a rather extensive cytokeratin 8 
and 18 staining reaction, while for example, vulvar carcinomas showed low 
levels of cytokeratin expression. In this series no consistent differences in the 
staining patterns between the primary tumour and metastasis were noticed. 
Although vimentin was also positive in these same types of budding tumour 
areas, no consistent topological correlation with the cytokeratin expression was 
seen (Table 3). 
DISCUSSION 
Although little is known about the function of the different types of intermediate 
filaments, new perspectives have been opened up by, as yet incompletely 
understood patterns of cytokeratin subtype and vimentin expression in the cour­
se of neoplastic disease 21·22·2·. Recently, we described the influence of the 
position of tumour cell clusters within transitional cell carcinoma on cytokeratin 
8 and 18 expression ia. In such tumours increased cytokeratin 8 and 18 
expression was found especially in the invasion front and to a lesser degree in 
areas of intratumorous stroma contact. In the present study we examined squa­
mous cell carcinomas of diverse sites of origin for this so-called "interface 
phenomenon". The normal squamous epithelium did not in general express 
cytokeratin 8 or 18 when tested with our antibodies. Squamous cell carcinomas 
were chosen because of their supposed low expression levels of cytokeratins 8 
and 18, in contrast to adenocarcinomas which normally show high levels of 
these intermediate filament protein subtypes 6. Although in our initial study 1β 
vimentin did not exhibit the interface phenomenon in transitional cell carcinoma, 
we included this intermediate filament protein in the present study, because of 
reported vimentin expression in squamous cell carcinoma 1β·27·2β. 
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Table 3: The number of cases showing cytokeratin 8 and 18 expression in the 
tumour invasion front (middle column) or with simultaneous vimentin expression 
in the invasion front area (right column)'. 
tumour site, grade and number of 
cases 
FLOOR of MOUTH G1 n = 3 
G2n = 5 
G3n = 3 
TONGUE G1 n = 3 
G2n = 7 
G3n = 3 
TONSIL G1 n = 1 
G2n = 3 
G3n = 1 
LARYNX G1 n = 7 
G2n = 5 
G3n = 13 
LUNG G1 n = 4 
G2n = 5 
G3n = 3 
OESOPHAGUS G2n = 2 
G3n = 3 
VULVA G1 n = 1 
G2n = 2 
totals η = 74 
increased expressi­
on of cytokeratin 8 
and/or 18 in the tu­
mour invasion front 
2 
3 63% 
2 
2 
4 69% 
3 
1 20% 
3 
2 36% 
4 
1 
1 4 1 % 
3 
40% 
2 
66% 
2 
35 48% 
simultaneous 
expression of vi-
mentin and 
cytokeratin 8 
and/or 18 in the 
tumour invasion 
front 
1 
2 
1 
2 
3 
3 
-
-
-
1 
1 
14 out of 35 
* Only those samples that actually contain a tumour margin (74 of the 120 samples) 
are scored. 
Simple Cytokeratins in Squamous Ceil Carcinomas 
Our present panel of cytokeratin subtype specific antibodies indicated gradients 
of expression of these constituents, especially for cytokeratin 18 in transitional 
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cell carcinomas and squamous cell carcinomas 8>1β. Such reaction patterns for 
cytokeratin subtype antibodies have also been described by others and related 
to antigen quantity or the epitope masking phenomenon 2e. Bosch et al. 2 β 
demonstrated cytokeratins 8 and 18 in basal cells of normal mucosal squamous 
epithelium, although in very low concentrations. These authors related the pre­
sence of these cytokeratins to the proliferative potential of the cells In these lay­
ers. In their view it was therefore understandable that cytokeratins 8 and 18 
were expressed in growing squamous cell carcinoma. 
As expected and in line with the results of others 9 · 1 5 we found most squamous 
cell carcinomas examined to express cytokeratins 8 and 18 rather commonly, 
although in variable degrees. In our study the expression level was not found to 
be related to tumour grade, as reported by others β,1β. However, In our view an 
additional important aspect was the topographical distribution of the cells 
expressing cytokeratins 8 and 18 1β. In the squamous cell carcinomas that we 
had examined these cytokeratins were predominantly expressed in the periphe­
rally located (basal) tumour cell. It is even more worthy of note, that the most 
likely area of detection is in the outer rim of the whole tumour, i.e. the invasion 
front, a phenomenon not observed for other cytokeratins (unpublished observa­
tions). This interface phenomenon was not found at every tumour margin. 
Similar observations of cytokeratin 8 and 18 expression in the stroma-tumour 
interface had been reported for squamous cell carcinoma derived from the 
keratinizing squamous epithelium of the skin 17. These findings showed that 
squamous cell carcinomas originating from normally keratinizing squamous 
epithelium might also express cytokeratins 8 and 18 and that this phenomenon 
was not only restricted to squamous cell carcinoma derived from mucosal 
epithelia. 
From Figure 3 it can be seen that expression of both cytokeratins 8 and 18 
occurs to a higher extent in the squamous cell carcinomas that originate from 
simple epithelia through squamous metaplasia (for example lung) as compared 
to those derived from pre-existing squamous epithelium. In this respect, the 
recent observations by Smedts et al. 13 in cervical squamous cell carcinoma 
support this finding. 
ms 
Expression of Cytokeratins 8, 18 and Vimentin in relation to Proliferation 
The observation that vimentin could be expressed in basal and parabasal cells of 
squamous cell carcinomas, and especially in cells budding from tumour cell clus­
ters, will for practical reasons be evaluated together with the peripheral expres­
sion of cytokeratins 8 and 18. 
These zonal phenomena have not yet been fully appreciated. For interpretation 
of these phenomena we have to consider firstly that the expression of a certain 
cytokeratin subtype is not necessarily monofunctional. This might especially be 
the case for cytokeratins 8 and 18. On the one hand they represent "primitive" 
cytokeratins expressed in early tissue development during embryogenesis 4 3 0 · 3 1 , 
and on the other hand they make up intermediate filaments in highly differentia­
ted and specialized tissues Б. At first sight this indicates diverse function. The 
expression of cytokeratins 8 and 18, and also of vimentin, in the embryo might 
be ¡nterpretated as being related to the undifferentiated state of cells or a 
transient type of differentiation, cell migration, proliferation, poor cell cohesion, 
etc. These conditions could be correlated in experimental situations with an 
increase in the appearance of vimentin and to a lesser extent also with an 
increased expression of cytokeratins 8 and 18 in tissue culture of squamous cell 
carcinoma and ascites or pleural effusion 11-3234. The above mentioned cellular 
processes may also play a role in solid cancer. 
Few reports on the relation between intermediate filament expression patterns 
and the biological behaviour of a tumour are available M. In this respect, recent 
publications on the presence of vimentin in breast carcinoma in relation to 
expression of the proliferation-associated marker КІ67, metastatic potential and 
prognosis are important 2 1 " . Coexpression of vimentin and cytokeratins in 
several other types of cancer has been reported to be correlated with a poor 
prognosis, but frequently this was only related to tumour grade 1 8 · 2 0 . 
Although in this study maximal expression of cytokeratins 8 and 18, as well as 
vimentin, was found in the proliferating front of squamous cell carcinomas, we 
were not satisfied with the hypothesis that the expression of these constituents 
was fully due to supposed proliferative activity of the tumour cells in this 
region. Recent data on cytokeratin 8 neo-expression in mouse skin squamous 
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cell carcinoma and absence of cytokeratin 8 in papilloma have been described 
as being important in relation to invasive growth ЗБ. Furthermore, an essential 
role of cytokeratin 18 in the invasive and metastatic behaviour of a melanoma 
cell line was suggested by Chu et al. з е . We must keep in mind that at the 
stroma-tumour interface, and especially in the tumour front several biological 
events take place. Possibly, differences in the physiological environment or 
status of cells in this area, for example, the presence of resting cells, might 
explain local differences in intermediate filament expression patterns. A morpho­
logical argument against the proliferation hypothesis and in favour of a corre­
lation between cytokeratin 8 and 18 expression on the one hand and an inter­
action with the neighbouring cells on the other hand, was the preferential 
presence of these proteins at the stromal side of the tumour cells (Figures 2a,b 
and similarly 1g). 
Environmental influences on cytokeratin expression 
Data on all sorts of environmental influences on cytokeratin expression must be 
taken into account when interpreting the cytokeratin 8 and 18 expression 
patterns as described above 3 7 · 3 8 . 
Treatment of the squamous cancers by means of radiotherapy and/or 
chemotherapy was shown to influence intermediate filament expression patterns 
in these tumours. Fischer et al. 2 8 correlated vimentin expression in head and 
neck cancers to previous non-surgical treatment. They found expression of 
vimentin in a lower percentage of cases compared to our study. This was 
remarkable as in our study only non-previously treated cases were included. 
This difference might be explained by the use of different antibody panels and 
other technical factors. 
Recent reports have shown an influence of underlying mesenchyme or base­
ment membrane component on cytokeratin expression in epithelial cells 3 M 0 . 
Collagen VII, which constitutes to the anchoring filaments of the basement 
membrane, was reported to be absent around simple epithelia which were 
cytokeratin 8 and 18 positive, and to be present at the border of stratified 
(squamous) epithelia 4 1, which are normally negative for cytokeratins 8 and 18 
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2 β
. This basement membrane constituent was also abundantly present in squa­
mous cell carcinomas of .different origin, but might be absent in the invasion 
front 41-42. It was therefore tempting to test the hypothesis of the coincidence of 
cytokeratin 8 and 18 or vimentin positive cell buds on the one hand, and the 
absence of collagen VII around these structures on the other hand. Our prelimi­
nary studies have not so far shown such a correlation (unpublished data). 
Cytokeratins 8 and 18 are not always associated with Vimentin 
In this study, we found co-localisation of vimentin and cytokeratins 8 and 18 in 
only a minority of cases. In most squamous cell carcinomas examined these 
intermediate filament proteins showed apparently independent expression 
patterns. Coexpression of vimentin and cytokeratins has been reported before in 
head and neck squamous cell carcinoma 1 e · 2 8 . Wallner et al. 2 7 have noted that 
vimentin and cytokeratin are coexpressed mainly in the tumour invasion front. In 
these studies, however, broad-spectrum cytokeratin antibodies, often recogni­
zing several of the cytokeratin subtypes, were used. In our study we concen­
trated deliberately on two cytokeratin subtypes normally not present in squa­
mous epithelium, i.e. cytokeratins 8 and 18. Henzen-Logmans et al. 1 8 have des­
cribed a relation in squamous cell carcinoma between tumour grade and vimen-
tin expression, while others have not found such a relationship " · 2 β . In our study 
the small cell clusters positive for cytokeratin 8, 18 or vimentin could be also 
found in well-differentiated carcinomas. 
Conclusions. Aberrant expression of cytokeratins 8 and 18 in squamous cell 
carcinoma has previously been related to tumour progression, emphasizing the 
role of grade of anaplasia 9 · 1 8 . In the present immunohistochemical study of 
squamous cell carcinoma lesions, the topographical localization of distinct tumor 
cells, i.e. at the stroma-tumor interface, was shown to be of special importance 
for expression of cytokeratins 8 and 18 and vimentin. This suggested a particu­
lar phenotype of the carcinoma cells involved in an environmental interaction 
that is expected to be most prominent during invasive growth. Further explora­
tion of the biological basis of this phenomenon and its possible prognostic 
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significance is needed. 
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INTRODUCTION 
Conventional pathology diagnosis is estimated to offer problems and to remain 
inconclusive in 4-10% of the neoplasms examined \ Part of these difficulties is 
a consequence of inadequate sampling and poor preservation of biopsies. In the 
more optimally sampled cases, additional techniques can help to reach a more 
precise diagnosis. In particular this is the case in those lesions where the type 
of differentiation or primary site of a certain cancer is unclear on basis of routine 
histology, using conventional staining techniques. Immunocytochemical proce­
dures play a major role in obtaining extra information on the type of cells, in 
particular since many tissue markers have been identified and antibodies to 
these antigens are available. In this respect, reagents the to cell lineage depen­
dent proteins that constitute the intermediate filament proteins (IFPs) play a 
central part. This family of cytoskeletal proteins has been described to consist 
of 6 types, classifying different tissues. The largest group of IFPs is formed by 
the cytokeratins (CKs), which are mainly found in epithelia. CKs are divided into 
type I (small, acidic; including CK9-CK20) and type II (large, neutral to basic; 
including CK1-CK8) 2'3. Type III IFPs comprise the mesenchymal protein vimen-
tin, the protein desmin specific for muscle tissue, glial fibrillary acidic protein 
expressed in glial cells and astrocytes 4 and peripherin specific for neuronal cells 
5
. Type IV IFPs consist of the neurofilament protein triplet expressed in nerve 
cells e, type V the nuclear A and B-type lamin proteins which constitute the 
nuclear lamina 7 e and the type VI IFP compises nestin, specific for CNS stem 
cells 10. In pathological situations and during neoplastic growth these cell lineage 
markers are generally retained, although switches in their expression patterns 
have been found (for recent reviews see 1 1 1·1 8). 
CYTOKERATINS 
In human tissues, cytokeratins form a subfamily of at least 20 different pro­
teins, not including the hair keratins. The latter comprise a group of approxima­
tely 10 additional primary gene products 1β. Our current understanding of CK 
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biology is mainly based on the following two issues. Firstly, Moll et al. 2 Э, have 
catalogued the human CKs and listed them numerically as CK 1 to 20. Heid et 
al. 1β have made an inventory of the hair or "hard" trichocytic keratins, which 
occur also in certain papillary appendages of the tongue and Hassal's bodies in 
the thymus M . The widely adopted numerical classification system facilitates 
discussions significantly, while it easily correlates the molecular weight and 
isoelectric pH of the individual CK estimated by different laboratories 18,21. 
Secondly, a cell lineage dependent pattern of CK expression has emerged from 
biochemical and immunohistochemical studies, showing that specific combinati­
ons can occur in different directions of epithelial differentiation 22. In general, an 
acidic CK protein has to combine into a pair with a neutral to basic CK protein 
to form intermediate filaments. Usually, a subset of 2 to 10 of the 20 CKs is ex­
pressed by any epithelium in a composition that is dependent on cell type, stage 
of embryonic development, cellular growth and environment, pathological sta­
tus, and the degree of cellular differentiation. These characteristics make CKs 
suitable as differentiation markers. In this overview we summarize their role in 
the study of biological processes and their potential for application in surgical 
pathology. 
Basic cytokeratin expression patterns in adult human tissues 
Many monoclonal antibodies (mAbs) have been developed against the various 
CKs. In addition to broadly cross-reacting mAbs, which stain virtually all 
epithelial tissue types, mAbs and some polyclonal antibodies have been develo­
ped which react with only one of the 20 CKs. The large majority of CKs can 
now be recognized individually by such reagents 1 І , 2 Э. 
The CK composition of epithelia appears to follow basic principles and can be 
summarized as follows 13,1β (see also Table 1). 
Simple epithelia express primarily CK8 and CK18 and often CK7 and CK19. The 
recently catalogued CK20 is less frequently found in these types of epithelia 
than the former CKs э. 
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ТаЫе 1. Major patterns of cytokeratin expression in relation to epithelial type of 
differentiation (simplification). 
CELL/TISSUE TYPE CKs EXAMPLES 
SECRETORY cells 
LUMINAL cells 
(mixed epithelia inclu­
ded) 
8.18 acinar cells (prostate, pancre­
as, etc.), liver parenchyma, en­
docrine cells, proximal renal 
tubules 
8,18,19,20 gastric foveolar and intestinal 
cells 
8,18,19 tubular area of prostate 
7,8,18,19 mamma, endometrium, distal 
renal tubules 
BASAL, RESERVE, 5,14,(151,17 
MYOEPITHELIAL cells in 
mixed epithelia 
BASAL cells of stratified 5,14,15 
epithelia 
glands (salivary glands, mam­
ma, prostate, etc.) bronchus, 
uterine endocervix 
squamous epithelium 
SUPRABASAL cells of 
stratified epithelium 
UROTHELIUM 
4,13 
1,2,10,11 
1,2,9 
3,12 
6,16 
(4),5,7,8,13, 
17,18,19,20 
nonkeratinizing squamous 
epithelium 
epidermis 
plantar epidermis 
cornea 
"reactive and (hyper)pro-
liferative" squamous epithelium 
urinary tract 
SEROSA, MESOTHE- 5,7,8,18,19 peritoneum, pleura 
LIUM 
Stratified epithelia express CK5, 14 and 15 2*"2e in the basal cell layer. The 
suprabasal cells express additionally at least one other pair of CKs, depending 
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on their morphologic type of differentiation. The expression of these diffe­
rentiation-specific CK pairs correlates to four distinguished differentiation 
pathways: a) Nonkeratinized squamous epithelium shows suprabasal expression 
of CK4 and CK13 " . b) Keratinized squamous epithelium expresses CK1 and 
CK10 suprabasally 1Э. с) The corneal epithelium contains CK3 and CK12 2 a. d) 
CK6 and CK16 may be expressed transiently in regenerating and hyperprolife­
rative statified epithelium, as an alternative suprabasal pair under conditions 
where the usual CKs as described above, are not expressed normally 1 3 M . 
Further specialized functions of squamous epithelium are reflected by the 
expression of CK2 and CK11, in particular in hard-worn epidermal sites and CK9 
in palm and sole skin areas 2 · 1 7 · 2 9 3 0 . 
CK19 occupies an ambiguous position within these classifications, since next to 
its presence in simple epithelia, it can also be expressed in statified epithelia, 
generally in basal cells, but also weakly in scattered suprabasal cells of nonke­
ratinized squamous epithelium 3 1. Also low levels of simple epithelial CK8 and 
CK18, can be demonstrated in nonkeratinized squamous epithelium 3 2. 
CK15 has been demonstrated in all cell layers of nonkeratinized squamous 
epithelium 2 e ·3 3 ·3 4, while in the skin this CK subtype is expressed in a topically 
restricted pattern 3 4 . 
Complex or mixed epithelia show a combination of simple and stratified CK 
profiles. They comprise pseudostratified epithelia, which have frequently a 
typical basal or myoepithelial cell layer, such as eccrine glands and respiratory 
tract epithelium 34"3B. Myoepithelial and other basal or reserve cell types such as 
those in mamma, prostate, bronchus and endocervix express CK5 2 4 and CK14 
as well as CK15 2 3·3*·3 6-3 8 and CK17, especially in the larger ducts or bronchi 
34.39.40
 C K 8 a n d CK18, a n a · m o r e variably CK7 and CK19, are expressed in the 
suprabasal or luminal compartment. 
Recently basal cells 4 1 of prostatic tubules and acini have been shown to display 
a complex pattern with unexpected CKs *°·42, comprizing CKs 5, 6, 8, 10, 13, 
14, 17 and 18, while CK19, was found to be only focally present in acinar 
basal cells. CK10 and CK13 have not been noticed by others in these ducts, 
using the same or similar mAbs 27-43. Salivary ducts show a similar, mixed CK 
expression pattern, although CK10 expression is found inconsistently 38-44 and 
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CK6 has not been examined as yet in this epithelium 24·3β·3β·44-4Β. Extensive study 
for the CK expression patterns in mammary glandular ducts *e48 show as additi­
onal features of basal cells weak expression of CK7 and CK19, at least in larger 
ducts. CK6 is not observed in normal breast, in contrast to its being reported in 
prostate. However, in larger ducts of the mamma some CK14 positive luminal 
cells are observed 4e. 
The transitional epithelium of the urinary tract is another complex epithelium 
with CK13 in basal and parabasal layers, while CKs5, 14 and 17 are additional­
ly, but heterogeneously expressed in basal cells and sporadically found in 
suprabasal cells. CK4 is sometimes found, while heterogeneous CK20 expres­
sion is observed in the superficial or so-called umbrella cells. CKs7, 8, 18 and 
19 are found in all cell layers of the urothelium 3·24Β°-Β4( CK15, however, is not 
observed M. 
Cytokeratin expression patterns during embryonic and fetal development 
Knowledge concerning CK expression in prenatal developing tissues is still 
largely incomplete, but certain patterns of expression are emerging. These 
patterns will be discussed here because of their relevance in understanding CK 
dynamics in pathology especially in neoplasms, showing an analogy with the 
above mentioned differentiation pathways. CK8 and CK18 are the first IFPs to 
be detected during embryogenesis and have been shown to occur in early 
mesenchymal tissues and developing organs, such as the early stages of the 
heart 6B. In fetal skin maturation β β ·6 7 the simple epithelial CKs8, 18 and 19 are 
expressed first, followed by CK4 and CK13, with CK4 also in the basal cell 
layers from which it disappears later on. The next step of maturation involves 
the onset of CK10 expression, while CKs4, 8, 13, 18 and 19 vanish. 
In the developing liver s e e o and pancreas β1 a transient expression of CK7 and 
CK19 occurs in the parenchym. Transient CK7 expression is also described in 
fetal and neonatal stomach, where the expression is the strongest in the 
superficial foveolar area e2. Most relevant for fetal kidney is that the proximal 
tubules display permanent CK8 and CK18 expression, and transiently CK19 and 
vimentin expression. The latter is not found in the distal tubules '3. 
i?n 
In fetal lung, basal cells become positive for CK14, only in the third trimester, 
although they can be detected morphologically in earlier stages '*. 
Basic cytokeratin expression patterns in squamous metaplasia, preneoplasia and 
carcinomas 
The pathways of CK expression described above for the different types of 
epithelia, as well as the fact that a considerable part of CKs can be detected 
separately by immunocytochemical techniques, has created expectations with 
respect to their applicability as markers in pathology diagnosis especially in 
distinguishing between different carcinoma types. Initially, the set of CKs, 
which is present in the normal epithelium, was presumed to remain present in a 
virtually unaltered combination in the neoplasm originating from that epithelium. 
Later on many exceptions to this "fingerprint" concept were found, most of 
which are related to loss of tumor differentiation, metaplastic changes or 
transdifferentiation and intrinsic changes inherent to neoplasia. Many of these 
exceptions that have been reported may be incorporated in the interpretation of 
CK expression patterns of malignancies. With regards to squamous metaplasia 
and dysplasia, important steps in the carcinogenesis of epithelia, these lesions 
will be discussed, preceding a general survey of CK expression in the major 
types of carcinoma. 
Squamous metaplasia generally shows loss or decrease of most simple epitheli­
um CKs, i.e. CK7, CK8 and CK18 2 3 3 4 S o e B f while CK19 may be homogeneously 
retained in all cell layers of metaplastic epithelium 3 4 Б 0 (for exceptions see e B ). 
Extensive CK 19 expression in squamous metaplasia contrasts to the more basal 
cell layer related pattern of CK19 in préexistent squamous epithelium, while 
other stratification-related CKs, also appear in the lesions э \ Expression of CK1 
and CK10/11 may precede morphological keratinization, while it is accompanied 
by a decrease in CK4 and CK13 expression M. 
Studies on preneoplasia using extensive panels of chain-specific CK mAbs are 
scarse and are mainly restricted to the squamoid lineage. In hyperplasia no signi-
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ficant alterations in CK expression are found β β 6 β , while an increase of CK19 
expression has in particular been correlated with early preneoplastic changes of 
nonkeratinized squamous epithelium β β β β · 7 0 . Especially in severe dysplasia an 
increased expression of other simple epithelial CKs, mostly CK8 and CK 18, 
becomes perceptible e7·71·72. Similar to other pathological situations, the levels of 
the specific squamous differentiation related CK pairs, i.e. CK4 and CK13 or CK 
1 and CK 10 decrease in dysplasia M·70·73-75. Expression of other stratification 
related CKs, such as CK5 and CK14, may persist depending on the degree of 
anaplasia 7 1 · 7 3 , with CK16 expression levels often clearly increase with increa­
sing grade of dysplasia. The complex situation in the uterine cervix has been 
extensively examined and will be described separately below. 
Early biochemical studies 2 show that the CK expression patterns of squamous 
cell carcinoma display significant levels of CKs 5, 6, 13, 14, 17, and 19 and 
lower or variable levels of CKs 4, 8, 10/11, 15, 16 and 18. In the more sensiti­
ve immunohistochemical studies using mAbs, these data are largely confirmed 
3β.ββ.73.7β.77 yy¡ tn increasing tumor grade an increased expression of the simple 
epithelial CKs β 9·7 β·7 β and a decrease of squamous differentiation related CKs, i.e. 
CK1, CK10, CK13 and CK16 occurs 3βββββ·70·7«. | n addition, keratinization of a 
squamous cell carcinoma may co-incide with changes in CK expression patterns 
2 3
·
7 7
. Different levels of CK8 and CK18 in squamous cell carcinoma (Figure 1) 
are reported for the different primary tumor sites, showing higher levels of these 
two simple CKs in carcinomas evolving through a "metaplastic" pathway as 
compared to carcinoma directly originating from squamous epithelium 7e. In 
squamous cell carcinoma frequently minor vimentin positive areas are described 
to be related to stroma interaction 7 M 0 , to tumor grade 81 or previous irradiation 
82 
All adenocarcinomas express CK8 and CK18, and frequently CK19. CK7 shows 
a distinctly organ related expression and is present in carcinomas of the 
mamma, lung, pancreas, biliary tract, ovary, endometrium and endocervix, while 
gastric carcinoma is heterogeneous in this respect and colonic and prostatic 
carcinoma are predominantly negative 7 β β 3 . CK20 is present in adenocarcinomas 
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arising from CK20-producing epithelia, such as colonic carcinoma 3·23·54. 
Stratified epithelium related CKs may occur in certain types of adenocarcinoma, 
for example pancreatic and pulmonary adenocarcinoma, as well as "Müllerian" 
epithelium derived carcinomas 
Figure 1. Squamous cell carcinoma of the floor of mouth immunostained with 
two different CK18 mAbs. Note the absence of expression of CK18 in the 
hyperplastic squamous epithelium (right side of the section) and presence of a 
heterogeneous expression in the carcinomatous area (left side). Different levels 
of immunostainig are seen as a result the use of two different mAbs (A is 
stained with the mAb CK18-2 and В with RGE53), known for their differences 
in immunoaffinity 5 1 - 5 2 · 7 9 . Most and/or preferential expression of CK18 was seen 
at the tumor margin, i.e. in the tumor invasion front, which is postulated to 
represent an "interface phenomenon"5 1-5 2 7Э. (Insert: detail of the invasion front -
see arrow - showing a more extensive staining in A as compared to B). Magnifi­
cation 25X, insert 140X. 
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ТаЫ 2. Nonepithelial human tissues which have been reported 
to stain with CK antibodies. 
FETAL TISSUES 
smooth muscle cells (vascular wall)5 5 8 9. 
stroma of umbilical cord55. 
myocardium55. 
spinal arachnoid cell2 4 6. 
Sertoli cells201 
ADULT TISSUES 
myofibroblasts in atherosclerotic pla­
ques247. 
submesothelialcells56·92·93·249, 
smooth muscle cells249·250. 
endothelial cells near synovia2 5 1 , 2". 
reticulum cells in lymph node' and spl-
een12·253·254. 
spinal arachnoidal cells24". 
spinal ependymal cells24'. 
plexus choroid255 
NEOPLASTIC TISSUE 
lymphoma224·259·257. 
epithelioid sarcoma258"280, 
malignant fibrous histiocytoma281,292. 
synovial sarcoma98,293. 
leiomyosarcoma249·250·294. 
rhabdomyosarcoma12,295. 
liposarcoma290. 
Ewing's sarcoma296"298. 
chondrosarcoma 299, 
chordoma270"272, 
melanoma·'224·273'279. 
vascular neoplasms259,277'279. 
chondroblastoma280, 
rhabdoid tumor12,261. 
granulosa cell tumor69·173·177. 
fibro-thecoma173, 
(Sertoli-)Leydig cell tumor173, 
germ cell tumors (see in text). 
desmoplastic round-cell tumor2 9 2·2 9 3. 
ependymal tumors 284, 
myxopapillary ependymoma265. 
meningeoma285. 
primitive neuroectodermal tumors289. 
astrocytoma297289, 
oligodendroglioma299. 
infantile fibromatosis290. 
tumor of arterioventricular nodal regio-
n2 9 1, 
(malignant) peripheral nerve sheath tu­
mor292'294. 
FOOTNOTES TO TABLE 2. 
* Increase of CK positive reticulum cells is observed in lymph nodes of fetus and 
neonate, in case of sarcoidosis, toxoplasmosis, Hodgkin's disease and metasta­
ses253·275 
CK expression may prevail in melanoma metastases, also seen in in vitro 
studies274·295. 
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Neuroendocrine carcinoma, in its spectrum from small cell undifferentiated 
carcinoma to carcinoid, has been shown to express CK8 and CK18 consistently. 
CK19 can be found in a more restricted fashion 2 3 β · 7 β , while CK4, CK7 7β7β, 
CK16 or CK17 are reported to occur sporadically 3e. CK20 is not expressed in 
these tumors, with Merkel cell tumor as clear exception 64. Vimentin is reported 
to be expressed more frequently in rectal than in non-rectal carcinoids e7. 
Cytokeratins in nonepithelial cells 
In human tissues, CKs have also been demonstrated in non-epithelial tissues 
(see Table 2 and for review " ) , while on the other hand vimentin can be found 
in several epithelia (see for review 1 Б ). The percentages of positive cases or the 
extent of CK expression vary widely depending on tissue type, reagents used 
and technical procedures. Gradually, it is becoming clear that apparently ectopic 
expression of CKs follows certain concepts. CKs expressed in nonepithelial 
tissues are generally the simple CKs ββ"β0, especially CK8 and CK 18, but not 
CK20. Sporadically the myoepithelial CK 17 has been found in tumor stroma 
*·'·'. This "ectopic" CK expression can possibly be related to their transient 
expression in developing fetal tissues or in proliferating cells such as myofibro­
blasts and (sub)mesothelial cells SB·90·92·93. Otherwise CKs can be found under 
normal physiological situations in smooth muscle. The expression of CK8 and/or 
CK18 can thus no longer be considered as typical of epithelium. In order to 
prevent diagnostic misinterpretation in the distinction between mesenchymal 
and epithelial differentiation, we suggest to use (cocktails of) broadly cross-
reacting CK-reagents which do not react with CK8 or CK18, but for example 
with CKs7, 19, 5 and 14. To be aware of CK expression in mesenchymal 
tumors may be invaluable, as it can help in the diagnostic process, for example 
in the case of epitheloid sarcoma and sarcomatoid mesothelioma. Unawareness 
of aberrant expression may lead to inproper interpretations and diagnostic 
errors. 
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TECHNICAL LIMITATIONS AND PITFALLS 
A major problem in the utilization of mAbs, and IFP antibodies in particular, Is 
the loss of immunogenicety upon fixation with cross-linking reagents. This has 
hampered the application of these antibodies in the past and is at present slowly 
being overcome by the fact that mAbs, reactive after formalin fixation and 
paraffin embedding, become available 1 β 5 4 β 3 · β 4 , 
The fixation problem is easily overcome by using frozen sections, but routine 
practice mostly employs paraffin embedded, formalin fixed tissue. As a result 
the most common causes of poor reproducibility of immunohistochemical 
assays are the unpredictable alterations that are introduced to the antigenic 
sites by the tissue processing procedures. In contrast to the cross-linking fixat­
ives, such as formaldehyde, the coagulating, often alcohol based fixatives, 
show more frequently a better preservation and/or presentation of the antigenic 
epitopes 1 6. Excessive heat during fixation or processing is also deleterious to 
the antigenic sites. Pretreatment of sections with proteases can make antigenic 
sites, masked by formalin, more accessible. The conditions of effective dige­
stion are related to the fixation time 9 S, type of fixative or even to tumor type β β . 
Antigen retrieval in formalin fixed tissue can be enhanced by microwave oven 
heating in the presence of heavy metal ions e 7. Microwave-irradiation in saline as 
an alternative fixation procedure, preceding embedding, has shown to give good 
antigen preservation β β β β . Battifora and co-workers 1 Б · 1 0 0 have suggested that 
antigen destruction can be best monitored by surveying vimentin staining 
results. 
Also with respect to antigen preservation it should be realized that autolysis can 
render tissue suboptimal for immunostaining procedures. These effects have 
recently been discussed 1 0 1 for vimentin and CK reagents, showing wide 
differences in antigen preservation. However, morphological decline does not 
necessarily mean a complete immunodeterioration of antigens. With respect to 
interpretation of antigen staining at the cellular level, one should keep in mind 
that the conditions (such as developing time and concentration) of enzyme-
precipitate reactions, such as peroxidase-DAB or alkaline phosphatase-Fast Red 
TR, influence the staining pattern 1 0 2 · 1 0 3 . 
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One of the problems arising during the interpretation of the immunostaining 
results may be caused by structural alterations of CK proteins, rendering some, 
in particular conformational, CK epitopes undetectable in immunohistological 
assays. This phenomenon is called epitope masking and may in part be over­
come by staining tissues and cells with more than one mAb against a single CK. 
For instance, CK 18 can hardly be detected in certain tissues with mAb 2C8 or 
RGE53, while RCK106 resulted in more extensive staining s052·86·79. Antigen 
quantity may also play a crucial role 5°-"·7β. Similarly, this phenomenon is 
observed with CK14 mAbs (RCK107 versus LL001 and LL002) and CK19 mAbs 
3i.ei,io4 j n e s e differences in reactivity patterns of the individual CK mAbs may 
be due to a different structural organisation of the CK filaments under different 
circumstances. 
Cytokeratin expression in specific tissues and their malignancies 
In the following paragraphs we will review the relevant CK expression patterns 
in normal and pathological situations arranged in alphabetical order according to 
the major organ systems. The basic rules of CK expression as discussed above, 
will not be emphasized again for the individual tissue and tumor types, unless 
relevant for the case. 
ADRENAL GLAND AND EXTRA-ADRENAL PARAGANGLIA 
In routinely fixed normal adrenal cortex, especially in the zona glomeru-
losa, CKs can be found after immunostaining, employing mAbs with strong CK8 
and CK18 reactivity. Focal CK19 positive cells may also be found 10S. Data on 
the percentage of positive cells diverge, partly depending on the cortical zones 
examined and the technique applied 10îMoa. A decrease in the detectability of 
CKs is reported in cortical tumors in the transition from adenoma to carcinoma, 
of which the latter are frequently negative 106-108. Vimentin staining, however, 
increased upon malignant progression. 
Several authors found that CKs were not expressed in ganglion cells in 
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normal adrenal medulla 107-10β, intestine or urinary bladder 1 0 β η 0 . Others, 
however, report CKs in adrenal medulla 1 1 1. In pheochromocytoma absence of 
CKs has been reported 1 0 7 l o e , but CK positive cells are also sparsely found in 
some cases 1 o e. Paragangliomas are reported to be CK negative in most studies 
I5.IOB.II2.U3( a i t n o u g h positive cases have been noted 1 1 4. Relatively extensive 
vimentin staining was found particularly in metatastic adrenal pheochromocy-
tomas 1 0 e. 
ENDOMETRIUM 
CKs8, 18 and 19 are uniformely distributed in normal endometrium, while 
CK7 is widely distributed in the secretory phase, although restricted to smaller 
and variable proportions of glandular cells in proliferative endometrium β θ. 
Endometrial adenocarcinoma cells M are all positive for CK8, CK18, almost all 
for CK19, while CK7 shows pronounced quantitative variability 8 3 M . Small 
traces of CK20 are found 8 S, while also stratification related CK4, 5 and 13 
have been detected mainly localized in squamous areas but not strictly confined 
to this type of diffentiation. It is remarkable that CK7 and CK18 have been 
reported to remain present in these squamous metaplastic areas β β . 
The epithelial component of normal endometrium and also that of endometrio­
sis, is shown to coexpress vimentin and CKs. The pattern and the extent of this 
phenomenon is different when pre-ovulatory and post-ovulatory conditions are 
compared β β · 1 1 5 · 1 1 β . Most extensive vimentin coexpression occurs in the prolifera­
tive phase. Vimentin is frequently retained and in general extensively expressed 
in endometrial carcinoma 1 6 B e · 1 1 7 . in endometrial clear cell carcinoma vimentin 
was only expressed to a limited extent, while the simple epithelial CKs are 
extensively present s e . For mixed Müllerian tumors and stromal cell sarcomas 
see the section "ovary". 
ESOPHAGUS 
The CK expression pattern of the esophageal mucosa is that of a typical 
nonkeratinized squamous epithelium as outlined above. CK19 is strongly 
expressed in basal cells and heterogeneously weakly expressed in the supraba-
sal layers з г . CK4 and CK 13 are present in all suprabasal cells 2 7. Moreover, very 
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low levels of CK8 and CK18 can also be detected in the basal cell compartment 
32
. An increased suprabasal expression of CK 19 is described with advancing 
grades of dysplasia 11B, while, as expected CK13 expression decreases 11θ. Also 
with respect to dysplasia, the morphological phenotype influences the CK ex­
pression patterns 71. The more undifferentiated adenoid pattern shows an 
increase of CK8, while an increase of squamous cell related CKs, as detected by 
the mAb 34UE12 2 1, is seen in typical squamoid dysplasia 71. In squamous cell 
carcinoma a similar relation was found for these characteristic stratification 
related CKs which are strongly expressed in typical squamous carcinoma but 
weakly or not at all in undifferentiated and spindle cell carcinoma. 
GALL BLADDER 
Adenocarcinomas of the gall bladder frequently express CK20, next to 
CKs7, 8, 18 and 19 3 , 6\ Surprisingly, normal gall bladder epithelium contains 
only sporadic CK20 positive cells 3. 
GASTROINTESTINAL TRACT 
From stomach to rectum the mucosal lining contains CKs8, 18 and 19. 
Recently the previously mentioned IT protein, has been characterized as CK20 3 
and is a member of the group of simple epithelium CKs. The gastric foveolar 
epithelium is uniformely and strongly positive for this latter CK subtype. The 
specific glands of the corpus mucosa as well as most mucus cells of the pyloric 
glands, however, remained unstained. In crypts of the small intestine CK20 is 
expressed in a patchy fashion, but stains the lining cells of the villi strongly and 
uniformly. In the colonic mucosa a similar pattern is found. Also a variable 
number of endocrine cells in the mucosa is CK20 positive. 
In the normal stomach, the presence of CK7 is still a matter of discussion. 
Several CK7 mAbs remain negative upon immunohistochemistry of stomach 
epithelium, while at least one CK7 mAb (OVTL12/30) shows significant 
positivity in frozen sections of this tissue e3. Metaplastic intestinal mucosa in 
the stomach shows CK7 positivity 11β. This is peculiar, since CK7 is normally 
not found in the small or large intestine 43,1Î0 (for exceptional staining in duode-
num, see 8 Э). In gastric adenocarcinomas, CK7 is found to be heterogeneously 
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expressed in some cases and is absent in others. This is dependent on the CK7 
mAb used J-78M·120·121. CK20 is frequently found in diverse types of gastric 
adenocarcinoma M . 
Intestinal adenocarcinomas are CK7 negative, while the expression of the other 
four simple epithelium CKs, i.e. CK8, CK18, CK19 and CK20, is maintained 6*. 
The observation of increased CK staining in normal mucosa and adenomatoid 
polyps of patients with familiairy polyposis coli 122 is possibly of biological 
importance. This phenomenon might be related to increased levels of inter-
mediate filament proteins upon malignant transformation of the colonic mucosa 
122-124 
KIDNEY 
In the normal glomerulus CKs7, 8, 17, 18 and 19 and some vimentin are 
present. In the tubules CK8 and CK18 are the major constituents, while CK7 
and CK19 are variably expressed depending on the cell type and segment of the 
tubule under investigation 43··3·83. in pathologically altered epithelium of the 
proximal tubule (i.e. atrophy) vimentin and some CK17 become expressed, 
while also in the distal tubule expression of CK7 and CK19 increases. This 
abnormal expression pattern partly resembles the earlier mentioned fetal situati-
on M . The recently described simple epithelium related CK20 is not found in the 
kidney 3. 
In renal cell tumors some authors have discriminated two "classes'1, i.e. those 
tumors with and those without vimentin coexpression 12S. To this latter group 
belong the relatively rare types of chromophobe renal cell carcinoma and the 
oncocytoma 126. The CKs expressed in the clear cell type of renal cell carcinoma 
are predominantly CK8 and CK 18 and rather frequently also heterogeneous 
expression of CK 19 is seen. CK7 can be found only in a minority of cases, but 
when present the tumor is usually high grade malignant. The eosinophylic-
granular and basophylic type of renal cell carcinoma additionally expresses 
CK19 and fequently also CK7 126. In other studies, presence of CK7 has only 
exceptionally been reported 7BS3. The data on vimentin and CK coexpression 
vary mostly depending on the type of tissue fixation, the antibodies used and 
tumor grade 10e·128"130, vimentin expression has, however, been related to poor 
prognosis 12e. 
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LIVER 
Different CK expression patterns have been reported for the various cell 
types which compose the liver. The liver parenchyma expresses CK8 and CK18 
and the intrahepatic bile ducts additionally express CK7 and CK19 1 S\ In the 
parenchyma a CK8 and CK18 expression gradient has been described depending 
on the location of the cell in the lobulus *°13'. in pathological situations, such as 
cirrhosis 132, nodular hyperplasia 133, cholestatic liver disease 1 M, alcoholic liver 
disease 1ЭБ, hepatocytes may express CK7 and CK19. These two CKs are also 
transiently present in the fetal liver s e e o. Initially hepatocellular carcinoma was 
considered to express СКВ and CK18 only. This was thought to distinguish 
these tumors from cholangiolar carcinoma and many metastatic carcinomas 13e. 
More recent studies show that hepatocellular carcinoma is able to express addi­
tionally CK7 and CK19 or even sporadically vimentin .^із2.іэ7.ізв
 Τ η β
 f ¡D r o | a . 
mellar type of hepatocellular carcinoma is conspicuous by abundant CK7 ex-
pression 'M . Hepatoblastoma express CKs8, 18 and 19 and in some cases CK7, 
while cells embedded in osteoid-like material coexpressed vimentin 14°. 
LUNG 
The CK patterns of developing and adult brocheal mucosa have been 
described '* and CKs typical of a mixed type of epithelium are expressed, i.e. 
CKs7, 8, 18, 19 and scarsely CK20 in columnar cells and CKs5, 14, 15 and 17 
in basal cells з м э в м . 
At first glance, the four major types of lung carcinoma show the typical diffe­
rentiation lineage related CK expression patterns. Squamous cell carcinoma may 
moderately express CKs4, 13, 16 and extensively CKs 14, 15 and 17. The 
expression of stratification related CKs4, 13 and 16 diminishes with increasing 
histological grade of malignancy, which does not influence the expression of the 
basal cell CKs 14, 15 and 17 M 3 e ·7 ·. However, the expression of simple epithelial 
CK8 and CK 18, which are already significantly present in well-differentiated 
squamous cell carcinoma ", was shown to increase upon progression 7e. 
Adenocarcinomas of the lung are characterized by the typical simple CKs7, 8, 
18 and 19, while focal expression of CK14 and CK17 can be found in a 
minority of cases M . The extensive CK7 expression in adenocarcinoma and large 
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cell undifferentiated carcinoma therefore, distinguishes these malignancies from 
squamous cell carcinoma. The stable expression of CK14 in poorly differentiated 
squamous cell carcinoma and its absence in adenocarcinoma and the neuro­
endocrine tumor types, including small cell undifferentiated carcinoma, is 
another important discriminating feature. 
Most neuroendocrine carcinomas, i.e small cell undifferentiated carcinoma and 
carcinoid, express only CK8 and CK18 3β,7β. Unexpected extensive expression of 
CK7 in sporadic squamous cell carcinoma is reported 7 e · 7 8 . This finding may be 
due to mixed differentiation, often occuring in lung cancer. Extensive expression 
of vimentin is notorius in part of the large cell undifferentiated carcinomas, and 
to some degree also in the adenocarcinomas 1 4 1 · 1 4 2 . 
The clear cell ("sugar") tumor of the lung is reported to express vimentin 14Э, but 
not CKs. When a tumor with this type of morphology occurs in the lung but 
expresses CKs it is reported most likely a metastasis of renal cell carcinoma. 
MAMMARY GLAND 
In the mammary gland the terminal ductal lobular units are of special 
interest, because of their proliferation in pregnancy and the concept that from 
the cells in these segments breast cancer develops. The luminal cells in this area 
extensively express CKs7, 8 and 18, while CK19 is found in the majority of 
cells, while basal cells express CKs5, 14 and 17. Occasionally luminal cells 
expressing CK5 and CK17 has been reported 4 β · 1 4 4 - 1 4 β . CK19 negative luminal 
cells appear at puberty 1 4 7 and are found in significant numbers in benign 
tumors. In general, the invasive component of breast cancers exists of CK19 
positive cells 47. In the heterogeneous group of benign tumors both luminal and 
basal cell CKs remain present in the respective cell types 4e. In some cases of 
sclerosing adenosis all cells may stain for CK14 14e. Similarly, also in epitheliosis 
the basal cell CK immunoreactivity is detected in the streaming sheetlike intralu­
minal proliferations 14θ-14β. in carcinoma CK8 and CK18 are uniformly expressed, 
as are CK7 and CK 19 in the large majority of tumors 4 7 · 7 8 (compare however for 
CK7 refs 1 6 0 · 1 6 1 ). Most of the carcinomas are negative for basal cell CKs. CK17 
is expressed in up to 3 0 % of carcinomas 49,49, while in an extended series CK 14 
is found in about 1 0 % of the invasive cancers 4β·14β·152. These cancers can not 
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be distinguished morphologically from CK14/17 negative invasive carcinomas, 
but this CK14 expression has been related to poor prognosis 17-163. A relatively 
high concordance is found between CK 14/17 expression and CK16 expression, 
but not between these markers and Ki-67 * · . The overlapping expression of 
basal CKs and CK16, formerly designated as hyperproliferation marker, may be 
explained by the fact that all three CKs are related to squamous differentiation 
23.2β,3β,β5.77.79.ΐ54
 E v e n cKT 5 positive carcinomas are found, especially in a 
subgroup of high grade malignant ductal carcinomas 2 e. 
Also vimentin expression is related to poor prognosis and correlated with high 
grade, low estrogen receptor content, a high Ki-67 defined growth fraction, p53 
expression and EGF receptor content β θ · 1 5 5 - 1 5 8 . Vimentin is extensively found in 
medullary breast carcinoma, but generally not in lobular carcinoma 1 4 B · 1 6 6 - 1 6 8 . 
Vimentin, however, has also been described in some cases of fibrocystic 
disease 4 в , 1 Б 8 and is expressed to low degree in normal basal cells 4 β · 1 4 Β . 
MERKEL CELL 
Merkel cells and Merkel cell tumors are described to express high levels of 
CK8 and CK20, as well as CKs7, 18 and 19 3 · 5 4 · 1 "- 1 9 1 . | n Merkel cell tumors 
coexpression with neurofilament proteins which occur in perinuclear aggregates, 
has been reported 1 6 9 · 1 β 0 · 1 β ζ . A positive staining is reported with a mAb (34SE12) 
recognizing stratification related CKs, but the authors speculated on cross-
reactivity as an explanation for this unexpected finding 1 β 3. 
MESOTHELIUM 
The IFP make-up of mesothelial or serosal cells is in part dependent on 
their morphological presentation. Normal mesothelium expresses CKs7, 8, 18 
and 19, and CK5 heterogeneously. Vimentin is also found and in reactive 
processes its expression increases 2*82. Proliferating, reactive (sub)mesothelial 
cells, showing myofibroblastic characteristics, coexpress CKs and vimentin 2*a2. 
The expression of simple epithelium CKs is largely retained in mesothelioma 
78.β3.ι«.ιβ4.ιβ5 Furthermore, the epithelial structures of mesothelioma may show 
an enhanced number of CK5 positive ceils, which may even occur in the 
sarcomatoid components. CK is however not expressed in pure sarcomatoid 
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mesothelioma 24. In some mesotheliomas even CKs4, 6, 14 and 17 have been 
reported 1 W . 
ORAL CAVITY 
The oral nonkeratinized epithelium (soft palate, buccal and vestibular 
mucosa, tongue, floor of mouth, oropharynx) and the keratinized epithelium 
(hard palate, gingiva, papillae of the tongue), including the unique junctional 
epithelium, have been described extensively with respect to their CK expression 
patterns a0·"·-1·1·1·7. The oral squamous epithelia deviate in the CK content from 
squamous epithelia occurring in other organs by expression of CK16, especially 
in the keratinized areas 2,1β1. The junctional epithelium is unique because it is 
thought to originate from reduced enamel epithelium and it is attached to the 
cementum of the tooth with an external as well as internal basal lamina. 
During development, the enamel epithelium is shown to coexpress vimentin and 
a complex CK pattern, i.e. CKs5, 14 and 17, which are typical of basal cells, as 
well as smaller amounts or traces of CKs7, 8, 18 and 19 " 8 . Furthermore, IFP 
antibodies are used in studies of several odontogenic tumors 1 β β · 1 7 0 and have 
shown relatively complex CK patterns. The mAb LP34 (recognizing CK5, CK6 
and CK 18 and possibly others 171) has been shown to differentiate dentigerous 
cysts from odontogenic keratocysts 172. 
OVARY 
The ovarian surface epithelium expresses CKs7, 8, 18 and 19 in all cells 
and vimentin in most, while CK20 is not found M · 1 7 3 . Rete ovarii cells and 
granulosa cells of primary as well as cystic follicles express CK8 and CK18 and 
vimentin, while oocytes appeared to be devoid of CKs or vimentin M · 1 7 3 · 1 7 4 . 
Sporadic cells positive for CK7 are observed in the ovarian stroma '7Э. The most 
common ovarian neoplasms are the epithelial neoplasms classified into benign, 
borderline and malignant variants, partly coexpressing CK and vimentin. In 
serous tumors, clear cell and endometrioid carcinoma frequent coexpression is 
present, with decreasing vimentin expression only in the poorly differentiated 
cases M - m - 1 7 3 . in mucinous tumors, minimal coexpression is found, similor to 
the endocervical mucinous epithelium, although acetone fixation of frozen 
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sections increased the number of vimentin coexpressing cases 173. The CK 
expression pattern of the above mentioned types of ovarian cancer is more or 
less similar to that of the endometrial neoplasms (see above). A discrepance 
involves the more extended CK7 expression in the ovarian tumors, although a 
few mucinous tumors may show low expression levels of CK7 M . Significant 
CK20 staining, furthermore, was only found in the mucinous carcinoma type M . 
Stratifcation related CKs were not found in the mucinous and clear cell type M , 
although others detected CKs4, 5, 10, 13 and 14 in mucinous tumors 173. 
Stratified CKs could be found in serous and endometrioid types 89,173. 
In Brenner tumor the epithelial component does not express vimentin and 
displays CKs typical of transitional epithelium (see section "urinary bladder"). 
The malignant mixed Mullerian tumors show CK and vimentin coexpression in 
both tumor components, although to a variable degree related to cell type 
ΐ73.ΐ75.ΐ7β Fibromas, (Sertoli-)Leydig cell tumors, granulosa cells, granulosa cell 
tumors 1 7 3 · 1 7 7 and endometrial stromal sarcoma 1 7 β · 1 7 β can also express CKs next 
to vimentin, which concerns mainly CK8 and CK18, although in a Leydig cell 
tumor only CK7 is mentioned 1?3. For germ cell tumors see the section "testis". 
PANCREAS 
The pancreatic ducts have been shown to express extensively CKs7, 8, 
18 and 19 and a small number of cells also contain CKs4, 5, 14 and 17 3 3 β 4 β Β . 
The adult exocrine pancreas β 1 β β shows CK8 and CK18. Adenocarcinomas are 
sofar shown to express CKs7, 8, 18 and 19 «•»·«·*«·»••·*>. | n typical adenocarci­
noma, CK4 varies between absence, and limited to extensive expression. Additi­
onally, heterogeneous staining is described for CKs5, 10, 13, 14 and 17, while 
their expression is related to morphologically recognizable squamous differenti­
ation only in some cases 86. Furthermore CK20 is often found to a significant 
degree 64. In the adult endocrine compartment of the pancreas CKs are less 
extensively expressed, manifesting as some weakly CK8 and CK18 positive 
cells β*βΒ, with an occasional report mentioning a subpopulation expressing CK7 
or CK19 " . In islet cell tumors CK expression is reported to be higher in non-
insulinoma then in insulinoma 109. 
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PITUITARY 
In the normal pituitary gland, the endocrine cells express only CK8 and 
CK18, while in the folliculo-stellate cells also CK7 and CK19, as well as 
vimentin and GFAP are detected , 8 0 · 1 β 1 . The squamous epithelial cells of the pars 
tuberalis and Rathke's cyst, which is considered as the origin of the crani­
opharyngioma, express next to the simple epithelial CKs, vimentin and GFAP 
also some stratified CKs 1β1. In adenomas distinguishable intracytoplasmic CK 
patterns, as detected with mAb CAM5.2, are suggested to be related the 
production of growth hormone182. Also in adenomas, Crooke's hyalin is shown 
to contain CK8 and CK18 1 M . 
PROSTATE 
As mentioned earlier, the basal cells of the prostate contain CKs5, 6, 8, 
10, 13, 14, 17, 18 and partly CK19 ^ 4 2 . Luminal cells of the most distal acinar 
structures, which becomes apparent during puberty, express CK8 and CK18, 
while in the more proximally located luminal cells also CK19 is found * 2 · 1 β \ in 
the pseudostratified and transitional epithelium-like lining of most proximal 
tubules CKs5, 7, 8, 13, 18 and 19 are found 4 2. CK20 is expressed in sporadic 
glandular cells 3. Vimentin is extensively coexpressed with CKs in alveolar 
luminal cells *2, is retained in hyperplasia and in a small part of cases of prosta­
tic intraepithelial neoplasia (PIN). In PIN, furthermore, an increased expression of 
CK19 is found *2. In basal cell hyperplasia, which may morphologically resemble 
PIN, these cells additionally express CK5 and CK13, thus distinguishing them 
from PIN cells. Adenocarcinoma of the prostate follows the CK expression of 
the PIN, with a variable number of CK 19 positive cells *2. CK7 is shown to be 
almost absent in luminal acinar cells and in adenocarcinoma 43·78·18*, although 
certain antibodies may detect expression of CK7 in prostatic cancer9Э. Vimentin 
expression in prostatic carcinoma is reported inconsistently 42- ie4- ies. The rare 
basaloid carcinoma of the prostate, which is suggested to be of limited malig­
nant potential, is reported to stain extensively with a mAb, reactive with basa­
loid or stratification related CKs 1 M . 
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SALIVARY GLAND 
Salivary glands and their tumors have been studied mainly with respect to 
their myoepithial component, which is extensively reactive with CKs 5, 14, 17 
2«.3β.3β.44.ιβ7
 ( s e e a b o v e ) < Luminal acinar cells show CK8 and CK18, while CK7 
and CK19 appear in the ductal structures. In pleiomorphic adenoma the diverse 
cell types retain their CK expression pattern, while most unstructured solid and 
trabecular regions showed staining variability, with most consistent staining for 
CK14 and inconsistent staining with the CKs of normal luminal cells, i.e. CKs7, 
8, 18 and 19 38-44. In epidermoid areas CKs10, 13 and 14 can be found 38. Basal 
cell adenoma and adenolymphoma (Whartin tumor) have been examined with 
broad spectrum mAbs 1 8 7 · 1 β β . 
SKIN 
The CK patterns in this typical keratinized squamous epithelium is 
outlined earlier. Basal cell heterogeneity is shown in rete pegs and in dermal 
papillae or flat epidermis 2S. In the skin of the adult nipple CK19 is expressed by 
some basal cells 147, while it is normally absent in the basal cell layer of skin 73. 
In pathological conditions of keratinized squamous epithelium, the expected CK 
reaction patterns can be percepted and correlated with tissue morphological 
parameters, such as anaplasia and proliferation 7Э. 
In squamous cell carcinoma 73,19° variable expression of simple epithelial CKs 
may be a common feature with CK7 limited and CK20 absent. With decrease of 
the differentiation level a down regulation of the stratified epithelial CKs1, 5, 10 
and 14 is noted. 
In basal cell carcinoma CK8 is commonly found, while CKs4, 18 and 19 are 
only expressed in a low number of cells and cases 19°. Habets et al. 1β1 could 
demonstrate significant levels of CK19, and CK7, but not CK8 in basal cell 
carcinoma. In immunoblotting studies CKs5, 14, 17 and low levels of CKs6, 8 
and 15 have been found, but CKs7, 18 and 19 are not listed 2. CKs can also 
discriminate cell types in skin appendages and their tumors 73-192. Also in 
nonneoplastic skin disorders CK-antibodies can be diagnostically useful or can 
clarify cell biological aspects of the skin differentiation process. For example, in 
basal cells of epidermolysis bullosa simplex 19Э clumped tonofilaments, labeled 
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with CK5 and CK 14 mAbs, are described to occur in basal and parabasal cells. 
In hyperproliferative skin disorders and after (experimental) trauma an increase 
of CK16 expression anticipates epidermal proliferation, followed by a decrease 
of CK 10 1 M . It is concluded that CK 16 expression is not a consequence of 
hyperproliferation but indicates that hyperproliferation has been triggered 1 β 6 Ι Μ . 
In psoriasis, CK 17, which is not present in normal epidermis, has been shown to 
be expressed in the upper part of the skin and a decrease of CK 17 expression 
parallels succesful therapy 1°7. Also a decrease of CK16 levels have been shown 
to correlate with succes of treatment1 9 e. In anogenital condylomata accuminata 
the alteration of CK1 and CK10, expressed in the normal squamous epithelium, 
into expression of CK4 and CK13 is described 19e. 
TESTIS AND GERM CELL TUMORS 
Differences in the pattern and level of CK and vimentin expression have 
been described for the developing and adult rete testis as well as epididymis, 
depending on age and anatomical region ^00. In developing, prepuberal, senile 
and atrophic testis, the Sertoli cell can coexpress CK8 and CK 18 along with 
vimentin ^ 1 · 2 0 2 , while in the normal mature testis these cells express vimentin 
only. In case of intratubular germ cell neoplasia, Soosay et al. тез found the 
atypical cells to lack CKs, while the Sertoli cells in these atypical and adjacent 
atrophic tubules could show CK expression. Niehans et al. Ν*, however, inter­
pret the atypical cell as CK positive. Initially, seminomas and dysgerminoma 
were decribed to express vimentin but not CKs, other than in sporadic cells, 
possibly representing syncytiotrophoblastic cells ^ 2 · 2 0 6 . More recently these 
germ cell tumors were found to react with CK antibodies showing limited tumor 
areas expressing CK8, CK18 and scanty CK19 »м™.гое.207( w n ¡ | e ¡n dysgermino-
ma CK7 is also observed 17Э. The occasional syncytiotrophoblastic cells in 
typical seminoma also express CK7 20e. Even sporadic CK4 or CK 17 positive 
cells have been observed in seminoma. Moreover, vimentin negative semino­
mas, and occasionally seminomas coexpressing several IFP types have recently 
been reported 9i20920t, These data are considered as suggestive for divergent 
types or transitional forms of seminoma. 
Recently, spermatocyte seminoma with scattered CK18 positive tumor cells, 
13B 
was reported β 1. 
In the group of nonseminoma, the embryonal cell carcinoma, choriocarcinoma 
and endodermal sinus tumor have been reported to stain extensively for CK8 
and CK 18. However, staining in embryonal cell carcinoma was weakly and 
formalin fixed tumors of this type easily loose their CK immunoreactivity 
9o.i73.203.2oe Additionally, CK 19 is expressed scarsely in embryonal cell carcino­
ma and strongly expressed in the latter two tumor types and CK7 is reported 
inconsistently »o·173·20·. Even some CKs4, 17 and some CK10 expression may be 
found in embryonal carcinoma and endodermal sinus tumor, indicating a potenti­
al for squamous epithelial differentiation M · 1 7 3 · 2 0 9 . individual scattered syn-
cytiotrophoblastic cells can be found to be CK7 positive ю· 2 0 8 . it is therefore 
surprising that CK7 is absent in a choriocarcinoma component w . Choriocarcino­
ma cell lines were, however, described to be CK7 positive 2 0 θ. Also of the 
placental syncytiotrophoblast only a typical subset of cells, i.e. at the main stem 
villi, stain for CK7 2 0 e. The more mature epithelial component in teratoma ex­
presses CKs according to their morphological type of differentiation 2 1 0 '2 1 1. 
THYMUS 
Epithelial cells of the normal thymus contain next to simple epithelium 
CKs, along with CKs characteristic of stratified epithelia 2 2 0 · 2 1 2 , while in ¡mmu-
nohistochemical studies the stratification related CK5 is found in reticulum cells 
24
, and also the simple epithelium CK20 is found in sporadic cells, mostly in the 
medulla 3. In Hassal's bodies СК1 has been immunostained by strongly reac­
ting mAbs (DA7 and DC10) 2 1 3 next to immunoreactivity for CK10. Different CK 
expression patterns are described in relation to the anatomic areas or in relation 
to hyperplasia of the thymus, such as in myasthenia gravis 2 1 4 - 2 1 β. in thymoma, 
even in those that are predominantly lymphocytic, a relatively high number of 
CK positive cells can be found u · 2 1 7 . in contrast, lymphomas involving the 
thymus will give negative results, except for foci of residual thymic tissue which 
may occasionally be found. 
THYROID 
The normal, nodular and neoplastic thyroid all three express CK8 and 
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CK18 to a similar extent. CK19, however is less extensively expressed, except 
in papillary and mixed papillary-follicular carcinoma, which both express CK19 
extensively г 1 в. In squamous areas CKs4, 13 and 10 can be found 2 , β · 2 1 β . Vimen­
tin coexpression is well known in the thyroid gland. This holds true for the neo­
plasms of which medullary carcinoma exhibits most limited vimentin expression 
108,220 
URINARY BLADDER 
In the early fetal renal pelvis the epithelial lining expresses CKs8, 18, 19 
and some CK7, but also some vimentin. In later developmental stages, vimentin 
expression decreases while CK7 levels increase еэ. Additionally, in the basal cell 
compartment of developing transitional epithelium CKs4, 5, 13 and 17 can be 
found *°аз. Juvenile ureter transitional epithelium has been mentioned to be 
uniformely CK 14 positive 2B, which is in contrast to the adult situation " . The 
superficial umbrella cells are strongly stained by CKs8, 18 and 20 reagents, 
while CK8 and CK 18 can furthermore also be demonstrated in basal and paraba­
sal cells, although only by a subgroup of mostly strongly staining mAbs 3 B 0 · 6 3 . in 
adult transitional epithelium, CK7 is homogeneously expressed in renal pelvis, 
ureter, and heterogeneously in the bladder lining M , even after use of strongly 
staining CK7 mAbs. 
In all grades of transitional cell carcinoma CK7, however, is homogeneously ex­
pressed (Figure 2) as long as squamoid differentiation is absentS1"53. During and 
tumor progression from noninvasive grade 1 to invasive grade 3 or metastasis, 
CK13 expression, typical for mature transitional epithelium, decreases conside­
rably and most high-grade cases are CK13 negative. In this respect transitional 
cell carcinoma resembles squamous cell carcinoma, which also looses CK13 
upon dedifferentiation. In a minority of cases of grade 3 transitional cell carcino­
ma CK13 can remain present Б 1 ' 5 3 · 7 4 . Surprisingly, in high grade transitional cell 
carcinoma CK20, which in normal urothelium is only present in the umbrella 
cells, is extensively expressed 64. During tumor progression several other CKs, 
such as CK 14 may become expressed, but these characteristics do not appear 
to have prognostic consequences В 1 Б 3. Squamous metaplasia in nonneoplastic 
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Figure 2. Metastasis of an unknown primary carcinoma in a axillary lymph node 
of a 47 year old male. (A) H&E stained paraffin section; (B) frozen section 
immunostained with a CK7 mAb (RCK105). Based on morphology, and a 
homogeneous and extensive positivity for CK7 we suggested the urinary bladder 
as the primary tumor site, which was confirmed in subsequent clinical analyses. 
Magnification (A) 400X, (B) 200X. 
urothelium and in transitional cell carcinoma displays CK expression patterns 
deviating from normal urothelium and from the classical transitional cell carcino-
ma pattern. This type of differentiation displays regular squamous characteris-
tics 5154221 , such as decreased expression of CK7, CK8, CK18 and CK20 and 
increased levels of CK4, CK13, CK14 and CK17. 
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UTERINE CERVIX 
The CK expression patterns of the diverse cell types at the cervical 
squamo-columnar junction and of these cell types during changes from basal 
cell hyperplasia, through (immature) squamous metaplasia and different stages 
of cervical intra-epithelial neoplasia (CIN), upto squamous cell carcinoma and 
adenocarcinoma, are extensively described 2 3- в Б ·7 7 ·1 7 1. The most important 
features are described in relation to the endocervical reserve cells, which are 
shown to express a complex mixture of basal cell or stratification related CKs 
and several simple epithelial CKs. These reserve cells express extensively CKs8, 
14, 15, 16, 17, 18 and 19, and to a lesser degree CKs5, 6 and 7 (Figure 3). 
t 
в 
. 
Figure 3. Frozen sections of a squamous cell carcinoma (A) and an adenocarci­
noma (B) of the uterine cervix immunostained using a CK5 mAb (AE14) sho­
wing positivity in (A) and no reaction in (B). Magnification (A) 400X, (В) 200X 
(courtesy: Dr. Frank Smedts, Delft, The Netherlands) 
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Some of the endocervical columnar cells may express basal cell or stratification 
related CKs, along with the simple epithelial CKs. The CK pattern in squamous 
metaplasia is more or less as can be expected from its type of morphological 
differentiation, but CK16 which is mostly not expressed, may in some cases be 
extensively present. In dysplasia or CIN, CK4 and CK13 expression decreases, 
in particular in CIN III, but some expression remains. Other stratification related 
CKs remain extensively present, except for CK17. The expression of simple epi­
thelial CK8 and CK18 and of CK17 increases considerably with increased 
severity of CIN. Approximately 10% of CIN I and CIN II lesions display this 
combination, while in CIN III, 50% of lesions contain this CK set. This has 
induced the hypothesis that expression of CK17 along with CK8 and CK18 may 
be a prognosticator of progression. In CIN III even some CK7 can be found in 
basal and parabasal cells. This pattern is continued in squamous cell carcinoma 
with an additional variable expression of CK17 depending on tumor type. In 
squamous cell carcinoma of the cervix the keratinized variant displays lower 
levels of CK8 and CK18 than the nonkeratinized type. The absence of CK15 in 
half of the nonkeratinized squamous cell carcinomas is remarkable since this CK 
has been related to a squamoid type of epithelial differentiation 2e-34. In cervical 
adenocarcinoma significant levels of CKs7, 8, 14, 17, 18 and 19 and sporadic 
expression of CKs4, 5, 6, 10, 13, 16 and even CK20 are found. 
VULVA 
In early stages of vulvar squamous cell carcinoma CK 10 is reported to be 
rarely detectable, regardless of tumor grade, while it is demonstrated in many 
advanced stage tumors 222. A CK10 negative reaction was suggested to be 
related to tumor relapse of vulvar squamous cell carcinoma "3. Relatively little 
CK8 and CK18 is reported in these carcinomas, as compared to the mucosal 
squamous cell carcinomas β7-7β. At the stroma-tumor interface significant 
vimentin expression can be observed in the carcinoma cells 79. 
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PRACTICAL APPLICATION OF CYTOKERATIN IMMUNOCHEMISTRY 
CK reagents are used most frequently to distinguish epithelial from nonepithelial 
cells, despite the awareness that CK expression may occur also in nonepithelial 
tissues (see Table 2). In general, CK immunohistochemistry will be used in 
diverse areas which will demand different types of CK reagents. Some general 
remarks in this respect are useful for a better understanding of the practical 
applications. 
1/- Strongly reacting CK antibodies with broad specificity are useful in the 
distinction of epithelial and mesenchymal cells or to detect sporadic epithelial 
tumor cells in a mesenchymal background. 
21- MAbs, recognizing formalin fixed and paraffin embedded CK epitopes or CKs 
subjected to other types of tissue processing techniques, are a prerequesite for 
full employment of CKs as markers in routine surgical pathology. 
3/- Monospecific CK rnAbs recognize one type of CK, some of which mark a 
certain epithelial differentiation pathway, and may therefore reveal the primary 
site of a carcinoma. 
4/- Strongly immunoreacting, but differentiation type specific mAbs are useful 
to distinguish different types of epithelial cells. For example, basal or stratified 
epithelial cells can be recognized separately from luminal or glandular type of 
differentiation in the differential diagnosis of adenocarcinoma versus nonmalig-
nant ductal structures. 
5/- Certain CK mAbs detect only specific CK configurations. Conformation 
dependent reactivity of such mAbs has been shown to be useful in the detecti-
on of apparent structural changes in the epithelial cytoskeleton. These may then 
correlate to the functional status of the cell 6°-62·79. 
It is stressed that certain monospecific CK mAbs still show broad tissue 
reactivity patterns because of the presence of the target CK in many tissues, 
which is for example the case for CK8. Of the broadly cross-reacting mAbs, 
which are shown to interact with more than one CK in immunoblotting, several 
are known to stain strongly only with a few of these CKs when applied to 
tissue sections, and react only weakly or not at all with the others. This limits 
the use of these mAbs as pan-epithelial reagents. A cocktail of different mAbs 
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can, however, help to increase CK detection or staining levels u · 2 2 * " 6 . Thus, it 
will be important to specify the different reactivity levels of mAbs or cocktails 
of mAbs with the individual CKs. This should not only be the case in scientific 
publications, but also in data sheets or manifacturers instructions of commer-
cially available mAbs. When comparing CK reagents to other "epithelium speci-
fic" markers, the former show in general a relatively high sensitivity as well as 
high specificity 1«·"«·»··»7. 
Applications in histopathology 
Consequent to the considerations described above, several applications of CK 
subtype specific mAbs in diagnostic histopathology can be anticipated. The 
main field of interest is in the differential diagnosis of tumors, with use in dis-
tinction between epithelial and non-epithelial type of differentiation. Moreover, 
some monospecific CK antibodies have already proven their usefulness in the 
distinction of different types of carcinoma, and it is to be expected that several 
of the newly developed CK reagents will further expand these possibilities. 
In the differential diagnosis of adenocarcinoma, detection of CK subtypes can 
be most helpful. For example, "Müllerian" derived carcinomas of the female 
genital tract show CK7 expression, while colonic carcinoma does not express 
significant levels of this protein. Gastric cancer may show CK7 only in some 
cases. On the contrary, CK20 can be detected in both gastro-intestinal tumors 
(albeit only in a part of gastric cancers) and is virtually absent in the non-
mucinous ovarian carcinomas and in endometrium carcinoma З Б 4 8 в. in male, the 
main CK7 positive carcinomas are transitional cell carcinoma (Figure 2) and non-
squamous, nonsmall cell pulmonary carcinomas 78. CK20 is frequently found in 
transitional cell carcinoma (without squamous differentiation) but is not signifi­
cantly present in pulmonary carcinoma ". 
The presence of basal cell or stratification related CKs may be helpful in the 
differential diagnosis of adenocarcinoma. Especially CK5 is consistently, alt­
hough limited, expressed in endometrial carcinoma (glandular structures inclu­
ded), distinguishing this "Müllerian" derived carcinoma from carcinoma of colon, 
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stomach, breast and kidney 2 4 M . CK4 in "Mullerian" carcinoma may also add 
some weight in discriminating these tumors from others although certain adeno­
carcinomas, such as pancreas and lung, occasionally express CK4 and or CK5, 
corresponding to their generally known potential for focal squamous differenti­
ation 2 4 M W . Clear cell carcinoma of ovary and endometrium can not be 
discriminated from renal cell carcinoma on basis on intermediate filament 
expression. Another basal cell marker, CK 14, has been shown to be consis­
tently expressed in pulmonary squamous cell carcinoma, also in the poorly 
differentiated subtype. Taken together with the observation that adenocarcino­
ma and large cell undifferentiated carcinoma of the lung express CK7 in signifi­
cant amounts, the data presented sofar 3β-7β indicate that a clear distinction 
between small cell anaplastic carcinoma of the lung, which contains almost 
exclusively CK8 and CK18 and nonsmall cell carcinoma, can be made. 
Next to these major areas of application these antibodies are applicable to 
specific cases. For example, CK reagents can facilitate and increase the detec­
tion rate of (micro)metastases in lymph nodes and bone marrow, but the clinical 
significance of the detection of micrometastases is disputed 228-230. Furthermore, 
in the absence of chorionic villi one can make a diagnosis of intrauterine 
pregnancy in abortion material or curettage by demonstration the CK positive 
intermediate trophoblast lying in-between the CK negative decidual cells 2 3\ In 
prostatic tissue, basal cell related or stratified CK mAbs are used in the differen­
tial diagnosis between adenocarcinoma versus atypical nonmalignant lesions, 
also after radiotherapy. The group of benign lesions more or less contain the 
basal cell layer, which can be stained with these CK mAbs 232"23\ Especially in 
needle biopsies caution is requested in the interpretation of this application of 
CK immunohistochemistry, because of sampling errors or rare deviating carcino­
ma subtypes 18e. 
Application in cytopathology 
The use of immunocytochemical procedures in cytopathology is slowly beco­
ming more widely acccepted. Different preparation techniques can be employed, 
including cytocentrifugation and fixation techniques 1β, or even paraffin-embed-
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ding of cell pellets 2 2 5 · 2 3 5 , special sedimentation and fixation techniques 1 β, and 
application of immmunocytochemistry to routinely-fixed and Papanicolaou stai­
ned smears 2 3 e · 2 3 7 . 
Figure 4. Cytological smears of ascites, previously Papanicolaou stained, and 
thereafter immunostained for CK7 using mAb OVTL12/30. The ovarian carcino­
ma cells are positive (A, clusters), while mesothelial cells (A, single cells) are 
negative in this specific procedure. Colonic carcinoma cells are CK7 negative 
(B). Magnif icat ion 1000X (courtesy: Dr. Frank Smedts, Delft, The Netherlands) 
Typical differential diagnostic problems in cytopathology concern the distinction 
of (atypical) mesothelial cells from malignant cells, in most cases adenocarcino­
ma on the one hand, and on the other the classification of the primary location 
of the adenocarcinoma. In this respect, CK7 is a useful marker. Recently, a mAb 
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to CK7, reactive in paraffin embedded tissues M , has also been shown to 
immunoreact in Papanicolaou stained slides 237. As in histopathology 7 8 8 3, this 
reagent (OVTL12/30) discriminates between different types of adenocarcinoma, 
but additionally separates mesothelial cells and mesothelioma (which do not 
stain with this mAb in this technique) from several CK7 positive adenocarcino­
mas (Figure 4) " 7 . This is surprising, since in fresh frozen sections the mAb 
reacts with mesothelial cells, including mesothelioma. Apparently, fixation and 
other steps in the staining process destroy or mask their epitope for CK7, recog­
nized by this mAb. 
For most of the questions in cytopathology, the rules described above for 
histopathology can be in general be applied 1β·23β·239. it should be kept in mind 
when evaluating IFP in cytological preparations that vimentin coexpression may 
be an even more common phenomenon in effusions than expected on the basis 
of histopathological data 1β. 
Other applications of cytokeratin antibodies 
Other possible applications of antibodies to CKs in medical diagnosis include the 
detection of extracellular CK in serum or body fluids. Such assays have been 
described for CK8 or CK18 in serum or urine, monitoring transitional cell 
carcinoma or different types of adenocarcinoma 24°-242. Antibodies to tissue 
polypeptide antigen (TPA) have been used extensively in serum assays for 
monitoring tumors. The antigens recognized by these antibodies have now been 
identified as CK8 and possibly also CK18 and CK19 2 4 3 · 2 4 * 
Flow cytometry of cell suspensions of tumors has proven to be a useful 
technique in the estimation and quantification of various cell components. These 
estimations may however, be severely impaired because of mixed cell populati­
ons found in such tumor cell suspensions. By staining cells for CK the epithelial 
and mesenchymal cell populations may be distinguished, enhancing specificity 
or sensitivity for the target cell population. The application of CK and vimentin 
reagents in the flow cytometric analysis of body cavity effusions reveals that 
this type of assay significantly increase the level of tumor cell detection 1 β · 2 4 6 . 
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Conclusions: Insight in CK expression patterns of diverse types of normal and 
malignant epithelial tissue is still increasing. The number of monospecific CK 
mAbs is gradually increasing, as is the availability of such mAbs suitable for 
application in formalin fixed tissue. Further exploration of their usefulness on 
large panels of cancer lesions is, however, still needed in order to improve their 
reliability for clinicopathological purposes. A possible prognostic significance of 
certain CK expression patterns now emerges 79.99.1 бз.іБв.223
 a n c j m a v ¡n t n e f u t u r e 
turn out to be relevant. Studies on biological processes in which CKs are invol-
ved will enhance our understanding and applicability of these intriguing cytoske-
letal proteins. 
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Summary 
This thesis focusses on the exploration of immunohistologically determined 
expression patterns of cytokeratin (CK) subtypes in human transitional cell 
tumors of the urinary tract. Transitional cell tumors cover a spectrum from a 
noninvasive transitional cell papilloma, without anaplastic cell changes and with 
a favourable prognosis on the one hand, to invasive, highly anaplastic and 
metastasizing carcinoma with a poor prognosis on the other hand. 
Our main interest was to explore the CK expression patterns in relation to the 
progression stage of transitional cell carcinoma lesions and to evaluate the 
biological or clinical significance of aberrating CK expression patterns found in 
the neoplasm as compared to the normal transitional epithelium. 
In Chapter 1 a short introduction is given concerning the general proper-
ties of the cytoskeletal proteins of which CKs form a subgroup. The aims, 
rationale and global approaches of the studies are also mentioned briefly. 
The CK expression patterns in normal urothelium are described in Chapter 
2, as a basis for the subsequent studies of the tumor lesions. One of our 
observation is that staining patterns of CK8 and CK 18 are antibody dependent, 
related to masking of certain epitopes. The difference in CK7 expression 
between the transitional epithelium of the upper and the lower urinary tract was 
also striking. For this phenomenon no plausible explanation could be provided 
sofar. Certain differentiation specific CKs, such as CK13, showed a cell type 
restricted expression pattern. 
In Chapter 3 the CK expression patterns are described in relation to 
progression of transitional cell carcinoma. CK8 and CK18 detectability was 
increased in the invasive tumor component and especially in the cells at the 
periphery of the invasive cell clusters. This phenomenon was observed using 
certain antibodies of the anti-CK8 and CK18 panel. We speculate on the 
biological significance of this phenomenon in relation to invasive growth and 
about the phenotype of potentially metatastic cells. Expression of the differen-
tiation related CK13 decreased in high grade and stage transitional cell carcino-
ma. Variable, aberrant expression of CK14 appeared in these carcinomas. In 
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high grade tumors squamoid differentiation was accompanied by loss of CKs 
normally present in transitional cell carcinoma. Especially the finding of loss of 
CK7 has practical consequences, because it is used in surgical pathology as a 
marker for transitional cell differentiation. 
The concept that increased detectability of CK8 and CK 18 might indicate 
a potentially metastatic phenotype was challenged in the study (Chapter 4) on 
transitional cell carcinomas and autologous metastases. It appeared that the 
metastases showed the same CK staining patterns as the original high grade 
bladder tumors, without a predominance of cells with increased СК and CK18 
staining. However, the possibility of a transiently increased exposure of CK8 
and CK18 epitopes during the actual proces of tumor cell spread could not be 
explored in our studies. In the invasion front of metastases we observed, 
otherwise, a similarly increased detectability of these two CKs as seen in the 
original bladder tumors. These findings are suggestive for a role of the CK 
cytoskeleton in tumor invasion of transitional cell carcinoma. 
In Chapter 5 we tested whether this phenomenon was restricted to 
transitional cell carcinoma or could be found also in another type of carcinoma. 
Similar staining patterns for CK8 and CK 18 in the invasion front and/or in the 
interface between tumor cells and stroma were observed in mucosal squamous 
cell carcinomas. In squamous cell carcinoma, also an increased vimentin expres­
sion was observed, although a direct topological relation between vimentin and 
the two CKs was not found. Our immunohistochemical findings, suggesting on 
a role of CK8 and CK18 in invasion or metastatic potential of tumor cells are in 
line with those obtained by other groups 1·2. 
In Chapter 6 we reviewed the most relevant literature on CK immunohis-
tochemistry in general and CK subtyping in human tissues in particular. Empha­
sis was put on the use of CK antibodies in surgical pathology. In addition, a 
detailed survey on the CK distribution in normal tissues and carcinomas was 
given. This survey showed particular patterns of CK expression that, according 
to the present views, are mainly differentiation related. However, CK expression 
in tumors may quite often not represent the pattern expected on basis of the 
distribution pattern seen in the corresponding normal tissue. For some types of 
carcinomas, such as breast cancer and Grawitz tumor, consistent relations have 
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been found between the prognosis of the disease and the type of IFP expressi-
on. 
In conclusion, our immunohistochemical studies on CK subtyping demonstrate 
that: 
1- In normal urothelium, CK expression is generally related to morphologically 
observed differentiation patterns, although in anatomical transition zones 
between different types of epithelium changes in the CK expression pattern can 
preceed morphological alteration. Furthermore, heterogeneity without a morpho-
logical substrate can be found, such as for CK7 expression, which is patchy in 
the bladder and homogeneous in the upper urinary tract. 
2- In the low grade malignant transitional cell neoplasms, the CK expression 
seen in the normal transitional epithelium is largely retained. However, expressi-
on of the differentiation related CK13 may be decreased. 
3- With progression of transitional cell carcinoma CK expression diverges from 
the nonneoplastic transitional epithelium by loss of some original CKs, e.g. 
especially of CK13 and to a lesser extent of CK7, 8 or 18. Also an increased 
expression or neo-expression of several other CKs, e.g. CK4, 10, 14, 16, and 
17 is notable. Changes in CK8 and CK18 detectability show a topological relati-
on to areas of tumor invasion and changes in the expression of the other CKs 
are mainly related to differentiation type or grade of anaplasia. 
4- Invasiveness of transitional cell carcinoma coincides with changes in the 
immunohistological detectability of CK8 and CK18. A basically similar phenome-
non is present in mucosal squamous cell carcinoma. 
5- Monoclonal antibodies, recognizing different epitopes of the same CK 
subtype, can yield different immunohistochemical staining patterns, which may 
confuse the interpretation of staining patterns. However, the underlying process 
of epitope masking/unmasking has probably biological significance. 
6- Bearing in mind the limitations due to aberrant expression patterns, CK 
subtypes can be used in surgical pathology as an aid in tracing the original site 
of carcinomas or in determining the precise direction of differentiation. Examples 
include the differential diagnosis of types of pulmonary neoplasms and the 
discrimination of intestinal adenocarcinoma from other types of adenocarcino-
ma. 
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Samenvatting 
Dit proefschrift richt zich op het onderzoeken van immuunhistologisch bepaalde 
expressiepatronen van cytokeratine (CK) subtypes in humane overgangscelcarci-
nomen van de urinewegen. Overgangsceltumoren beslaan een spectrum 
waarvan de ene zijde begrensd wordt door het niet-invasieve overgangscelpapil-
loom, zonder anaplastische celveranderingen en met een gunstige prognose, en 
de andere zijde door het invasieve, sterk anaplastische en metastaserende 
carcinoom met een slechte prognose. 
Ons hoofddoel is het zoeken naar CK expressiepatronen in relatie tot stadia van 
progressie van overgangscelcarcinoom alsmede het biologische of klinische 
belang schatten van CK expressiepatronen in het neoplasma, die afwijken van 
het normale overgangsepitheel. 
In Hoofdstuk Τ wordt een korte inleiding gegeven over de algemene 
eigenschappen van cytoskeleteiwitten waarvan CKs een subgroep zijn. De 
doelstellingen, overwegingen en globale benadering worden ook kort genoemd. 
De CK expressiepatronen in normaal urotheel worden beschreven in 
Hoofdstuk 2 en dienen als basis voor de vervolgstudies betreffende de tumoren. 
Een van onze waarnemingen is dat aankleuringspatronen van CK8 en CK18 
antilichaam afhankelijk zijn, hetgeen gerelateerd is aan maskering van bepaalde 
epitopen. Het verschil in expressie van CK7 tussen het overgangsepitheel van 
de hogere urinewegen en dat van de lagere is ook opmerkelijk. Wij kunnen tot 
nog toe hier geen plausibele verklaring voor geven. Bepaalde differentiatie 
specifieke CKs, zoals CK13, tonen een celtype bepaald expressiepatroon. 
In Hoofdstuk 3 worden de CK-expressiepatronen beschreven gerelateerd 
aan progressie van het overgangscelcarcinoom. In het tumorinvasiefront en 
vooral in de cellen die aan de rand van de invaderende celclusters liggen, 
kunnen wij immuunhistologisch CK8 en CK18 gemakkelijker en/of vaker vinden. 
Dit fenomeen wordt waargenomen doordat wij gebruik maken van bepaalde 
antilichamen behorend tot het anti-CK8 en CK18 panel. Wij speculeren over het 
biologische belang van dit fenomeen in relatie tot invasieve groei en over het 
fenotype van potentieel metastaserende cellen. Expressie van het differentiatie 
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gerelateerde CK13 neemt af in het overgangscelcarcinoom van hoge graad en 
stadium. In deze carcinomen blijkt sprake te zijn van variabele, onverwachte 
expressie van CK14. In hooggradige tumoren gaat plaveiselcellige differentiatie 
gepaard met een verlies aan CKs, die normaliter aanwezig zijn in overgangscel-
carcinoom. Vooral het verlies van CK7 heeft practische gevolgen, omdat dit CK 
in de diagnostiek als een marker voor overgangsceldifferentiatie gebruikt wordt 
door de patholoog. 
Het concept dat een verhoogde mogelijkheid om CK8 en CK18 te 
signaleren zou kunnen duiden op een in potentie metastaserend fenotype, wordt 
beproefd in de studie van overgangscelcarcinomen en autologe metastasen 
(Hoofdstuk 4). Het blijkt dat de metastasen hetzelfde CK expressiepatroon 
hebben als de oorspronkelijke blaastumoren, zonder dat het aantal CK8 en CK18 
aankleurende cellen is toegenomen. De mogelijkheid van voorbijgaande verhoog-
de expressie van CK8 en CK 18 epitopen tijdens het ware moment van tumorcel-
uitzaaiing kan echter niet bekeken worden in onze studies. Aan de andere kant 
zien wij in het invasiefront van metastasen een gelijksoortige verhoogde 
herkenning van deze twee CKs, net als in de blaastumoren zelf. Deze bevindin-
gen zijn suggestief voor een rol van het CK cytoskelet bij tumorinvasie van 
overgangscelcarcinoom. 
In Hoofdstuk 5 testen wij uit of dit fenomeen beperkt blijft tot overgangs-
celcarcinoom of dat het ook in een ander type carcinoom gevonden kan worden. 
Gelijksoortige kleuringspatronen voor CK8 en CK 18 in het invasiefront en/of in 
het raakvlak tussen tumorcellen en stroma worden gezien in plaveiselcelcarci-
noom van slijmvliezen. Bij plaveiselcelcarcinoom wordt ook nog verhoogde 
expressie van vimentine gevonden, hoewel een direct topologisch verband 
tussen vimentine en de beide CKs niet wordt gevonden. Onze immuunhistoche-
mische bevindingen, die suggestief zijn voor een rol van CK8 en CK18 bij 
invasie of metastaserend vermogen van tumorcellen, passen bij die welke 
verkregen zijn door anderen 12. 
In Hoofdstuk 6 geven we een overzicht van de meest relevante literatuur 
over CK immuunhistochemie in het algemeen en CK subtypering in humane 
weefsels in het bijzonder. Nadruk wordt gelegd op het gebruik van CK antilicha-
men in diagnostische pathologie. Voorts wordt een gedetailleerd overzicht 
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gegeven van de CK distributie in normale weefsels en carcinomen. Het blijkt dat 
CK expressie patronen, volgens de huidige opvattingen, voornamelijk gerelateerd 
zijn aan differentiatie. Het kan echter nog al eens voorkomen dat de CK expres-
sie in tumoren niet overeenkomt met het patroon zoals dat verwacht wordt op 
basis van de verdeling in het corresponderende normale weefsel. Voor enkele 
typen carcinoom, zoals bijvoorbeels borstkanker en de Grawitz tumor, wordt een 
relatie gevonden tussen prognose en het type IFP expressie. 
Concluderend, tonen onze immuunhistochemiuche studies het volgende aan: 
1- In normaal urotheel, is de CK expressie in het algemeen gerelateerd aan 
morfologisch herkenbare differentiatiepatronen, hoewel in anatomische over-
gangsgebieden tussen verschillende typen epitheel reeds verschuivingen 
optreden voorafgaand aan de morfologische veranderingen. Bovendien kan 
heterogeniteit gevonden worden zonder morfologisch substraat, zoals bijvoor-
beeld het geval is voor CK7 dat vlekkerige expressie heeft in de blaas en 
homogene expressie in de hogere urinewegen. 
2- In laaggradige overgangsceltumoren, komt de expressie van CKs overeen met 
die in normaal overgangsepitheel. De expressie van het aan differentiatie 
gerelateerde CK13 kan echter reeds afgenomen zijn. 
3- Bij progressie van overgangscelcarcinoom wijkt de CK expressie verder af van 
die in niet-neoplastisch overgangsepitheel door het verloren gaan van oorspron-
kelijke CKs, met name CK13 en in mindere mate CK7, 8 of 18. Toegenomen 
expressie of neo-expressie van verscheidene andere CKs, zoals CK4, 10, 14, 16 
en 17 is vermeldenswaardig. Veranderingen in de traceerbaarheid van CK8 en 
CK18 tonen een topologische relatie met gebieden van invasieve tumorgroeï. 
Veranderingen in de expressie van andere CKs zijn merendeels gerelateerd aan 
de differentiatierichting of mate van anaplasie. 
4- Monoclonale antilichamen, die verschillende epitopen herkennen van hetzelf-
de CK subtype, kunnen verschillende immuunhistochemische kleuringspatronen 
opleveren, waardoor verwarring kan optreden bij de interpretatie van aankleu-
ringspatronen. Het onderliggende mechanisme van epitope maskering/demaske-
ring is waarschijnlijk echter biologisch gezien van waarde. 
6- CK subtypes kunnen gebruikt worden in diagnostische pathologie als hulp-
181 
middelen bij het vinden van de primaire haard van carcinomen of in het bepalen 
van de differentiatierichting, maar men moet beducht blijven voor de beperkin­
gen als gevolg van afwijkende expressie. Voorbeelden zijn de differentiaal 
diagnose bij de hoofdtypen van longtumoren en het onderscheiden van intesti­
naal adenocarcinoom van andere typen adenocarcinoom. 
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STELLINGEN 
1- De gelokaliseerde expressie van cytokeratines 8 en 18 speelt een rol bij het 
proces van invasieve groei van het overgangscelcarcinoom van de urinewegen 
en van het plaveiselcelcarcinoom. 
(dit proefschrift) 
2- Bij de interpretatie van immuunhistochemisch bepaalde expressie van 
cytokeratines dient rekening gehouden te worden met verandering in epitoop-
configuratie. Dit maskeringsfenomeen kan ondervangen of onderkend worden 
door toepassing van meerdere monoclonale antistoffen tegen hetzelfde antigeen. 
(dit proefschrift) 
3- Voor het verschil in expressie van cytokeratine 7 tussen het urotheel van de 
urineblaas en dat van de hogere urinewegen bestaat geen afdoende weten-
schappelijke verklaring. 
(dit proefschrift) 
4- Morfologische waarneming aan ziekteprocessen behoort niet zelfstandig door 
goedwillende medisch-biologische onderzoekers te worden verricht, maar 
behoort door een professional, in casu de patholoog, te worden gesuperviseerd. 
5- Cytokeratine-subtypes dienen primair aangeduid te worden volgens de door 
Moll beschreven nummering. 
(Moll et al.. Cell 1982, 31:11-24) 
6- Met het oog op efficiente bedrijfsvoering, opleiding en kwaliteitseisen is het 
opportuun om te streven naar een combinatie van analist/obductie-assistent en 
niet voort te borduren op de oude combinatie van mortuariummedewerker/ob-
ductie-assistent of zelfs op de full-time obductie-assistent. 
7- De WHO-gradering voor het oppervlakkige blaascarcinoom kan niet zonder 
meer worden toegepast in gevallen van diep-invasieve blaascarcinoom. 
8- De patholoog die prostaatweefsel beoordeelt dient op de hoogte te zijn van 
de morfologische beelden van prostaatcarcinoom, die het gevolg zijn van vooraf-
gaande behandeling d.m.v. medicamenteuze "totale androgene deprivatie", te 
weten een sterke tumorcelatrofie. Bovendien dient deze er bij vriescoupe-
onderzoek tijdens prostatectomie door de chirurg nadrukkelijk op attent gemaakt 
te worden of deze behandeling heeft plaats gevonden. 
9- In de opleiding tot klinisch werkzaam patholoog dient binnen de bestaande 
opleidingsduur meer tijd ingeruimd te worden voor de cytologie. Deze wordt 
verkregen door een reductie in de tijd die nu door de arts-assistent in opleiding 
aan de obducties wordt besteed. 
10- De positie van de wedstrijdroeier in het schip, te weten met zijn gezicht in 
de richting van het zog, versterkt de satisfactie bij een winnende race, zeker 
wanneer reeds kort na de start een voorsprong is genomen. 
11- Om hinder veroorzaakt door honden en hun begeleiders in te perken, 
verdient het overweging de viervoeters op de openbare weg aan de voorzijde te 
voorzien van een muilkorf en aan de achterzijde van een vuilkorf. 
Stellingen behorend bij het proefschrift "Cytokeratins in bladder cancer: an 
immunohistochemical study on features of tumor progression" 
Nijmegen, 27 mei 1993, H.E.Schaafsma 


